0001437749-13-005499.txt : 20130508 0001437749-13-005499.hdr.sgml : 20130508 20130508160111 ACCESSION NUMBER: 0001437749-13-005499 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20130331 FILED AS OF DATE: 20130508 DATE AS OF CHANGE: 20130508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATURAL HEALTH TRENDS CORP CENTRAL INDEX KEY: 0000912061 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MISCELLANEOUS NONDURABLE GOODS [5190] IRS NUMBER: 592705336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-26272 FILM NUMBER: 13824449 BUSINESS ADDRESS: STREET 1: 2603 OAK LAWN AVE. STREET 2: FIFTH FLOOR CITY: DALLAS STATE: TX ZIP: 75219 BUSINESS PHONE: 972-241-4080 MAIL ADDRESS: STREET 1: 2603 OAK LAWN AVE. STREET 2: FIFTH FLOOR CITY: DALLAS STATE: TX ZIP: 75219 10-Q 1 nhtc_10q-033113.htm FORM 10-Q nhtc_10q-033113.htm


UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)
þ
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2013
 
OR
 
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from ____­__ to _______
 
Commission File Number: 0-26272
 
NATURAL HEALTH TRENDS CORP.
(Exact name of registrant as specified in its charter)
 
Delaware
59-2705336
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)
 
4514 Cole Avenue
Suite 1400
Dallas, Texas  75205
(Address of principal executive offices, including zip code)
 
Registrant’s telephone number, including area code:  (972) 241-4080

Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ  No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for shorter period that the registrant was required to submit and post such files). Yes þ  No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):
 
  Large accelerated filer ¨    Accelerated filer ¨
  Non-accelerated  filer  ¨       Smaller reporting company þ
                                                                                                                                          
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No þ
 
At April 30, 2013, the number of shares outstanding of the registrant’s common stock was 11,335,276 shares.



 
 

 
 
NATURAL HEALTH TRENDS CORP.
Quarterly Report on Form 10-Q
March 31, 2013
 
INDEX
 
   
Page
PART I – FINANCIAL INFORMATION  
Item 1.
Financial Statements
1
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
10
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
15
Item 4.
Controls and Procedures
15
     
PART II – OTHER INFORMATION  
Item 1.
Legal Proceedings
16
Item 1A.
Risk Factors
16
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
16
Item 3.
Defaults Upon Senior Securities
17
Item 4.
Mine Safety Disclosures
17
Item 5.
Other Information
17
Item 6.
Exhibits
17
     
Signatures
18
 

 
 

 
 
FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q, in particular “Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operation,” includes “forward-looking statements” within the meaning of section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).  When used in this report, the words or phrases “will likely result,” “expect,” “intend,” “will continue,” “anticipate,” “estimate,” “project,” “believe” and similar expressions are intended to identify “forward-looking statements” within the meaning of the Exchange Act.  These statements represent our expectations or beliefs concerning, among other things, future revenue, earnings, growth strategies, new products and initiatives, future operations and operating results, and future business and market opportunities.

Forward-looking statements in this report speak only as of the date hereof, and forward looking statements in documents incorporated by reference speak only as of the date of those documents.  We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.  We caution and advise readers that these statements are based on certain assumptions that may not be realized and involve risks and uncertainties that could cause actual results to differ materially from the expectations and beliefs contained herein.

For a summary of certain risks related to our business, see “Item 1A.  Risk Factors” in our most recent Annual Report on Form 10-K, which include the following:

 
·
We may experience substantial negative cash flows, which may have a significant adverse effect on our business and could threaten our solvency;
 
·
If we experience negative cash flows, we may need to seek additional debt or equity financing, which may not be available on acceptable terms or at all.  If available, it could have a highly dilutive effect on the holdings of existing stockholders;
 
·
We could be adversely affected by management changes or an inability to attract and retain key management, directors and consultants;
 
·
Because our Hong Kong operations account for a majority of our overall business, and most of our Hong Kong business is derived from the sale of products to members in China, any material adverse change in our business relating to either Hong Kong or China would likely have a material adverse impact on our overall business;
 
·
Our failure to maintain and expand our distributor relationships could adversely affect our business;
 
·
The high level of competition in our industry could adversely affect our business;
 
·
An increase in the amount of compensation paid to distributors would reduce profitability;
 
·
Failure of new products to gain distributor and market acceptance could harm our business;
 
·
Direct-selling laws and regulations may prohibit or severely restrict our direct sales efforts and cause our revenue and profitability to decline, and regulators could adopt new regulations that harm our business;
 
·
Challenges by third parties to the form of our business model could harm our business;
 
·
Our products and related activities are subject to extensive government regulation, which could delay, limit or prevent the sale of some of our products in some markets; 
 
·
New regulations governing the marketing and sale of nutritional supplements could harm our business;
 
·
Regulations governing the production and marketing of our personal care products could harm our business;
 
·
If we are found not to be in compliance with good manufacturing practices our operations could be harmed;
 
·
Failure to comply with domestic and foreign laws and regulations governing product claims and advertising could harm our business;
 
·
Although our distributors are independent contractors, improper distributor actions that violate laws or regulations could harm our business;
 
·
Adverse publicity associated with our products, ingredients or network marketing program, or those of similar companies, could harm our financial condition and operating results;
 
·
We have a limited product line;
 
·
We rely on a limited number of independent third parties to manufacture and supply our products;
 
·
Growth may be impeded by the political and economic risks of entering and operating foreign markets;
 
·
Currency exchange rate fluctuations could lower our revenue and net income;
 
·
Transfer pricing, duties and other tax regulations affect our business;
 
·
Failure to properly pay business taxes or customs duties, including those in China, could have a material adverse effect;
 
·
We may be held responsible for certain taxes or assessments relating to the activities of our distributors, which could harm our financial condition and operating results;
 
·
We may face litigation that could harm our business;
 
·
We may be unable to protect or use our intellectual property rights;
 
·
We do not have product liability insurance and product liability claims could hurt our business;
 
 
 

 
 
 
·
Our internal controls and accounting methods may require modification;
 
·
If we fail to achieve and maintain an effective system of internal controls in the future, we may not be able to accurately report our financial results or prevent fraud.  As a result, investors may lose confidence in our financial reporting;
 
·
We rely on and are subject to risks associated with our reliance upon information technology systems;
 
·
System failures and attacks could harm our business;
 
·
Terrorist attacks, cyber attacks, acts of war, epidemics or other communicable diseases or any other natural disasters may seriously harm our business;
 
·
Because our system, software and data reside on third-party servers, our access could be temporarily or permanently interrupted;
 
·
Disappointing quarterly revenue or operating results could cause the price of our common stock to fall;
 
·
Our common stock is particularly subject to volatility because of the industry in which we operate;
 
·
There is no assurance of an active public trading market;
 
·
The exercise of our warrants may result in substantial dilution and may depress the market price of our common stock;
 
·
Future sales by us or our existing stockholders could depress the market price of our common stock; and
 
·
Penny stock regulations are applicable to investment in our shares of common stock.
 
Additional factors that could cause actual results to differ materially from our forward-looking statements are set forth in this report, including under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in our financial statements and the related notes.

 
 
 

 
 
PART I – FINANCIAL INFORMATION
 
Item 1.              FINANCIAL STATEMENTS

NATURAL HEALTH TRENDS CORP.

CONSOLIDATED BALANCE SHEETS
(In Thousands, Except Share Data)

   
December 31, 2012
   
March 31, 2013
 
         
(Unaudited)
 
ASSETS
           
Current assets:
           
Cash and cash equivalents
    $4,207       $5,173  
Accounts receivable
    122       179  
Inventories, net
    867       888  
Other current assets
    641       406  
Total current assets
    5,837       6,646  
Property and equipment, net
    121       123  
Goodwill
    1,764       1,764  
Restricted cash
    239       231  
Other assets
    258       255  
Total assets
    $8,219       $9,019  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
                 
Current liabilities:
               
Accounts payable
    $1,385       $1,811  
Income taxes payable
    10       22  
Accrued distributor commissions
    1,308       1,512  
Other accrued expenses
    1,688       1,403  
Deferred revenue
    836       1,136  
Deferred tax liability
    92       92  
Other current liabilities
    991       856  
Total current liabilities
    6,310       6,832  
Commitments and contingencies
               
Stockholders’ equity:
               
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 1,761,900 shares designated Series A convertible preferred stock, 138,400 shares issued and outstanding at December 31, 2012 and March 31, 2013, aggregate liquidation value of $333
      124         124  
Common stock, $0.001 par value; 50,000,000 shares authorized; 11,324,048 and 11,323,369 shares issued and outstanding at December 31, 2012 and March 31, 2013, respectively
    11       11  
Additional paid-in capital
    80,584       80,603  
Accumulated deficit
    (78,708 )     (78,421 )
Accumulated other comprehensive loss:
               
Foreign currency translation adjustments
    (102 )     (130 )
Total stockholders’ equity
    1,909       2,187  
Total liabilities and stockholders’ equity
    $8,219       $9,019  

See accompanying notes to consolidated financial statements.
 
1

 
 
NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In Thousands, Except Per Share Data)

   
Three Months Ended March 31,
 
   
2012
   
2013
 
             
Net sales
    $9,090       $8,651  
Cost of sales
    2,399       2,228  
Gross profit
    6,691       6,423  
Operating expenses:
               
Distributor commissions
    3,691       3,674  
Selling, general and administrative expenses (including stock-based compensation expense of $20 and $30 during the three months ended March 31, 2012 and 2013, respectively)
    2,437       2,445  
Depreciation and amortization
    12       12  
Total operating expenses
    6,140       6,131  
Income from operations
    551       292  
Other income (expense), net
    (63 )     7  
Income before income taxes
    488       299  
Income tax provision (benefit)
    (19 )     12  
Net income
    507       287  
Preferred stock dividends
    (4 )     (4 )
Net income available to common stockholders
    $503       $283  
                 
Income per share:
               
Basic
    $0.05       $0.03  
Diluted
    $0.04       $0.03  
                 
Weighted-average number of shares outstanding:
               
Basic
    10,863       11,069  
Diluted
    11,181       11,248  

See accompanying notes to consolidated financial statements.

 
2

 
 
NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
(In Thousands)

   
Three Months Ended March 31,
 
   
2012
   
2013
 
             
Net income
    $507       $287  
Other comprehensive income (loss), net of tax:
               
Foreign currency translation adjustment
    51       (28 )
Comprehensive income
    $558       $259  

See accompanying notes to consolidated financial statements.
 
3

 
 
NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In Thousands)

   
Three Months Ended March 31,
 
   
2012
   
2013
 
             
CASH FLOWS FROM OPERATING ACTIVITIES:
           
Net income
    $507       $287  
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
    12       12  
Stock-based compensation
    20       30  
Changes in assets and liabilities:
               
Accounts receivable
    (240 )     (59 )
Inventories, net
    95       (28 )
Other current assets
    (102 )     232  
Other assets
    3       (2 )
Accounts payable
    (213 )     428  
Income taxes payable
    11       12  
Accrued distributor commissions
    78       215  
Other accrued expenses
    306       (279 )
Deferred revenue
    359       304  
Other current liabilities
    24       (134 )
Net cash provided by operating activities
    860       1,018  
                 
CASH FLOWS FROM INVESTING ACTIVITIES:
               
Purchases of property and equipment, net
    (18 )     (14 )
Decrease in restricted cash
    247        
Net cash provided by (used in) investing activities
    229       (14 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES
               
Repurchase of common stock
          (12 )
Net cash used in financing activities
          (12 )
 
               
Effect of exchange rates on cash and cash equivalents
    52       (26 )
Net increase in cash and cash equivalents
    1,141       966  
CASH AND CASH EQUIVALENTS, beginning of period
    1,617       4,207  
CASH AND CASH EQUIVALENTS, end of period
    $2,758       $5,173  

See accompanying notes to consolidated financial statements.
 
 
4

 
 
NATURAL HEALTH TRENDS CORP.
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
 
1.
NATURE OF OPERATIONS AND BASIS OF PRESENTATION
 
Nature of Operations

Natural Health Trends Corp. (the “Company”), a Delaware corporation, is an international direct-selling and e-commerce company headquartered in Dallas, Texas.  Subsidiaries controlled by the Company sell personal care, wellness, and “quality of life” products under the “NHT Global” brand.  In most markets, we sell our products to an independent member network that either uses the products themselves or resells them to consumers.

Our majority-owned subsidiaries have an active physical presence in the following markets:  North America; Greater China, which consists of Hong Kong, Taiwan and China; Russia; South Korea; Japan; and Europe, which consists of Italy and Slovenia.

Basis of Presentation

The unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  As a result, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.  In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial information for the interim periods presented.  The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year.  These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our 2012 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (SEC) on March 12, 2013.
 
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Principles of Consolidation
 
The consolidated financial statements include the accounts of the Company and all of its majority-owned subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period.

The most significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates associated with obsolete inventory and the fair value of acquired intangible assets, including goodwill, as well as those used in the determination of liabilities related to sales returns and income taxes.  Various assumptions and other factors prompt the determination of these significant estimates.  The process of determining significant estimates is fact specific and takes into account historical experience and current and expected economic conditions.  The actual results may differ materially and adversely from the Company’s estimates.  To the extent that there are material differences between the estimates and actual results, future results of operations will be affected.

 
5

 
Income Taxes

The Company recognizes income taxes under the liability method of accounting for income taxes.  Deferred income taxes are recognized for differences between the financial reporting and tax bases of assets and liabilities at enacted statutory tax rates in effect for the years in which the differences are expected to reverse.  Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized.  The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution.  The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense.  Deferred taxes are not provided on the portion of undistributed earnings of subsidiaries outside of the United States when these earnings are considered permanently reinvested. 

The Company and its subsidiaries file income tax returns in the United States, various states, and foreign jurisdictions.  The Company is no longer subject to U.S. federal income tax examinations for years prior to 2009, and is no longer subject to state income tax examinations for years prior to 2008.  No jurisdictions are currently examining any income tax returns of the Company or its subsidiaries.

Fair Value of Financial Instruments

The carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value because of their short maturities.  The carrying amount of the noncurrent restricted cash approximates fair value since, absent the restrictions, the underlying assets would be included in cash and cash equivalents.

Accounting standards permit companies, at their option, to choose to measure many financial instruments and certain other items at fair value.  The Company has elected to not fair value existing eligible items.

Revenue Recognition
 
Product sales are recorded when the products are shipped and title passes to independent distributors.  Product sales to distributors are made pursuant to a distributor agreement that provides for transfer of both title and risk of loss upon our delivery to the carrier that completes delivery to the distributors, which is commonly referred to as “F.O.B. Shipping Point.”  The Company primarily receives payment by credit card at the time distributors place orders.  Amounts received for unshipped product are recorded as deferred revenue.  The Company’s sales arrangements do not contain right of inspection or customer acceptance provisions other than general rights of return.

Actual product returns are recorded as a reduction to net sales.  The Company estimates and accrues a reserve for product returns based on its return policies and historical experience.

Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized over the term of the arrangement, generally twelve months.  Enrollment packages provide distributors access to both a personalized marketing website and a business management system.  No upfront costs are deferred as the amount is nominal.

Shipping charges billed to distributors are included in net sales.  Costs associated with shipments are included in cost of sales.

Various taxes on the sale of products and enrollment packages to distributors are collected by the Company as an agent and remitted to the respective taxing authority.  These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority.

Income Per Share

Basic income per share is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding during the period.  Diluted income per share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of non-vested restricted stock and shares that might be issued upon the exercise of outstanding warrants and the conversion of preferred stock.

The dilutive effect of non-vested restricted stock and warrants is reflected by application of the treasury stock method.  Under the treasury stock method, the amount of compensation cost for future service that the Company has not yet recognized and the amount of tax benefit that would be recorded in additional paid-in capital when the award becomes deductible are assumed to be used to repurchase shares.

 
6

 

The following tables illustrate the computation of basic and diluted income per share for the periods indicated (in thousands, except per share data):

   
Three Months Ended March 31,
 
   
2012
   
2013
 
   
Income
(Numerator)
   
Shares
(Denominator)
   
Per Share Amount
   
Income
(Numerator)
   
Shares
(Denominator)
   
Per Share Amount
 
Basic EPS:
                                   
Net income available to common stockholders
    $503       10,863       $0.05       $283       11,069       $0.03  
                                                 
Effect of dilutive securities:
                                               
Non-vested restricted stock
            318                       179          
                                                 
Diluted EPS:
                                               
Net income available to common stockholders plus assumed conversions
    $503       11,181       $0.04       $283       11,248       $0.03  

Certain non-vested restricted stock is anti-dilutive upon applying the treasury stock method since the amount of compensation cost for future service results in the hypothetical repurchase of shares exceeding the actual number of shares to be vested.  Other common stock equivalents are also anti-dilutive since the average market price of the related common stock for the period exceeds the exercise price.

The following securities were not included for the time periods indicated as their effect would have been anti-dilutive:

   
Three Months Ended March 31,
 
   
2012
   
2013
 
             
Warrants to purchase common stock
    3,704,854       3,704,854  
Non-vested restricted stock
          98,607  
Convertible preferred stock
    138,400       138,400  

Warrants to purchase 3,704,854 shares of common stock were still outstanding at March 31, 2013.  Such warrants have expirations through April 21, 2015.

Recently Issued and Adopted Accounting Pronouncements

In February 2013, the FASB issued Accounting Standards Update ("ASU") No. 2013-02, Comprehensive Income (Topic 220) —Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, to require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component.  In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items in net income but only if the amount reclassified is required under U.S. generally accepted accounting principles ("GAAP") to be reclassified to net income in its entirety in the same reporting period.  For other amounts that are not required under U.S. GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under U.S. GAAP that provide additional detail about those amounts.  ASU 2013-02 is effective prospectively for reporting periods, including interim periods, beginning after December 15, 2012.  The Company’s adoption of the standard on January 1, 2013 did not have a material impact on its consolidated financial statements.
 
In March 2013, the FASB issued ASU No. 2013-05, Foreign Currency Matters (Topic 830) —Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity, to clarify the guidance for entities that cease to hold a controlling financial interest in a subsidiary or group of assets within a foreign entity when (1) the subsidiary or group of assets is a nonprofit activity or a business (other than a sale of in substance real estate or conveyance of oil and gas mineral rights) and (2) there is a cumulative translation adjustment balance associated with that foreign entity.  ASU 2013-05 is effective prospectively for reporting periods, including interim periods, beginning after December 15, 2013.  Early adoption is permitted.  The Company is currently evaluating the impact of adopting ASU 2013-05.

Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

 
7

 
 
3.
STOCK-BASED COMPENSATION

Stock-based compensation expense totaled approximately $20,000 and $30,000 for the three months ended March 31, 2012 and 2013, respectively.  No tax benefits were attributed to the stock-based compensation because a valuation allowance was maintained for substantially all net deferred tax assets.

The following table summarizes the Company’s restricted stock activity:

   
 
Shares
   
Wtd. Avg.
Grant-Date
Fair Value
 
       
Nonvested at December 31, 2012
    261,658       $0.37  
Granted
           
Vested
    (51,668 )     0.37  
Forfeited
           
Nonvested at March 31, 2013
    209,990       0.37  

As of March 31, 2013, total unrecognized stock-based compensation expense related to non-vested restricted stock was approximately $79,000, which is expected to be recognized over a weighted-average period of 1.0 year.

On August 13, 2012, the Company’s Board of Directors authorized the Company, acting as trustee for certain of its non-officer, overseas employees, to execute a Rule 10b5-1 plan to purchase 100,000 shares of its common stock in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934 and the Company's policies regarding stock transactions.  The employees will receive the stock as incentive compensation in quarterly increments over three years beginning March 15, 2013, provided that they are employees of the Company on the date of the distribution.  The following table summarizes this stock award activity:

   
 
Shares
   
Wtd. Avg.
Grant-Date
Fair Value
 
       
Nonvested at December 31, 2012
    100,000       $1.37  
Granted
           
Vested
    (8,336 )     1.37  
Forfeited
           
Nonvested at March 31, 2013
    91,664       1.37  

As of March 31, 2013, total unrecognized stock-based compensation expense related to these stock awards was approximately $111,000, which is expected to be recognized over a weighted-average period of 2.7 years.

4. 
CONTINGENCIES
 
Consumer Indemnity

As required by the Door-to-Door Sales Act in South Korea, the Company maintains insurance for consumer indemnity claims with a mutual aid cooperative by possessing a mutual aid contract with Mutual Aid Cooperative & Consumer (the “Cooperative”).  The contract secures payment to distributors in the event that the Company is unable to provide refunds to distributors.  Typically, requests for refunds are paid directly by the Company according to the Company’s normal Korean refund policy, which requires that refund requests be submitted within three months.  Accordingly, the Company estimates and accrues a reserve for product returns based on this policy and its historical experience.  Depending on the sales volume, the Company may be required to increase or decrease the amount of the contract.  The maximum potential amount of future payments the Company could be required to make to address actual distributor claims under the contract is equivalent to three months of rolling sales.  At March 31, 2013, non-current other assets include KRW 100 million (USD $91,000) underlying the contract, which can be utilized by the Cooperative to fund any outstanding distributor claims.  The Company believes that the likelihood of utilizing these funds to provide for distributors claims is remote.

 
8

 
Registration Payment Arrangements

Pursuant to the agreement with the investors in the Company’s October 2007 financing of variable rate convertible debentures having an aggregate face amount of $4,250,000, seven-year warrants to purchase 1,495,952 shares of the Company’s common stock, and one-year warrants to purchase 1,495,952 shares of the Company’s common stock, the Company was obligated to (i) file a registration statement covering the resale of the maximum number of Registrable Securities (as defined) that is permitted by SEC Guidance (as defined) prior to November 18, 2007, (ii) cause the registration statement to be declared effective within certain specified periods of time and (iii) maintain the effectiveness of the registration statement until all Registrable Securities have been sold, or may be sold without volume restrictions pursuant to Rule 144(k) under the Securities Act.  The Company timely filed that registration statement covering the shares of common stock underlying the debentures, which have been redeemed, and the one-year warrants, which have expired.  At the time, the 1,495,952 shares of common stock underlying the seven-year warrants were not deemed Registrable Securities and were not included in the Registration Statement.  If they are subsequently deemed Registrable Securities and we fail to file a new registration statement covering them, then the warrants may be exercised by means of a cashless exercise. The maximum number of shares that could be required to be issued upon exercise of the warrants (whether on a cashless basis or otherwise) is limited to the number of shares indicated on the face of the warrants.  As of March 31, 2013, no contingent obligations have been recognized under registration payment arrangements.

5.
RELATED PARTY TRANSACTIONS

In February 2013, the Company entered into a Royalty Agreement and License with Broady Health Sciences, L.L.C. (“BHS”) regarding the manufacture and sale of a new product called Restor™.  Under this agreement, the Company has agreed to pay BHS a royalty of 2.5% of sales revenue for this product for 2011 and subsequent years in return for the right to manufacture (or have manufactured), market, import, export and sell this product worldwide, with certain rights being exclusive outside the United States.  George Broady, a director of the Company and owner of more than 5% of its outstanding common stock, is owner of BHS, a Texas limited liability company.  During 2011 and 2012, BHS permitted the Company to manufacture (or have manufactured), market and sell the Restor™ product.  In April 2012, the Company reimbursed BHS $42,000 in expenses incurred in 2011 to promote the Restor™ product on the Company’s behalf.  To permit the Company to continue selling Restor™ and obtain certain exclusive rights outside of the United States, BHS requested that the Company enter into the Royalty Agreement and License.  This agreement was reviewed, considered, authorized and approved by the sole disinterested, non-employee member of the Board of Directors under appointment by the full Board of Directors as an ad hoc committee for this purpose.  Upon signing this agreement, the Company paid BHS $12,000 and $25,000 as royalties for 2011 and 2012, respectively.  Royalties accrued, but unpaid for the first three months of 2013 are approximately $7,000.  The Company is not required to purchase any product under the agreement, and the agreement may be terminated at any time on 120 days’ notice or, under certain circumstances, with no notice.

The Company is considering entering into another royalty agreement and license with BHS regarding the manufacture and sale of a new product called Soothe™, which the Company began selling in the fourth quarter of 2012 with the permission of BHS.  To continue selling this product, BHS has requested that the Company pay a royalty of 2.5% of sales revenue for 2012 and subsequent years.  The Company is considering that proposal and discussing the terms of a definitive agreement.  At a royalty of 2.5% of net sales, the Company calculates that royalties for 2012 and the first three months of 2013 would total approximately $2,400.

6.
SUBSEQUENT EVENTS

On April 10, 2013, 14,707 shares of the Company’s Series A preferred stock were converted into an equal number of shares of common stock.

On April 21, 2013, warrants issued to the placement agent in an October 2007 convertible debentures financing representing the right to purchase 149,595 shares of the Company’s common stock expired unexercised.  On May 4, 2013, warrants issued by the Company in a May 2007 private equity placement representing the right to purchase 2,059,307 shares of common stock expired unexercised.

 
9

 
 
Item 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Business Overview

We are an international direct-selling and e-commerce company.  Subsidiaries controlled by us sell personal care, wellness, and “quality of life” products under the “NHT Global” brand.  In most markets, we sell our products to an independent distributor network that either uses the products themselves or resells them to consumers.  Our majority-owned subsidiaries have an active physical presence in the following markets:  North America; Greater China, which consists of Hong Kong, Taiwan and China; Russia; South Korea; Japan; and Europe, which consists of Italy and Slovenia.

Our distributor network operates in a seamless manner from market to market, except for the Chinese market.  We believe that each of our operating segments should be aggregated into a single reportable segment as they have similar economic characteristics.  Additionally, we believe that each of the operating segments are similar in the nature of the products sold, the product acquisition process, the types of customers products are sold to, the methods used to distribute the products, and the nature of the regulatory environment.  Our e-commerce retail business in China does not require a direct selling license and allows for discounts on volume purchases.  There is no separate segment manager who is held accountable by our chief operating decision-makers, or anyone else, for operations, operating results and planning for the Chinese market on a stand-alone basis.  Accordingly, we consider ourselves to be in a single reporting segment and operating unit structure.

As of March 31, 2013, we were conducting business through approximately 20,400 active distributors.  We consider a distributor “active” if they have placed at least one product order with us during the preceding year.  Currently we do not intend to devote material resources to opening any additional foreign markets in the near future.  Our priority is to focus our resources in our most promising markets, which we consider to be Greater China and certain Commonwealth of Independent States (“CIS”) countries, namely Russia, Ukraine and Kazakhstan.  Currently, orders received from members located in Ukraine and Kazakhstan are fulfilled by our North American subsidiary.

We generate about 94% of our net sales from subsidiaries located outside North America, with sales in Hong Kong representing 70% of net sales in the latest fiscal quarter.  Because of the size of our foreign operations, operating results can be impacted negatively or positively by factors such as foreign currency fluctuations, and economic, political and business conditions around the world.  In addition, our business is subject to various laws and regulations, in particular regulations related to direct selling activities that create certain risks for our business, including improper claims or activities by our distributors and potential inability to obtain necessary product registrations.

China has been and continues to be our most important business development project.  In June 2004, NHT Global obtained a general business license in China.  Direct selling is prohibited in China without a direct selling license that we do not have.  In December 2005, we submitted a preliminary application for a direct selling license.  In June 2006, we submitted a revised application package in accordance with new requirements issued by the Chinese government.  In June 2007, we launched a new e-commerce retail platform in China that does not require a direct selling license and is separate from our current worldwide platform.  We believe this model, which offers discounts based on volume purchases, will encourage repeat purchases of our products for personal consumption in the Chinese market.  The platform is designed to be in compliance with our understanding of current laws and regulations in China.  In November 2007, we filed a new, revised direct selling application incorporating a name change, our new e-commerce model and other developments.  These direct selling applications were not approved or rejected by the pertinent authorities, but did not appear to materially progress.  By 2009, the information contained in the most recent application was stale.  The Company applied to temporarily withdraw the license application in February 2009 to furnish new information and intends to amend its application with the goal to re-apply in the future.   We are unable to predict whether we will be successful in obtaining a direct selling license to operate in China, and if we are successful, when we will be permitted to enhance our e-commerce retail platform with direct selling operations.

Most of the Company’s Hong Kong revenue is derived from the sale of products that are delivered to members in China.  After consulting with outside professionals, the Company believes that its Hong Kong e-commerce business does not violate any applicable laws in China even though it is used for the internet purchase of our products by buyers in China.  But the government in China could, in the future, officially interpret its laws and regulations – or adopt new laws and regulations – to prohibit some or all of our e-commerce activities with China and, if our members engage in illegal activities in China, those actions could be attributed to us.  In addition, other Chinese laws regarding how and when members may assemble and the activities that they may conduct, or the conditions under which the activities may be conducted, in China are subject to interpretations and enforcement attitudes that sometimes vary from province to province, among different levels of government, and from time to time.  Members sometimes violate one or more of the laws regulating these activities, notwithstanding training that the Company attempts to provide.  Enforcement measures regarding these violations, which can include arrests, raise the uncertainty and perceived risk associated with conducting this business, especially among those who are aware of the enforcement actions but not the specific activities leading to the enforcement.  The Company believes that this has led some existing members in China – who are signed up as distributors in Hong Kong - to leave the business or curtail their selling activities and has led some potential members to choose not to participate.  Among other things, the Company is combating this with more training and public relations efforts that are designed, among other things, to distinguish the Company from businesses that make no attempt to comply with the law.  This environment creates uncertainty about the future of doing this type of business in China generally and under our business model, specifically.
 
 
10

 

Income Statement Presentation

We derive revenue from sales of products, enrollment packages, and shipping charges.  Substantially all of our product sales are to independent distributors at published wholesale prices.  Product sales are recorded when the products are shipped and title passes to independent distributors, which generally is upon our delivery to the carrier that completes delivery to the distributors.  We estimate and accrue a reserve for product returns based on our return policies and historical experience.  Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized over the term of the arrangement, generally twelve months.

Cost of sales consists primarily of products purchased from third-party manufacturers, freight cost for shipping products to distributors, import duties, costs of promotional materials sold to the Company’s distributors at or near cost, and provisions for slow moving or obsolete inventories.  Cost of sales also includes purchasing costs, receiving costs, inspection costs and warehousing costs.

Distributor commissions are typically our most significant expense and are classified as an operating expense.  Under our compensation plan, distributors are paid weekly commissions, generally in their home country currency, for product sold by their down-line distributor network across all geographic markets, except China, where we launched an e-commerce retail platform and do not pay any commissions.  Distributors are not paid commissions on purchases or sales of our products made directly by them.  This "seamless" compensation plan enables a distributor located in one country to sponsor other distributors located in other countries where we are authorized to conduct our business.  Currently, there are basically two ways in which our distributors can earn income:

 
·
Through retail markups on sales of products purchased by distributors at wholesale prices (in some markets, sales are for personal consumption only and income may not be earned through retail mark-ups on sales in that market); and
 
·
Through commissions paid on product purchases made by their down-line distributors.

Each of our products is designated a specified number of sales volume points, also called bonus volume or “BV.”  Commissions are based on total personal and group sales volume points per sales period.  Sales volume points are essentially a percentage of a product’s wholesale cost.  As the distributor’s business expands from successfully sponsoring other distributors who in turn expand their own businesses by sponsoring other distributors, the distributor receives higher commissions from purchases made by an expanding down-line network.  To be eligible to receive commissions, a distributor may be required to make nominal monthly or other periodic purchases of our products.  Certain of our subsidiaries do not require these nominal purchases for a distributor to be eligible to receive commissions.  In determining commissions, the number of levels of down-line distributors included within the distributor's commissionable group increases as the number of distributorships directly below the distributor increases.  Under our current compensation plan, certain of our commission payouts may be limited to a hard cap in terms of a specific percentage of total product sales.  In some markets, commissions may be further limited.  In some markets, we also pay certain bonuses on purchases by several generations of personally sponsored distributors, as well as bonuses on commissions earned by several generations of personally sponsored distributors.  Distributors can also earn income, trips and other prizes in specific time-limited promotions and contests we hold from time to time.  Distributor commissions are dependent on the sales mix and, for the first three months in 2012 and 2013, represented 41% and 43% of net sales, respectively.  From time to time we make modifications and enhancements to our compensation plan to help motivate distributors, which can have an impact on distributor commissions.  From time to time we also enter into agreements for business or market development, which may result in additional compensation to specific distributors.

Selling, general and administrative expenses consist of administrative compensation and benefits (including stock-based compensation), travel, credit card fees and assessments, professional fees, certain occupancy costs, and other corporate administrative expenses.  In addition, this category includes selling, marketing, and promotion expenses including costs of distributor conventions, which are designed to increase both product awareness and distributor recruitment.  Because our various distributor conventions are not always held at the same time each year, interim period comparisons will be impacted accordingly.

The functional currency of our international subsidiaries is generally their local currency.  Local currency assets and liabilities are translated at the rates of exchange on the balance sheet date, and local currency revenues and expenses are translated at average rates of exchange during the period.  Equity accounts are translated at historical rates.  The resulting translation adjustments are recorded directly into a separate component of stockholders’ equity and represent the only component of accumulated other comprehensive income.

 
11

 
 
Sales by our foreign subsidiaries are transacted in the respective local currencies and are translated into U.S. dollars using average rates of exchange for each monthly accounting period to which they relate.  Most of our product purchases from third-party manufacturers are transacted in U.S. dollars.  Consequently, our sales and net earnings are affected by changes in currency exchange rates, with sales and earnings generally increasing with a weakening U.S. dollar and decreasing with a strengthening U.S. dollar. 

Results of Operations

The following table sets forth our operating results as a percentage of net sales for the periods indicated.

   
Three Months Ended March 31,
 
   
2012
   
2013
 
             
Net sales
    100.0 %     100.0 %
Cost of sales
    26.4       25.8  
Gross profit
    73.6       74.2  
Operating expenses:
               
Distributor commissions
    40.6       42.5  
Selling, general and administrative expenses
    26.8       28.3  
Depreciation and amortization
    0.1       0.1  
Total operating expenses
    67.5       70.9  
Income from operations
    6.1       3.3  
Other income (expense), net
    (0.7 )     0.1  
Income before income taxes
    5.4       3.4  
Income tax provision (benefit)
    (0.2 )     0.1  
Net income
    5.6 %     3.3 %

Net Sales

The following table sets forth revenue by market for the periods indicated (in thousands):

   
Three Months Ended March 31,
 
   
2012
   
2013
 
                         
North America
    $435       4.8 %     $529       6.1 %
Hong Kong
    6,126       67.4       6,048       69.9  
China
    215       2.4       144       1.7  
Taiwan
    499       5.5       601       6.9  
South Korea
    114       1.2       96       1.1  
Japan
    45       0.5       29       0.3  
Russia
    1,573       17.3       1,130       13.1  
Europe
    83       0.9       74       0.9  
Total
    $9,090       100.0 %     $8,651       100.0 %

Net sales were $8.7 million for the three months ended March 31, 2013 compared with $9.1 million for the comparable period a year ago, a decrease of $439,000, or 5%.  Hong Kong net sales decreased $78,000, or 1%, over the comparable period a year ago.  In January 2013, we launched a 12-month incentive program around our international recognition program called the Supreme Bonus. This year-long program rewards members with additional cash bonuses and other prizes for maintaining and advancing rank in our international recognition program.  Similar incentive programs during 2012 were more quarterly-focused and only offered during the first six months of the year, which may result in more sales during the first and/or second quarter of 2012 as compared to the current year periods.

Outside of our Hong Kong business, net sales elsewhere decreased $361,000, or 12%, over the same period in the prior year.  The Russian market decreased $443,000, or 28%, as last years’ sales were boosted by an incentive trip qualification period that ended in February for which many members worked to qualify.  The Russian and European markets are currently running a six-month long Paris incentive trip promotion for which the qualification period does not end until May 2013.  Historically, we have experienced a strong sales push leading up to the end of a qualification period.

 
12

 
 
North American sales increased $94,000, or 22%, over the same period in the prior year because of continued development in emerging markets, such as Kazakhstan and Ukraine.  Our Taiwan market also increased $102,000, or 20%, over the same period in the prior year primarily due to a price increase on two products, Premium Noni Juice™ and La Vie™, which took effect on March 1, 2013, as well as the market’s participation in the year-long international recognition system incentive bonus.  Taiwan did not participate in similar programs during early 2012.

As of March 31, 2013, the operating subsidiaries of the Company had approximately 20,400 active distributors, roughly the same as March 31, 2012. As of March 31, 2013, the Company had deferred revenue of $1.1 million, of which $966,000 pertained to product sales and $170,000 pertained to unamortized enrollment package revenue.

Gross Profit

Gross profit was 74.2% of net sales for the three months ended March 31, 2013 compared with 73.6% of net sales for the three months ended March 31, 2012.  The gross profit margin percentage increase is attributable to lower fees paid to our third-party service provider in Russia and less importation costs as a percentage of overall net sales, which occurs when sales from the Russian market comprise a lower percentage of our overall net sales.

Distributor Commissions

Distributor commissions were 42.5% of net sales for the three months ended March 31, 2013 compared with 40.6% of net sales for the three months ended March 31, 2012.  The increase as a percent of net sales can be largely attributable to our business in the CIS countries, namely Russia, which recognized commissions at a greater rate when compared to the same period in the prior year.  Their commission rate during the first quarter of 2013 is more consistent with our overall rate during the first quarter of 2013.  As our once emerging markets mature and member organizations in those markets grow deeper we see that more people begin earning commissions more regularly.  We believe this may be the case with our Russian market.  Additionally, we recognized about one-half a percentage point more supplemental and incentive program expense than that recognized in the prior year.  These programs include the cost of supporting our member-funded brick-and-mortar project in China, called Healthy Lifestyle Centers, as well as the cost of member rewards with respect to maintaining and advancing rank in our international recognition program.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were $2.4 million for each of the three months ended March 31, 2012 and 2013.  We incurred professional fees totaling $20,000 during the first quarter of 2013 for development of the Ukraine and Kazakhstan markets, plus higher rent expense of $21,000 for office space in Dallas and Beijing as compared to the first quarter of 2012.  These increases were offset by a reduction of $49,000 in distributor-related event costs as the annual global ambassador incentive trip to Hawaii that occurred in March 2012 will take place later in 2013.

Other Income (Expense), Net

Loss on foreign exchange totaling $64,000 was incurred in the first quarter of 2012 due to impact of strengthening currencies (against the U.S. dollar) on inter-company balances, namely the European euro and Russian ruble.  A gain on foreign exchange totaling $7,000 was recognized in the first quarter of 2013.

Income Taxes

An income tax provision of $12,000 was recognized during the first three months of 2013, related to our operations outside the United States.  An income tax benefit of $19,000 was recorded during the first three months of 2012.  The Company did not recognize a tax benefit for U.S. tax purposes due to uncertainty that the benefit will be realized.

Liquidity and Capital Resources

At March 31, 2013, the Company’s cash and cash equivalents totaled $5.2 million.  Total cash and cash equivalents increased by $966,000 from December 31, 2012 to March 31, 2013.

At March 31, 2013, the ratio of current assets to current liabilities was 0.97 to 1.00 and the Company had a working capital deficit of $186,000.  Current liabilities included deferred revenue of $1.1 million that consisted of unamortized enrollment package revenues and unshipped orders.  The ratio of current assets to current liabilities, excluding deferred revenue, is 1.17 to 1.00.  Working capital as of March 31, 2013 increased $287,000 compared to that as of December 31, 2012 due to cash generated from operations.
 
 
13

 

Cash provided by operations for the first three months of 2013 was $1.0 million compared with $860,000 in the comparable period of 2012.  The increase in operating cash flows results primarily from more timely collections from our third-party service provider in Russia as compared to the prior year.

No significant investing activities occurred during the first three months of 2013.  Cash provided by investing activities for the first three months of 2012 was $229,000, which resulted from a $247,000 decrease in restricted cash.  In April 2010, the Company’s primary credit card processing company required that the Company gradually increase to and maintain the reserve balance at $500,000.  The Company reached the necessary reserve requirement during the second quarter of 2011.  In January 2012, 50% of the reserve balance was returned to the Company.

No significant financing activities occurred during the first three months of 2012 or 2013.

The Company believes that its existing internal liquidity, supported by cash on hand and cash flows from operations should be adequate to fund normal business operations and address its financial commitments for at least the next 12 months, assuming no significant unforeseen expense or revenue decline.  If the Company’s foregoing beliefs or assumptions prove to be incorrect, however, the Company’s business, results of operations and financial condition could be materially adversely affected.

The Company does not have any significant unused sources of liquid assets.  Potentially the Company might receive additional external funding if currently outstanding warrants are exercised.  Furthermore, if necessary, the Company may attempt to generate more funding from the capital markets, but currently does not believe that will be necessary.

On October 19, 2007, the Company issued warrants to purchase 3,141,499 shares of common stock in connection with a convertible debentures financing.  The warrants consisted of seven-year warrants to purchase 1,495,952 shares of common stock, one-year warrants to purchase 1,495,952 shares of common stock, and five-year warrants to purchase 149,595 shares of common stock.  The term for each of the warrants began six months and one day after their respective issuance and each have an exercise price of $3.52 per share.  Such one-year warrants expired unexercised on April 21, 2009 and such five-year warrants expired unexercised on April 21, 2013.  Additionally, on May 4, 2013, warrants issued by the Company in a May 2007 private equity placement representing the right to purchase 2,059,307 shares of common stock expired unexercised.

We do not intend to devote material resources to opening any additional foreign markets in the near future.  Our priority is to focus our resources in our most promising markets, which we consider to be Greater China and certain CIS countries, namely Russia, Ukraine and Kazakhstan.

Critical Accounting Policies and Estimates

The Company has identified certain policies and estimates that are important to the portrayal of its financial condition and results of operations.  Critical accounting policies and estimates are defined as both those that are material to the portrayal of our financial condition and results of operations and as those that require management’s most subjective judgments.  These policies and estimates require the application of significant judgment by the Company’s management.

The most significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates associated with obsolete inventory and the fair value of acquired intangible assets, including goodwill, as well as those used in the determination of liabilities related to sales returns and income taxes.  Various assumptions and other factors prompt the determination of these significant estimates.  The process of determining significant estimates is fact specific and takes into account historical experience and current and expected economic conditions.  The actual results may differ materially and adversely from the Company’s estimates.  To the extent that there are material differences between the estimates and actual results, future results of operations will be affected.  The Company’s critical accounting policies at March 31, 2013 include the following:

Inventory Valuation.  The Company reviews its inventory carrying value and compares it to the net realizable value of its inventory and any inventory value in excess of net realizable value is written down.  In addition, the Company reviews its inventory for obsolescence and any inventory identified as obsolete is reserved or written off.  The Company’s determination of obsolescence is based on assumptions about the demand for its products, product expiration dates, estimated future sales, and management’s future plans.  Also, if actual sales or management plans are less favorable than those originally projected by management, additional inventory reserves or write-downs may be required.  At December 31, 2012 and March 31, 2013, the Company’s inventory value was $867,000 and $888,000, respectively, net of reserves of $72,000 and $3,000, respectively.  No significant provision was recorded during the periods presented.

Valuation of Goodwill.  In accordance with accounting principles generally accepted in the United States of America, the value of residual goodwill is not amortized, but is tested at least annually for impairment.  The Company first assesses qualitative factors in order to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount.  If, through this qualitative assessment, the conclusion is made that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, a two-step impairment test is performed.  The Company’s policy is to test for impairment annually during the fourth quarter.  At December 31, 2012 and March 31, 2013, goodwill of approximately $1.8 million was reflected on the Company’s balance sheet.  No impairment of goodwill was recognized during the periods presented.

 
14

 
Allowance for Sales Returns. An allowance for sales returns is provided during the period the product is shipped.  The allowance is based upon the return policy of each country, which varies from 14 days to one year, and their historical return rates, which range from approximately 1% to 5% of sales.  Sales returns were approximately 2% of sales for each of the three month periods ended March 31, 2012 and 2013.  The allowance for sales returns was approximately $181,000 and $199,000 at December 31, 2012 and March 31, 2013, respectively.  No material changes in estimates have been recognized during the periods presented.

Revenue Recognition. Product sales are recorded when the products are shipped and title passes to independent distributors.  Product sales to distributors are made pursuant to a distributor agreement that provides for transfer of both title and risk of loss upon our delivery to the carrier that completes delivery to the distributors, which is commonly referred to as “F.O.B. Shipping Point.”  The Company primarily receives payment by credit card at the time distributors place orders.  The Company’s sales arrangements do not contain right of inspection or customer acceptance provisions other than general rights of return.  Amounts received for unshipped product are recorded as deferred revenue.  Such amounts totaled $647,000 and $966,000 at December 31, 2012 and March 31, 2013, respectively.  Shipping charges billed to distributors are included in net sales.  Costs associated with shipments are included in cost of sales.

Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized over the term of the arrangement, generally twelve months.  Enrollment packages provide distributors access to both a personalized marketing website and a business management system.  No upfront costs are deferred as the amount is nominal.  At December 31, 2012 and March 31, 2013, enrollment package revenue totaling $189,000 and $170,000 was deferred, respectively.  Although the Company has no immediate plans to significantly change the terms or conditions of enrollment packages, any changes in the future could result in additional revenue deferrals or could cause us to recognize the deferred revenue over a longer period of time.

Tax Valuation Allowance. The Company evaluates the probability of realizing the future benefits of any of its deferred tax assets and records a valuation allowance when it believes a portion or all of its deferred tax assets may not be realized.  The Company increased the valuation allowance to equal its net deferred tax assets during 2005 due to the uncertainty of future operating results.  The valuation allowance will be reduced at such time as management believes it is more likely than not that the deferred tax assets will be realized.  During each of the three month periods ended March 31, 2012 and 2013, no such reduction in the valuation allowance occurred.  Any reductions in the valuation allowance will reduce future income tax provisions.

Provision for income taxes depends on the statutory tax rates in each of the jurisdictions in which we operate.  We believe that we operate in compliance with all applicable transfer pricing laws and we intend to continue to operate in compliance with such laws.  However, there can be no assurance that we will continue to be found to be operating in compliance with transfer pricing laws, or that those laws would not be modified, which, as a result, may require changes in our operating procedures.  If the United States Internal Revenue Service or the taxing authorities of any other jurisdiction were to successfully challenge these agreements, plans, or arrangements, or require changes in our transfer pricing practices, we could be required to pay higher taxes, interest and penalties, and our earnings would be adversely affected.

Item 3.            QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable under smaller reporting company disclosure rules.

Item 4.            CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Management, with the participation of the Company’s principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of March 31, 2013.  The Company’s disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to management, including the Company’s principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.  Based on this evaluation, the principal executive officer and principal financial officer concluded that, as of March 31, 2013, the Company’s disclosure controls and procedures were effective.

 
15

 
Changes in Internal Control over Financial Reporting
 
There were no changes in internal control over financial reporting that occurred during the fiscal quarter ended March 31, 2013 that have materially affected, or are reasonably likely to materially affect, internal control over financial reporting.


PART II — OTHER INFORMATION

Item 1.              LEGAL PROCEEDINGS

None.

Item 1A.           RISK FACTORS

Not applicable under smaller reporting company disclosure rules.

Item 2.              UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

(c)      Purchases of Equity Securities by the Issuer and Affiliated Purchasers

A summary of the Company’s purchases, as Trustee, of shares of its common stock during the quarter ended March 31, 2013 is as follows:

 
 
 
 
 
 
Period
 
 
 
Total Number of Shares Purchased (a)
   
 
 
Average Price Paid Per Share
   
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (b)
   
Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs (c)
 
                         
January 1–31, 2013
    3,415       $1.21       50,120       94,310  
February 1—28, 2013
    2,800       1.27       52,920       91,510  
March 1—31, 2013
    2,800       1.41       55,720       88,710  

 
(a)
The shares were purchased in open market transactions under the Employee Plan described in footnote (b) below.

 
(b)
On August 13, 2012, the Company disclosed in its Quarterly Report on Form 10-Q that its Board of Directors had, on that day, authorized the Company, acting as trustee for certain of its distributors, to execute a Rule 10b5-1 plan to purchase up to $60,000 of its common stock (less commissions and other transaction costs) in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934 and the Company's policies regarding stock transactions (the “Distributor Plan”) and that, on that same date, the Company’s Board of Directors further authorized the Company, acting as trustee for certain of its non-officer, overseas employees, to execute a Rule 10b5-1 plan to purchase 100,000 shares of its common stock in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934 and the Company's policies regarding stock transactions (the “Employee Plan”).  The Company may terminate the plans at any time. The distributors for whom the Company was authorized to purchase the stock as trustee under the Distributor Plan were authorized to receive the stock as compensation under a special incentive plan offered to certain distributors who are not citizens or residents of the United States.  The employees for whom the Company was authorized to purchase stock as trustee under the Employee Plan are authorized to receive the stock as incentive compensation in quarterly increments over three years beginning March 15, 2013, provided that they are employees of the Company on the date of the distribution.  Any stock that is purchased under the Employee Plan that is forfeited by an employee whose employment terminates will be delivered to the Company and held by it as treasury stock.

 
(c)
The Company, as Trustee, completed its purchases under the Distributor Plan in October 2012, and all of those shares have been transferred to the qualifying distributor for whom they were purchased.  The Company, as Trustee, began purchasing under the Employee Plan in December 2012.  Under the 10b5-1 plan executed by the Company, as Trustee, with the Board’s authorization, the Company, as Trustee, will not purchase more than 2,800 shares per month.  The current 10b5-1 plan for the Employee Plan shares will expire on November 30, 2013, unless terminated earlier, and the Company, as Trustee, intends at or after that time to enter into a new 10b5-1 plan or plans to complete the Employee Plan purchases authorized by the Board.

 
16

 
Item 3.              DEFAULTS UPON SENIOR SECURITIES

      None.

Item 4.              MINE SAFETY DISCLOSURES

Not applicable.

Item 5.              OTHER INFORMATION

      None.

Item 6.              EXHIBITS

Exhibit
Number
 
 
Exhibit Description
     
31.1
 
Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2
 
Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1
 
Certifications of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS**
 
XBRL Instance
101.SCH**
 
XBRL Taxonomy Extension Schema
101.CAL**
 
XBRL Taxonomy Extension Calculation
101.DEF**
 
XBRL Taxonomy Extension Definition
101.LAB**
 
XBRL Taxonomy Extension Labels
101.PRE**
 
XBRL Taxonomy Extension Presentation
 
 
17

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
    NATURAL HEALTH TRENDS CORP.  
       
Date:  May 8, 2013
  /s/ Timothy S. Davidson  
    Timothy S. Davidson
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
 
       
 
 
 
18

 
 
 
 
Exhibit
Number
 
EXHIBIT INDEX
 
 
Exhibit Description
     
31.1
 
Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2
 
Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1
 
Certifications of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS**
 
XBRL Instance
101.SCH**
 
XBRL Taxonomy Extension Schema
101.CAL**
 
XBRL Taxonomy Extension Calculation
101.DEF**
 
XBRL Taxonomy Extension Definition
101.LAB**
 
XBRL Taxonomy Extension Labels
101.PRE**
 
XBRL Taxonomy Extension Presentation
    **XBRL Filed herewith

 
EX-31.1 2 ex31-1.htm EXHIBIT 31.1 ex31-1.htm
 
EXHIBIT 31.1
 
CERTIFICATION
 
I, Chris T. Sharng, certify that:
 
1.        I have reviewed this quarterly report on Form 10-Q of Natural Health Trends Corp.;
 
2.         Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.         Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.         The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a)         Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b)         Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c)         Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)         Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5.         The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
a)         All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
       
Date: May 8, 2013   
  /s/ Chris T. Sharng  
   
Chris T. Sharng
 
   
President
(Principal Executive Officer)
 
       
 
EX-31.2 3 ex31-2.htm EXHIBIT 31.2 ex31-2.htm
 
 
EXHIBIT 31.2
 
CERTIFICATION
 
I, Timothy S. Davidson, certify that:
 
1.        I have reviewed this quarterly report on Form 10-Q of Natural Health Trends Corp.;
 
2.         Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.         Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.         The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a)         Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b)         Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c)         Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)         Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5.         The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
a)         All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
       
Date: May 8, 2013   
  /s/ Timothy S. Davidson  
    Timothy S. Davidson
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
 
 
EX-32.1 4 ex32-1.htm EXHIBIT 32.1 ex32-1.htm
 
 
EXHIBIT 32.1
 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the quarterly report of Natural Health Trends Corp. (the “Company”) on Form 10-Q for the period ended March 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Chris T. Sharng, and Timothy S. Davidson, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
 
1.        The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.        The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
       
Date: May 8, 2013   
  /s/ Chris T. Sharng  
   
Chris T. Sharng
 
   
President
(Principal Executive Officer)
 
       
 
 
 
       
Date: May 8, 2013   
  /s/ Timothy S. Davidson  
    Timothy S. Davidson
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
 
 
EX-101.INS 5 nhtcpk-20130331.xml XBRL INSTANCE 0000912061 2012-12-31 0000912061 2013-03-31 0000912061 nhtcpk:TotalMember 2012-12-31 0000912061 nhtcpk:TotalMember 2013-03-31 0000912061 nhtcpk:SeriesAConvertiblePreferredStockMember 2012-12-31 0000912061 nhtcpk:SeriesAConvertiblePreferredStockMember 2013-03-31 0000912061 2012-01-01 2012-03-31 0000912061 2013-01-01 2013-03-31 0000912061 2011-12-31 0000912061 2012-03-31 0000912061 2013-04-30 0000912061 us-gaap:WarrantMember 2012-01-01 2012-03-31 0000912061 us-gaap:WarrantMember 2013-01-01 2013-03-31 0000912061 us-gaap:RestrictedStockMember 2013-01-01 2013-03-31 0000912061 nhtcpk:ConvertiblePreferredStockAntidilutiveMember 2012-01-01 2012-03-31 0000912061 nhtcpk:ConvertiblePreferredStockAntidilutiveMember 2013-01-01 2013-03-31 0000912061 us-gaap:RestrictedStockMember 2012-03-31 0000912061 us-gaap:RestrictedStockMember 2013-01-01 2013-03-31 0000912061 2012-08-01 2012-08-13 0000912061 us-gaap:RestrictedStockMember 2012-12-31 0000912061 us-gaap:RestrictedStockMember 2013-03-31 0000912061 us-gaap:PerformanceSharesMember 2012-12-31 0000912061 us-gaap:PerformanceSharesMember 2013-01-01 2013-03-31 0000912061 us-gaap:PerformanceSharesMember 2013-03-31 0000912061 nhtcpk:KoreanBusinessSegmentMember 2013-03-31 0000912061 nhtcpk:SevenYearWarrantsMember 2007-10-31 0000912061 nhtcpk:SevenYearWarrantsMember 2010-10-31 0000912061 nhtcpk:OneYearWarrantsMember 2010-10-31 0000912061 nhtcpk:NotDeemedRegistrableSecuritiesMember nhtcpk:SevenYearWarrantsMember 2007-11-18 0000912061 nhtcpk:BroadyHealthSciencesLLCMember 2011-01-01 2011-12-31 0000912061 nhtcpk:BroadyHealthSciencesLLCMember 2012-06-30 0000912061 nhtcpk:BroadyHealthSciencesLLCMember 2012-04-01 2012-04-30 0000912061 nhtcpk:BroadyHealthSciencesLLCMember 2012-01-01 2012-12-31 0000912061 nhtcpk:BroadyHealthSciencesLLCMember 2013-03-31 0000912061 nhtcpk:NetSalesMember nhtcpk:BroadyHealthSciencesLLCMember 2012-01-01 2012-12-31 0000912061 nhtcpk:BroadyHealthSciencesLLCMember 2013-01-01 2013-03-31 0000912061 us-gaap:PreferredClassAMember us-gaap:SubsequentEventMember 2013-04-01 2013-04-10 0000912061 us-gaap:SubsequentEventMember 2013-04-21 0000912061 us-gaap:SubsequentEventMember 2013-04-04 iso4217:USD iso4217:USD xbrli:shares xbrli:shares iso4217:KRW xbrli:pure 4207000 5173000 122000 179000 867000 888000 641000 406000 5837000 6646000 121000 123000 1764000 1764000 239000 231000 258000 255000 8219000 9019000 1385000 1811000 10000 22000 1308000 1512000 1688000 1403000 836000 1136000 92000 92000 991000 856000 6310000 6832000 0 0 124000 124000 11000 11000 80584000 80603000 -78708000 -78421000 -102000 -130000 1909000 2187000 8219000 9019000 0.001 0.001 5000000 5000000 1761900 1761900 138400 138400 138400 138400 333000 0.001 0.001 50000000 50000000 11324048 11326323 11324048 11326323 9090000 8651000 2399000 2228000 6691000 6423000 3691000 3674000 2437000 2445000 12000 12000 6140000 6131000 551000 292000 -63000 7000 488000 299000 -19000 12000 507000 287000 4000 4000 503000 283000 0.05 0.03 0.04 0.03 10863000 11069000 11181000 11248000 20000 30000 51000 -28000 558000 259000 12000 12000 240000 59000 -95000 28000 102000 -232000 -3000 2000 -213000 428000 11000 12000 78000 215000 306000 -279000 359000 304000 24000 -134000 860000 1018000 18000 14000 -247000 229000 -14000 12000 -12000 52000 -26000 1141000 966000 1617000 2758000 NATURAL HEALTH TRENDS CORP 10-Q --12-31 11335276 false 0000912061 No No Smaller Reporting Company No 2013 Q1 2013-03-31 <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-40" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top" style="LINE-HEIGHT: 1.25;"> <td style="WIDTH: 18pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.</font> </div> </td> <td> <div align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NATURE OF OPERATIONS AND BASIS OF PRESENTATION</font> </div> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Nature of Operations</font></font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Natural Health Trends Corp. (the &#8220;Company&#8221;), a Delaware corporation, is an international direct-selling and e-commerce company headquartered in Dallas, Texas.&#160;&#160;Subsidiaries controlled by the Company sell personal care, wellness, and &#8220;quality of life&#8221; products under the &#8220;NHT Global&#8221; brand.&#160;&#160;In most markets, we sell our products to an independent member network that either uses the products themselves or resells them to consumers.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our majority-owned subsidiaries have an active physical presence in the following markets:&#160;&#160;North America; Greater China, which consists of Hong Kong, Taiwan and China; Russia; South Korea; Japan; and Europe, which consists of Italy and Slovenia.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Basis of Presentation</font></font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.&#160;&#160;As a result, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.&#160;&#160;In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company&#8217;s financial information for the interim periods presented.&#160;&#160;The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year.&#160;&#160;These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our 2012 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (SEC) on March 12, 2013.</font></font> </div><br/> <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-42" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top" style="LINE-HEIGHT: 1.25;"> <td style="WIDTH: 18pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.</font> </div> </td> <td> <div align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font> </div> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Principles of Consolidation</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The consolidated financial statements include the accounts of the Company and all of its majority-owned subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Use of Estimates</font></font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The most significant accounting estimates inherent in the preparation of the Company&#8217;s financial statements include estimates associated with obsolete inventory and the fair value of acquired intangible assets, including goodwill, as well as those used in the determination of liabilities related to sales returns and income taxes.&#160;&#160;Various assumptions and other factors prompt the determination of these significant estimates.&#160;&#160;The process of determining significant estimates is fact specific and takes into account historical experience and current and expected economic conditions.&#160;&#160;The actual results may differ materially and adversely from the Company&#8217;s estimates.&#160;&#160;To the extent that there are material differences between the estimates and actual results, future results of operations will be affected.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Income Taxes</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recognizes income taxes under the liability method of accounting for income taxes.&#160;&#160;Deferred income taxes are recognized for differences between the financial reporting and tax bases of assets and liabilities at enacted statutory tax rates in effect for the years in which the differences are expected to reverse.&#160;&#160;Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized.&#160;&#160;The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.&#160; The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution.&#160; The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense.&#160; Deferred taxes are not provided on the portion of undistributed earnings of subsidiaries outside of the United States when these earnings are considered permanently reinvested.&#160;</font></font> </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company and its subsidiaries file income tax returns in the United States, various states, and foreign jurisdictions.&#160;&#160;The Company is no longer subject to U.S. federal income tax examinations for years prior to 2009, and is no longer subject to state income tax examinations for years prior to 2008.&#160;&#160;No jurisdictions are currently examining any income tax returns of the Company or its subsidiaries.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Fair Value of Financial Instruments</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The carrying amounts of the Company&#8217;s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value because of their short maturities.&#160;&#160;The carrying amount of the noncurrent restricted cash approximates fair value since, absent the restrictions, the underlying assets would be included in cash and cash equivalents.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Accounting standards permit companies, at their option, to choose to measure many financial instruments and certain other items at fair value.&#160; The Company has elected to not fair value existing eligible items.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revenue Recognition</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Product sales are recorded when the products are shipped and title passes to independent distributors.&#160;&#160;Product sales to distributors are made pursuant to a distributor agreement that provides for transfer of both title and risk of loss upon our delivery to the carrier that completes delivery to the distributors, which is commonly referred to as &#8220;F.O.B. Shipping Point.&#8221;&#160;&#160;The Company primarily receives payment by credit card at the time distributors place orders.&#160;&#160;Amounts received for unshipped product are recorded as deferred revenue.&#160;&#160;The Company&#8217;s sales arrangements do not contain right of inspection or customer acceptance provisions other than general rights of return.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Actual product returns are recorded as a reduction to net sales.&#160;&#160;The Company estimates and accrues a reserve for product returns based on its return policies and historical experience.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized over the term of the arrangement, generally twelve months.&#160;&#160;Enrollment packages provide distributors access to both a personalized marketing website and a business management system.&#160;&#160;No upfront costs are deferred as the&#160;amount is nominal.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Shipping charges billed to distributors are included in net sales.&#160;&#160;Costs associated with shipments are included in cost of sales.</font></font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Various taxes on the sale of products and enrollment packages to distributors are collected by the Company as an agent and remitted to the respective taxing authority.&#160;&#160;These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Income Per Share</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic income per share is computed by dividing net income&#160;available to common stockholders by the weighted-average number of common shares outstanding during the period.&#160;&#160;Diluted income per share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of non-vested restricted stock and shares that might be issued upon the exercise of outstanding warrants and the conversion of preferred stock.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The dilutive effect of non-vested restricted stock and warrants is reflected by application of the treasury stock method.&#160;&#160;Under the treasury stock method, the amount of compensation cost for future service that the Company has not yet recognized and the amount of tax benefit that would be recorded in additional paid-in capital when the award becomes deductible are assumed to be used to repurchase shares.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following tables illustrate the computation of basic and diluted income per share for the periods indicated (in thousands, except per share data):</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="22" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three Months Ended March 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Numerator)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font> </div> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Denominator)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Per Share Amount</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Numerator)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font> </div> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Denominator)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Per Share Amount</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic EPS:</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="34%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net income available to common stockholders</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$503</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,863</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$283</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,069</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.03</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="34%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="34%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Effect of dilutive securities:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="34%" style="PADDING-BOTTOM: 2px"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-vested restricted stock</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">318</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">179</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="34%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="34%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Diluted EPS:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="34%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net income available to common stockholders plus assumed conversions</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$503</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,181</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.04</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$283</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,248</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.03</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certain non-vested restricted stock is anti-dilutive upon applying the treasury stock method since the amount of compensation cost for future service results in the hypothetical repurchase of shares exceeding the actual number of shares to be vested.&#160;&#160;Other common stock equivalents are also anti-dilutive since the average market price of the related common stock for the period exceeds the exercise price.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following securities were not included for the time periods indicated as their effect would have been anti-dilutive:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three Months Ended March 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants to purchase common stock</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,704,854</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,704,854</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-vested restricted stock</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">98,607</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Convertible preferred stock</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">138,400</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">138,400</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Warrants to purchase 3,704,854 shares of common stock were still outstanding at March 31, 2013.&#160;&#160;Such warrants have expirations through April 21, 2015.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Recently Issued and Adopted Accounting Pronouncements</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In February 2013, the FASB issued Accounting Standards Update ("ASU") No. 2013-02,&#160;<font style="FONT-STYLE: italic; DISPLAY: inline">Comprehensive Income (Topic 220) &#8212;Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income</font>, to require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component.&#160;&#160;In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items in net income but only if the amount reclassified is required under U.S. generally accepted accounting principles ("GAAP") to be reclassified to net income in its entirety in the same reporting period.&#160;&#160;For other amounts that are not required under U.S. GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under U.S. GAAP that provide additional detail about those amounts.&#160;&#160;ASU 2013-02 is effective prospectively for reporting periods, including interim periods, beginning after December 15, 2012.&#160;&#160;<font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">The Company&#8217;s adoption of the standard on January 1, 2013</font> did not have a material impact on its consolidated financial statements.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In March 2013, the FASB issued ASU No. 2013-05,&#160;<font style="FONT-STYLE: italic; DISPLAY: inline">Foreign Currency Matters (Topic 830) &#8212;Parent&#8217;s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity</font>, to clarify the guidance for entities that cease to hold a controlling financial interest in a subsidiary or group of assets within a foreign entity when (1) the subsidiary or group of assets is a nonprofit activity or a business (other than a sale of in substance real estate or conveyance of oil and gas mineral rights) and (2) there is a cumulative translation adjustment balance associated with that foreign entity.&#160;&#160;ASU 2013-05 is effective prospectively for reporting periods, including interim periods, beginning after December 15, 2013.&#160;&#160;Early adoption is permitted.&#160;&#160;<font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">The Company is currently evaluating the impact of adopting ASU 2013-05.</font></font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company&#8217;s present or future financial statements.</font></font> </div><br/> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Principles of Consolidation</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The consolidated financial statements include the accounts of the Company and all of its majority-owned subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation.</font></font></div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Use of Estimates</font></font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The most significant accounting estimates inherent in the preparation of the Company&#8217;s financial statements include estimates associated with obsolete inventory and the fair value of acquired intangible assets, including goodwill, as well as those used in the determination of liabilities related to sales returns and income taxes.&#160;&#160;Various assumptions and other factors prompt the determination of these significant estimates.&#160;&#160;The process of determining significant estimates is fact specific and takes into account historical experience and current and expected economic conditions.&#160;&#160;The actual results may differ materially and adversely from the Company&#8217;s estimates.&#160;&#160;To the extent that there are material differences between the estimates and actual results, future results of operations will be affected.</font></font></div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Income Taxes</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recognizes income taxes under the liability method of accounting for income taxes.&#160;&#160;Deferred income taxes are recognized for differences between the financial reporting and tax bases of assets and liabilities at enacted statutory tax rates in effect for the years in which the differences are expected to reverse.&#160;&#160;Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized.&#160;&#160;The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.&#160; The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution.&#160; The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense.&#160; Deferred taxes are not provided on the portion of undistributed earnings of subsidiaries outside of the United States when these earnings are considered permanently reinvested.&#160;</font></font> </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company and its subsidiaries file income tax returns in the United States, various states, and foreign jurisdictions.&#160;&#160;The Company is no longer subject to U.S. federal income tax examinations for years prior to 2009, and is no longer subject to state income tax examinations for years prior to 2008.&#160;&#160;No jurisdictions are currently examining any income tax returns of the Company or its subsidiaries.</font></font></div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Fair Value of Financial Instruments</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The carrying amounts of the Company&#8217;s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value because of their short maturities.&#160;&#160;The carrying amount of the noncurrent restricted cash approximates fair value since, absent the restrictions, the underlying assets would be included in cash and cash equivalents.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Accounting standards permit companies, at their option, to choose to measure many financial instruments and certain other items at fair value.&#160; The Company has elected to not fair value existing eligible items.</font></font></div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revenue Recognition</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Product sales are recorded when the products are shipped and title passes to independent distributors.&#160;&#160;Product sales to distributors are made pursuant to a distributor agreement that provides for transfer of both title and risk of loss upon our delivery to the carrier that completes delivery to the distributors, which is commonly referred to as &#8220;F.O.B. Shipping Point.&#8221;&#160;&#160;The Company primarily receives payment by credit card at the time distributors place orders.&#160;&#160;Amounts received for unshipped product are recorded as deferred revenue.&#160;&#160;The Company&#8217;s sales arrangements do not contain right of inspection or customer acceptance provisions other than general rights of return.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Actual product returns are recorded as a reduction to net sales.&#160;&#160;The Company estimates and accrues a reserve for product returns based on its return policies and historical experience.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized over the term of the arrangement, generally twelve months.&#160;&#160;Enrollment packages provide distributors access to both a personalized marketing website and a business management system.&#160;&#160;No upfront costs are deferred as the&#160;amount is nominal.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Shipping charges billed to distributors are included in net sales.&#160;&#160;Costs associated with shipments are included in cost of sales.</font></font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Various taxes on the sale of products and enrollment packages to distributors are collected by the Company as an agent and remitted to the respective taxing authority.&#160;&#160;These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority.</font></font></div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Income Per Share</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic income per share is computed by dividing net income&#160;available to common stockholders by the weighted-average number of common shares outstanding during the period.&#160;&#160;Diluted income per share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of non-vested restricted stock and shares that might be issued upon the exercise of outstanding warrants and the conversion of preferred stock.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The dilutive effect of non-vested restricted stock and warrants is reflected by application of the treasury stock method.&#160;&#160;Under the treasury stock method, the amount of compensation cost for future service that the Company has not yet recognized and the amount of tax benefit that would be recorded in additional paid-in capital when the award becomes deductible are assumed to be used to repurchase shares.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following tables illustrate the computation of basic and diluted income per share for the periods indicated (in thousands, except per share data):</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="22" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three Months Ended March 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Numerator)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font> </div> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Denominator)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Per Share Amount</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Numerator)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font> </div> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Denominator)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Per Share Amount</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic EPS:</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="34%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net income available to common stockholders</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$503</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,863</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$283</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,069</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.03</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="34%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="34%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Effect of dilutive securities:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="34%" style="PADDING-BOTTOM: 2px"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-vested restricted stock</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">318</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">179</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="34%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="34%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Diluted EPS:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="34%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net income available to common stockholders plus assumed conversions</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$503</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,181</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.04</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$283</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,248</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.03</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certain non-vested restricted stock is anti-dilutive upon applying the treasury stock method since the amount of compensation cost for future service results in the hypothetical repurchase of shares exceeding the actual number of shares to be vested.&#160;&#160;Other common stock equivalents are also anti-dilutive since the average market price of the related common stock for the period exceeds the exercise price.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following securities were not included for the time periods indicated as their effect would have been anti-dilutive:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three Months Ended March 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants to purchase common stock</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,704,854</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,704,854</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-vested restricted stock</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">98,607</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Convertible preferred stock</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">138,400</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">138,400</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Warrants to purchase 3,704,854 shares of common stock were still outstanding at March 31, 2013.&#160;&#160;Such warrants have expirations through April 21, 2015</font></font></div> 3704854 <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Recently Issued and Adopted Accounting Pronouncements</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In February 2013, the FASB issued Accounting Standards Update ("ASU") No. 2013-02,&#160;<font style="FONT-STYLE: italic; DISPLAY: inline">Comprehensive Income (Topic 220) &#8212;Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income</font>, to require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component.&#160;&#160;In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items in net income but only if the amount reclassified is required under U.S. generally accepted accounting principles ("GAAP") to be reclassified to net income in its entirety in the same reporting period.&#160;&#160;For other amounts that are not required under U.S. GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under U.S. GAAP that provide additional detail about those amounts.&#160;&#160;ASU 2013-02 is effective prospectively for reporting periods, including interim periods, beginning after December 15, 2012.&#160;&#160;<font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">The Company&#8217;s adoption of the standard on January 1, 2013</font> did not have a material impact on its consolidated financial statements.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In March 2013, the FASB issued ASU No. 2013-05,&#160;<font style="FONT-STYLE: italic; DISPLAY: inline">Foreign Currency Matters (Topic 830) &#8212;Parent&#8217;s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity</font>, to clarify the guidance for entities that cease to hold a controlling financial interest in a subsidiary or group of assets within a foreign entity when (1) the subsidiary or group of assets is a nonprofit activity or a business (other than a sale of in substance real estate or conveyance of oil and gas mineral rights) and (2) there is a cumulative translation adjustment balance associated with that foreign entity.&#160;&#160;ASU 2013-05 is effective prospectively for reporting periods, including interim periods, beginning after December 15, 2013.&#160;&#160;Early adoption is permitted.&#160;&#160;<font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">The Company is currently evaluating the impact of adopting ASU 2013-05.</font></font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company&#8217;s present or future financial statements.</font></font></div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="22" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three Months Ended March 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Numerator)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font> </div> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Denominator)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Per Share Amount</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Numerator)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font> </div> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Denominator)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Per Share Amount</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic EPS:</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="34%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net income available to common stockholders</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$503</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,863</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$283</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,069</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.03</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="34%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="34%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Effect of dilutive securities:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="34%" style="PADDING-BOTTOM: 2px"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-vested restricted stock</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">318</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">179</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="34%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="34%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Diluted EPS:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="34%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net income available to common stockholders plus assumed conversions</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$503</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,181</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.04</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$283</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,248</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="8%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.03</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 318000 179000 503000 283000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three Months Ended March 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants to purchase common stock</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,704,854</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,704,854</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-vested restricted stock</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">98,607</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Convertible preferred stock</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">138,400</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">138,400</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 3704854 3704854 98607 138400 138400 <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-43" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top" style="LINE-HEIGHT: 1.25;"> <td style="WIDTH: 18pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.</font> </div> </td> <td> <div align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">STOCK-BASED COMPENSATION</font> </div> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock-based compensation expense totaled approximately $20,000 and $30,000 for the three months ended March 31, 2012 and <font style="DISPLAY: inline; FONT-FAMILY: times new roman">2013</font><font style="DISPLAY: inline">,</font> respectively.&#160;&#160;No tax benefits were attributed to the stock-based compensation because a valuation allowance was maintained for substantially all net deferred tax assets.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table summarizes the Company&#8217;s restricted stock activity:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"> &#160; </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Wtd. Avg.</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grant-Date</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair Value</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">261,658</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.37</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vested</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(51,668</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.37</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="72%" style="PADDING-BOTTOM: 2px"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="72%" style="PADDING-BOTTOM: 4px"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at March 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">209,990</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.37</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of March 31, 2013, total unrecognized stock-based compensation expense related to non-vested restricted stock was approximately $79,000, which is expected to be recognized over a weighted-average period of 1.0 year.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">On August 13, 2012, the Company&#8217;s Board of Directors authorized the Company, acting as trustee for certain of its non-officer, overseas employees, to execute a Rule 10b5-1 plan to purchase 100,000 shares of its common stock in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934 and the Company's policies regarding stock transactions.&#160; The employees will receive the stock as incentive compensation in quarterly increments over three years beginning March 15, 2013, provided that they are employees of the Company on the date of the distribution.&#160;&#160;</font>The following table summarizes this stock award activity:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"> &#160; </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Wtd. Avg.</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grant-Date</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair Value</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">100,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$1.37</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vested</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,336</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.37</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="72%" style="PADDING-BOTTOM: 2px"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="72%" style="PADDING-BOTTOM: 4px"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at March 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">91,664</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.37</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of March 31, 2013, total unrecognized stock-based compensation expense related to these stock awards was approximately $111,000, which is expected to be recognized over a weighted-average period of 2.7 years.</font></font> </div><br/> 20000 30000 0 0 79000 P1Y 100000 111000 P2Y255D <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"> &#160; </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Wtd. Avg.</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grant-Date</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair Value</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">261,658</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$0.37</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vested</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(51,668</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.37</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="72%" style="PADDING-BOTTOM: 2px"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="72%" style="PADDING-BOTTOM: 4px"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at March 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">209,990</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.37</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"> &#160; </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Wtd. Avg.</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grant-Date</font> </div> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair Value</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">100,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$1.37</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="72%"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vested</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,336</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.37</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="72%" style="PADDING-BOTTOM: 2px"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #C0FFFF;"> <td align="left" valign="bottom" width="72%" style="PADDING-BOTTOM: 4px"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at March 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">91,664</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.37</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 261658 0.37 0 0 -51668 0.37 0 0 209990 0.37 100000 1.37 -8336 1.37 91664 1.37 <table border="0" cellpadding="0" cellspacing="0" id="hangingindent-44" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top" style="LINE-HEIGHT: 1.25;"> <td align="right" style="WIDTH: 18pt"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.&#160;</font> </div> </td> <td align="left"> <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CONTINGENCIES</font> </div> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Consumer Indemnity</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As required by the Door-to-Door Sales Act in South Korea, the Company maintains insurance for consumer indemnity claims with a mutual aid cooperative by possessing a mutual aid contract with Mutual Aid Cooperative &amp; Consumer (the &#8220;Cooperative&#8221;).&#160;&#160;The contract secures payment to distributors in the event that the Company is unable to provide refunds to distributors.&#160;&#160;Typically, requests for refunds are paid directly by the Company according to the Company&#8217;s normal Korean refund policy, which requires that refund requests be submitted within three months.&#160;&#160;Accordingly, the Company estimates and accrues a reserve for product returns based on this policy and its historical experience.&#160;&#160;Depending on the sales volume, the Company may be required to increase or decrease the amount of the contract.&#160;&#160;The maximum potential amount of future payments the Company could be required to make to address actual distributor claims under the contract is equivalent to three months of rolling sales.&#160;&#160;At March 31, 2013, non-current other assets include KRW 100 million (USD $91,000) underlying the contract, which can be utilized by the Cooperative to fund any outstanding distributor claims.&#160;&#160;The Company believes that the likelihood of utilizing these funds to provide for distributors claims is remote.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Registration Payment Arrangements</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the agreement with the investors in the Company&#8217;s October&#160;2007 financing of variable rate convertible debentures having an aggregate face amount of $4,250,000, seven-year warrants to purchase 1,495,952 shares of the Company&#8217;s common stock, and one-year warrants to purchase 1,495,952 shares of the Company&#8217;s common stock, the Company was obligated to (i)&#160;file a registration statement covering the resale of the maximum number of Registrable Securities (as defined) that is permitted by SEC Guidance (as defined) prior to November&#160;18, 2007, (ii)&#160;cause the registration statement to be declared effective within certain specified periods of time and (iii) maintain the effectiveness of the registration statement until all Registrable Securities have been sold, or may be sold without volume restrictions pursuant to Rule 144(k) under the Securities Act.&#160; The Company timely filed that registration statement covering the shares of common stock underlying the debentures, which have been redeemed, and the one-year warrants, which have expired.&#160;&#160;At the time, the 1,495,952 shares of common stock underlying the seven-year warrants were not deemed Registrable Securities and were not included in the Registration Statement.&#160;&#160;If they are subsequently deemed Registrable Securities and we fail to file a new registration statement covering them, then the warrants may be exercised by means of a cashless exercise. The maximum number of shares that could be required to be issued upon exercise of the warrants (whether on a cashless basis or otherwise) is limited to the number of shares indicated on the face of the warrants.&#160;&#160;As of March 31, 2013, no contingent obligations have been recognized under registration payment arrangements.</font></font> </div><br/> 100000000 91000 4250000 1495952 1495952 1495952 <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-45" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top" style="LINE-HEIGHT: 1.25;"> <td style="WIDTH: 18pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5.</font> </div> </td> <td> <div align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">RELATED PARTY TRANSACTIONS</font> </div> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In February 2013, the Company entered into a Royalty Agreement and License with Broady Health Sciences, L.L.C. (&#8220;BHS&#8221;) regarding the manufacture and sale of a new product called <font style="FONT-STYLE: italic; DISPLAY: inline">Restor&#8482;.&#160;&#160;</font>Under this agreement, the Company has agreed to pay BHS a royalty of 2.5% of sales revenue for this product for 2011 and subsequent years in return for the right to manufacture (or have manufactured), market, import, export and sell this product worldwide, with certain rights being exclusive outside the United States.&#160;&#160;George Broady, a director of the Company and owner of more than 5% of its outstanding common stock, is owner of BHS, a Texas limited liability company.&#160; During 2011 and 2012, BHS permitted the Company to manufacture (or have manufactured), market and sell the <font style="FONT-STYLE: italic; DISPLAY: inline">Restor&#8482;</font> product.&#160;&#160;In April 2012, the Company reimbursed BHS $42,000 in expenses incurred in 2011 to promote the <font style="FONT-STYLE: italic; DISPLAY: inline">Restor&#8482;</font> product on the Company&#8217;s behalf.&#160;&#160;To permit the Company to continue selling <font style="FONT-STYLE: italic; DISPLAY: inline">Restor&#8482;</font> and obtain certain exclusive rights outside of the United States, BHS requested that the Company enter into the Royalty Agreement and License.&#160;&#160;This agreement was reviewed, considered, authorized and approved by the sole disinterested, non-employee member of the Board of Directors under appointment by the full Board of Directors as an ad hoc committee for this purpose.&#160;&#160;Upon signing this agreement, the Company paid BHS $12,000 and $25,000 as royalties for 2011 and 2012, respectively.&#160;&#160;R<font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">oyalties accrued, but unpaid for the first three months of 2013 are approximately $7,000.&#160;&#160;</font>The Company is not required to purchase any product under the agreement, and the agreement may be terminated at any time on 120 days&#8217; notice or, under certain circumstances, with no notice.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company is considering entering into another royalty agreement and license with BHS regarding the manufacture and sale of a new product called <font style="FONT-STYLE: italic; DISPLAY: inline">Soothe</font>&#8482;, which the Company began selling in the fourth quarter of 2012 with the permission of BHS.&#160;&#160;To continue selling this product, BHS has requested that the Company pay a royalty of 2.5% of sales revenue for 2012 and subsequent years.&#160; The Company is considering that proposal and discussing the terms of a definitive agreement.&#160; At a royalty of 2.5% of net sales, the Company calculates that royalties for 2012 and the first three months of 2013 would total approximately $2,400.</font></font> </div><br/> 0.025 0.05 42000 25000 25000 7000 0.025 0.025 2400 <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-46" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top" style="LINE-HEIGHT: 1.25;"> <td style="WIDTH: 18pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">6.</font> </div> </td> <td> <div align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">SUBSEQUENT EVENTS</font> </div> </td> </tr> </table><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 10, 2013, 14,707 shares of the Company&#8217;s Series A preferred stock were converted into an equal number of shares of common stock.</font></font> </div><br/><div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 21, 2013, warrants issued to the placement agent in an October 2007 convertible debentures financing representing the right to purchase 149,595 shares of the Company&#8217;s common stock expired unexercised.&#160;&#160;On May 4, 2013, warrants issued by the Company in a May 2007 private equity placement representing the right to purchase 2,059,307 shares of common stock expired unexercised.</font></font> </div><br/> 14707 149595 2059307 EX-101.SCH 6 nhtcpk-20130331.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Statement - Consolidated Balance Sheets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Consolidated Balance Sheets (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Consolidated Statements of Operations (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Consolidated Statements of Comprehensive Income (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Note 1 - Nature of Operations and Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Note 2 - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Note 3 - Stock-Based Compensation link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Note 4 - Contingencies link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Note 5 - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Note 6 - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Note 3 - Stock-Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Note 1 - Nature of Operations and Basis of Presentation (Detail) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Detail) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Detail) - Basic and Diluted Income Per Share link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Detail) - Antidilutive Securities Excluded From the Dilutive Calculations link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Note 3 - Stock-Based Compensation (Detail) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Note 3 - Stock-Based Compensation (Detail) - Restricted Stock Activity link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Note 4 - Contingencies (Detail) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Note 5 - Related Party Transactions (Detail) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Note 6 - Subsequent Events (Detail) link:presentationLink link:definitionLink link:calculationLink 000 - Disclosure - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 nhtcpk-20130331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION EX-101.DEF 8 nhtcpk-20130331_def.xml XBRL TAXONOMY EXTENSION DEFINITION EX-101.LAB 9 nhtcpk-20130331_lab.xml XBRL TAXONOMY EXTENSION LABELS EX-101.PRE 10 nhtcpk-20130331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 12 0001437749-13-005499-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-13-005499-xbrl.zip M4$L#!!0````(`"Z`J$*T/7X`4'(``)MI!P`3`!P`;FAT8W!K+3(P,3,P,S,Q M+GAM;%54"0`#&*^*41BOBE%U>`L``00E#@``!#D!``#L7>MSVLBR_WZK[O^@ MXU-W:[DS_^C$]W3T/O?M'K:9\Q#9VD8=-Y7:ED(M?O<5O2DVY)0:Q,74\5T#4W9!J=4Z"OOS MW__UCA&Y<#$C<:9\`SI?T$JIMQ7UY$QKGFD-Y>OD0M'JJAZ\!&\\W+J6\K"P M;/K^*$:(77[KN+-CK5[7CXE-/60;^"AX\HS=)16>-_'F:?XDQ<;;F7-W##?@ M#56KU=6:KL:;-U-OA&VWCH.;T:,^K=BVZ2&XRZ9RA@JO:YO,`%: M;[7$5,@'OR-@A%"GH:DGV_00/!&]$%K/^@61-6W83HOI7N<-JZ>GI\?\[OI1 M*GH.`*C'?WRY'AMSO$"UM4ETN*4JRCO6Q!GE=T=XJO`FSQBO[X\H62PMI@%^ M;>[BZ?NC0+JU2')O'ZAY=+QNS'"@\SQX"C'?'QGU[UTZG.KJ)3:8U#A)_A@\ MB&V/>*O.^@)<(B:[."70V3@C3AW^G*I:O:6^.]Z\%F__>$,@ MNK3$+G',)$DN#:_#E0K_Z:R]\-JZIGO$\=#UA>\N,7N4>>1N(?F*)XM\(8+?BWP4V?X86D1@W@!*,4D\"`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`>9JT]\1\78(!BB0'I]?1'WX2_$HD;88IMT;B!' M6$U`4Y3M^W%L^F$5OY/0[5;F2]F6G`Q'K9#AK)=K[9GAZ-'*I=]]/I?Z:@E/ M9`G)Z8N6C.59>K@\*UB4QJ;)P_5IKUI^%OU=8\OPRM?O@R5[^_9W+;-T(JHX MOMK$\[")"@L>)(T!Z2K7JR4\^1@@JZ*B9Y=*1?U]@+TQLM:IQ,^C]+YM.`N\ MKII=.P9?N)),*Q+,RT\@7I3=/;T'RE]R]?.8Y0NVB:>8>]%;\>@5;$*-=E=\ M7R\@X^6#;E0+\6\I_ML'[GIW^"4N*U][K+`J$BR/2\[2B#@O+$)4`I&48G:B M2"CF1UTC5#IHYL^J$H+FH(2J1;:8;VHOQ-">GX[3NY,T":%/4%%M%"GM56>2 M=%9O[*(SWR:!PGQJQB=E%QA1W\6=\*B5LZ_CRW?'T45ETQY[/_9[O+D;[%(^ MEQWKFB:Y`_TD^&"O#/P%.T#(B6^0*`-B(\1T*\GV+['M+(@=W1/1X&?_G`6` M!9QNJ*3;6LMZPUN!;-922EO!<8M1.@F.WLRK( M-A=-,"`Z[]HF^Z?WMT_N(.:W/=KU+I#KKH@]^S>R?*RPET?L+!QF@TIHH?Q" MYL@;Q<0&62"+OC^JZ4>=AE8_@:[_[K@2P8YTF.E#:E(PF^J)+@%FUS`<'YX; M80/#.[<6ACSJPH>`Q/;V$**J:0EPV\AT,BK>%52!R-23TSU`]6WFA!UW!0_M M(9EV*VE=\68[.Y(LX+O=;IN`V.ZM[JQ8)P'%\+HCXYCWA/+VD0&=.6!%'F0 MMJKN",3UL1F4[B?H`4L84QF0)!(QB73?VPE+D=UG(MQ*6*X)NB467_(DPUCJ M;1&:+!%AL%T=3Y'--%6A=,K@"?S'(834:HL\YF,@*Q)7HZ[OA>PRK"&/V)HV M7X+W:>O)$%),(&W:U6$4"48MBT,,!/JA5!,ZU81HA&0$0][.L(J&J/U@<6N3 M*Z=30>)7NHM)E4V[*4@!RT"1*I"6GAJZ2BE&JB!:;5VK#N'"62R(M^"E)`AV M@1ZQ9]@VX*4]Q!$O6^432+N7';$4R&4W+,D3+_:M.:I:(Y659EKO[$6_,"NN M2I^)RK'E,)_T%>F6LSVS"NW"`:8B[:YI$C;'CZP;1"#:NT!+XJ%]"@+M>K.= ME'X.C73&41U)D:NLMU)Q2#DD(^PA8F,S.D4&`A=_X?,%$#`4L3FJ/<13.VF? MI(+;8GI9O>V'L4!P@+&AI>L$U3'&GN&C%#NBQ\5S-F]XAX/$XMJA],IQ,9G9 M@<\V@H4G5K`>ROS+IUY8O1I.8?S?1_!J/1/#RX8G*@L\KA"*-*OJF93S$83` M/=#K*`D6U];PA%N;+:/JD.(1:@P'`L52:9VE$1K4R* ML0^XJA6GRN"2X_<-EMG*W>JT=T:RNP% M=HM@#P(VV%??];VYXY+_8',#4@AOVR!"'@L[?H;@$5CH4^H_F@9T%@AO1Q_@*7!X%:#+ MDKQ`;#P36!,=;DL=N^ MV::N!^E5-8);$^#'&]M+$,VI'\F`6FEDWQMJ1?>]18[Q`5)<:!`-CY)P;1': M(7"5SD89,@LNW8 M^$ZN<)*'K5BA!:M^\C_YD\FM3I,6+Z*4];A5\>1_52>S'+"I[H#GPJ'><,KO MCR$3E"(:33\]33F#!)&]4)06B*9I[6HH/KH.I3>N,]U>PRLMAU8K-7L5(]#9 MB71IYEN-U/*T?-+<3OB$!67;"EAAX`IOGP@I+0$]+8$<8GD=MQJLTM+16R>- M76%ARP)/$WQ4V(+GNN:"V/ST&79*>>]AB6VZ-;0KWXT:J76?Y6@?!'3Y7M=H M-.6`OL1+%YKFX2O\;&%>](3W%PZ$\O_AUZ7(64U/>A?3%2VTMM)(?$#)E,Z%<)2'GOIZ866U8`LBF]2Y%)LYF#9$.GLQ>2 M\CTSM;BC!!(V+S%P;"?YI$P?5VL)UBOEDLQJ;6>$I<5V4@E?:M=%)%CXR?)9 MA'K#>B5T4,]SR:WOL66/$X>M;@5LKL,])?\B/:9R0I!&9L?&/I"RVTH.Q6`% MJSX].(,3]!`J^`.,8K*BPYHJ0IZA)=H_5!G4KJ/+%DSI/19P69[33&V M+(4/9Q\_($H,2::3'%`J8C@@"Q5L4"H+F4\R98#FE4I+"5WC1=/F!JZ07D<6 MIE)2###I^V&Z9!^>PJ9L237R4844!;G0/MCD2"P?VS?,#F;%9O<.0J(9'OAL M2F4XS13G4CK>78[!_HUV*G*L!"/CS&4R47ZP5>NMT\,S$:JN:FFVO"Y4M:V6 M82,/2-ICR>6C@CJT1ELF'Y&KP29;W`7QD[R:A9:J/0LII0M]E>&4+ZCM`*?J MJK?@2*RN;>Z\1*]\$"'8="`=:A4>52&D%US3!CJ?#B"0SMY2F(5?5S?0D M02X]P2Z"7:"5CP.;Z5F4TM#B5<%#UT@[NY&64?#,UEM<#%[G$@?_]NWLP1R2 M*O/U=)I<2%A@V_OB+2W"9J;24`YN`=KH^(^";3/E*R*GS0*<,8J%NB^)KD): M5@5<"?$%/C38,%6\N;Q":)RIX102/@#>"D.+O@O@,F`WQP9(E&]-+X,V3;J\ MA*N`+F^\.V,NZ;'"/?QR)*RI13).D:WD7$M`+5\7*_0*(J3%0%,G`,B4;FJG M6@7RF813$O0]JM/RH<>V2$@1]TD)`TG1K6`C)=&6]Q-JT1"<`[>4:SN0B/74 MX5REJ1\*>86Q[Z0H-,N%7@`[=<"!'$$7!I(IJF4LN0+0"O6(AGR@\2A$M@EK M17ASB!\(=WD#5O6=D:NPZ:6S`^KKY3Y\?4BA:[AD3MY\FZWDAE< M>?*"&2()P,L/@76UO3ORU-PI6O$C"B9.U_C;)R[./<-.3N"1!%Z>>GKGG!38 MY27>D`,[VS.21\!)"IT;Z5-!MU/-&$6./;'DEAZ@(VK::1ES%I`OV1$K`J_@ M^1J2@$<6=>6X([ST76,.>AI.8].[APB>BZD*HJ,<)J^(C6SC$#+6RLA80#XS M"3Z=8L,;3GL/P*<]PR/DX:$M/GE13ETYB;P*?='\KR3X%0+3UA[XDV5RX4,W M_.SWM'>2E."F3@NN@B!3Y)>$OK3D3UNM/<"7P%[AY/!V8N>0FCT'3WT6!YR? M)C8198>8D_0<3R68)B9G/?[-@^@SL[8W0`M<5K^=07?R==2]5C[UNM>33\ID MU!MCFW7%>XYT8\4O'\!?A=QU*$U7KM7\%S<=?WZ0+[$X8E%\1:B"+ M?<"V%WP+I3216O2-IVVM==)BW&>[6/1)TO##':+]8GI3.VG%)5MRQQA[H0N" M,IFPKBPT*RV&*=#'`<5$`YV,!5W`'1=9?=O$#Y_QJC0%EJQ$GQ#);4U@L:%. M8(!G:V#M&=N_ZM/RENLDR`D;2YI4\.2_'2NKHB%W5WII5I)J2IXAM^Z M`"N;.6YY<8[!8N`]9+R&[:LS[9S;X_!]SHV1")L\Z:[ M([K^B'V M=_1IL=S6,N/.!Y\2&U-ZB:GADF6X0($MK0(7__.T[WKF!V3+SX&?EUG%-[(9WZN%%`XQ@B4SFF01WZ!(9 MV3O$#"^PP(RP_]@WAFJ-Z/X],;UY^`C$1?\37J;>RL+AY:OA8%*[ZG[I7_]Y MIGAD`>&[C>\5X`[9YPJ_.^[_;^],4>M++^]"SOL!A5]F\/\_'\SS=2?>_.'" M=T?]&J?>OV/GR9`^JW6/,^VGFP[;-U,-/.M?SGY!`VTEUXQ MNJ@-D]PE&IGT_IC4^H/+W@"P<"E\Z8X^]@>UZ]Y5ZLHH`%PO2RX@.`5;2U"\ M[(]OKKL@86);8+@IL4^XV`<@]I%0;1O2ZEO6_#%K/X9$S#7[;E`"KDB\QYZY M>48L_[(2CMN`A:<9@3VZL'CPULLS+O9G>*4,;WJC[J0_'(R5[N!2^=`=]\?L M^LVH-P;[X+<$,C^,R(/;;FX3P7WFG/@C\-NM>QS]F+;R;(]3LH:_EO4MI92_3'0QJ1L/'@Z5;Y5=O MCI5?T&)Y_L^VIM7/PZ!U?44]_^V-@H3-76(+W;,C<@QHR0G,Y8U"J()LX`*B M$AL%Q[,J)G&QX=5HL&U;8&Z0."FX9D!2A5V#-M'>[4ACS$[A&HOQWG#8,=D!5(L=KACUJ'A#%IGBF%"5I>N8OL$K:Q"R*2DM M##Y-E(^6.[ZZI"_7J.8$& M3;S$/.Y3%L%G(FWLW3ON#P"+/`43-@>G^&Q_-?PD;&G-)#RP`.)W\*SC*BP, MALB37P5JPE=!3Y1]W9"^+?0YKP[G*1W.T'?%76>!_G)\5?&UO.';8) M*NX(!^H*AX['?I*.L']`QLL$PM$C7CFH%I"].L>GM(E);&!,L.3;R#>)QZ,: M<$)DP3N_8[&C%>'B-)A]A)"#1A]I#YRFP$/>8FPS-[E$89"$#`C(3,2R/?PNRWNLJ` MC/#,#S;_"(0SKOTAC(ZZ$*6R.,2WO#>*@5UV'GX:7Q;)U'$\V_$P!+34L!SV M26"JV.P=)C+"#X<(1+9F6H`IIM)R:A/+=Z/+"FH3]J](E7Q4YN8$QFBRLQE, M%JXY"^)!(WE1YCKXBS?I+(G-Q`CZ@1Z"9IS?-QP2XXM'W,'43*H?B,:$XJ[! MHGJF09!!%@M:[PF#*#@<8QEMP!;H#@R!K5%GU^+/"E3'WS9Y-F)C`W(`Y*Y8 M#P!CFB+B;B"QQO.BXE2*I9ZN;(+OG=,P3LI3$_BAT-IYWW4V MV;T((#S!LJ^H`PV(9$,)Y(40!)YO\]`BR6N:V1![Q;J,.SQ M8V;9P>(9'H*&2RV4S;ETRJ_CWL5OC,P7Y!IS`8.J]H8!TPL#T,)88S-=7GV> M)#/5,H88@DS!_&RONW:5-Z`H]D6DESF]HCW7Z977R96GG%S17B=7R@MK_/4+ M:/'/7/[9G^&5,NY_'/2O^A?=P43I7EP,OPXF_<%'Y69XW;_H]\:O,RL%:1L+ MD\AT5=0_'C]U*Y%Q[VQ;-^GT*14U7:PCA>UY>L;S/=/MSD>0Y!/;](\;)$%L!?FBT;<>LM4&Y]]N3''?G\.\]V_WOB5XKR20`\$ MMV`91-7IWV?OT_Y_UAN#0E-050#OD^/4TC4H<5O">F)A#4K<5K:>Z&*^`XK& MZD:L6K!`/[""UU:9+?(PUTJIOUB&!08V1XGX#H.P#,&R:0"%%BEOG6@E.!V! M-6;%=C5RGSJ/E_T88I99\D_P>@(X.0T%8-C($E:(1-4%I62!(8"IV]Z,LSC\E%&E`JX/ZAP'!BSUP4D51\:@B@KD*"%LQ2]. M`^F%A(?O.X_"=5OP8U78@?\?#GP\>",S"'-@4H$RE30U3/4=F90G@3^`+8F7 M0,`'811X6FB%ZB-AM!2QMX0QRODKV(1^)`L`AV/YJ@2C#Y:>'YA#N:,`MBPT MK@$_A&7F>&5Z5>E6E4:5X048#L;QDA>82WSR/)EC1*FF;\D1M_%;C6N`](!F8SZBT<(.XXDX*=78JM'.#7'\)[,>.A;I,N7RK, M,U+)`AW0'K*Q:1<=`4HGL'!Y@=#Z$%63\\`#R>%??=B1,F%:>`-\-1)_"I66 M'&CU`MJ)!6:93F85SY(KCZ''PT?T!M10F6SBK-6*C2/%5&A9_4A5$9K#_"A: M,+Y!/RK-S.?KF;J[&'6L:%AE".1K*7RIUCAD-FRGV9!$*`(`1,#I?W3""G9: M:Z5IU8&YO8+2JZ;SDF8JQ7DP!37Q'!T3&^+KRM`M MLU6"])265CA/TQ#58U)[)N6V//>82E^BY1,IV0).E.3&NJ MSW7]EW8QTJF7>%]!+F\*%@8:^Z!92NP&-XK+&;!JCLT956*<6<@!FF,#(%F6 MXE;O<2(;K8AX6[*5&EVH4*NFQ"O)S[@'MI6KU8QK5*$!!X'\9T8JV\"M,!T8 M6-TD4;)$I7@C+RGVP`=&OM0ZW_(]S&9C6`Y-DJ$?(*/_E9O?I/W)/)4,3W1N M8;A$[5DRDO@N+*,P%:?P)Y;:8W$Q,@RCF%)?;(E\UE*,B"/D+/7"7+@]\)05 MA!ZT5L$X5#*;'!6MNWBF14H5:9\(5UIQ:7(_%3%E!$S+IL=(Z8!<->0,'6:G ML`S+9<$]7M<23T31T12IQ#*=^[A04Q&]+_KA&)U4S,SJ/1(#7X-.C^>*94P, M944C;"`;,Q_:++X;F6A4K`DWTD?J`"PN`I$!/&KF3EK_D3<;J_);8:FU8CC7 M]^("D@SY$I<]+Q%3U#K/B68,E1>J]4D1 M&E85J%8FQNG/7[]6K$=LHL&AW*)@?L+O(5E+GGN3_QGX9EKC`J, MUK(>8G=9QO_&=_1U`W/\9!4(ZPI[M_"7S%5CP9[F^=\\#XU[!0OY404?? M^O;N]IW5YP[&18O"G.*^5+:`L@.,U5VPD`"'ZK;;)WHA^0GD7Z866S"T)I'& M_-K".XZ-Z[\T^^$%PFE1UGXW2*I^E[:OQKFUF]%9[VXQR(25AY.,T8BDU*YY MC)^9"*89\M'8$]M23MA]S M$>@>MUDD$VL(*X'!?C=8M$,\GJGL^E)-,T'#"0,K/YB7]M9&4S9NP!>3*)NF MS,]3`BG-1Y!83^H@(D\'0US7-=O*_7?UK+1_]QB7SDXO,5_H6KI=FT-R$O** M0GXZ>?Y@X@R#Y[``"\\QYA_&1W:5OZH]8F`Y?Z2/!(-M88./!N*11?2+82/E M(F+&=URHA$\A0/-0[+FKK(=I'#`"ARHNDS%\B6.G/$ONIB$)\)-,E=V9W/"G M^-``N)LZN:1>MJ$T:=-+9%9ICL3-F8W">J.]]894[S4:G:[UT7*S"Z:2KDFH M.'"2>&:H\Y7Z2#I^+0=B-,+:"<\ MZ8`+3!U89G6 MR&4VV(IXFL3,*:?:?"[)O*IYZ$-3D9?P<,S81;9G,@W8FT*]"@GGA3P*1KMB M73.K!GBP2&MK1VG4]%1>@#<>ZH`FYOEU]-'@$]J@B_PA\)&N(%-E:(IWI8[1 MJVH'%06.B\WTR"7%V#JL0(5,]<;QTT*)P01J*89.BV)6Q@J6" M:T0LNTF6O?"P@=`PLP(*7,OLO]@]3\`U'[M`5@.7'10:N-,J[@">]%XTLOJ< MFWL:B0R^XQ.E:7+.?XCS\5AS-2-&D,/E5JY&-WS$;CQE)81>.#!+3;;T9*$R ML2[,8Q74'L*ZU&=_T?!@:6,EM2+=SZ4D@_?(>Q(\+BV@5B\^/9JO$99C"1[9 M(O'K:-0/D$=L7\;V8$9LW=,H'2$.Q0BCZL,",E@$A31J+[D+#&X\6A@;EB8F ML` M'OB=<8&M.:.G6X8D_B&83LM"%M>('K9YE`38[: M4TV5$NV9&8]I'9N%04YWI#IIJM-C>AAU>X2JIHJOCS"&%K.# M6LGY+%/)K'"C,*N8S1-@>FK):0VLBI/)X'/G:Z;7]"*F9]R*>RMEW7[*/`8L MR0.0C6ME$S4O*><.)!"S&B,<\S(?E@*O^EV:,]I<%:S!F9YVB7MR\JY^N[NZN?OE@=4=/(RCTRY]Y:4Q\]8<(6F8$21*8K8/HI`0I)NTL&O M&J$^7=V<7]RD=.JY#/0P4,M2'2%F.^/9+#88,\BW1RR+=JQI?^\&`3>9W,F? M7U16P[KPT#Y0K2ZM_4[+'*LQTWE9K?7`[GD,V"A>O_['0FPS?3"EDL1MM<#I MK\O[Y!&LOX`AB2*3%"G">J=-L+XA6,>.R`32VR8^!"B3%"%`J0^@[!.@;(GX MD-5'(+TY9WZ5&%T.T55P<^VH&2?+9P42"\2>!YJDD;)7O[G$BPY9Z`=OET=@ MTDJ$H+N*H`0IJGI)K@*N:ZF=WIQS781=@J%DV]<9,PA%)RE2"Q2MI:1?\Y*; MTY(_"ODL?7Z2W/QM8WR"@DF*$!202THN*2$H(>A6(RA!"KFDY))N#680BDY2 MI!8H6DM))Y>TB5!0-?-<6$H/&/L^@'UV]D!>_."#]:^S]F?X4_W::_.9B_*- M6H%+LU?AW(C^R7,/CJQ=1LN.BB9_+JYO/RS/-'FQEIDW@RV1H>.#T9,I`?KR6Q.S-;S\9L>]D[DAT9/GSW'%C'59UN_W,%O-!YQL20!O:KS$=;(OH+"JZ13,T&QP4I=#R/0HHW MC="V>=YZ?=@V'GA=I]I=F-UJ2LL5<2'!',%<#2BTU3#7:;>.WU<\V4]01U"W MG>1[`9F,55A`*\OQ([#Y8X=G%A;N&!6-<+@0%7,,OK'HT^OVN_;AQN,NA(J$ MBIN69S(`&VT`ONX>DY];;RXDF".8JP&%MAKF.IU6^_T)^;DUYT2".O)SMX2* MS?%SS>$_0L5-,V356H1E'Z9:L'"A>24RBS'JCIJ#9#`OQV!NJA"M10\TE7B$ M0(1`A$"$0'5G,$(@0B!"($*@S8O@CLH7(1`A$"%0+41P1^6+$(@0B!"H%B*X MH_)%"$0(1`A4VW/0B_9FG)=E---U@^VBJV[_BAG@HM_G=CCK]7[?*! M6Y+;42!"P:6IA>/T=J=,L?(VCJ3:2+61:B/55A,&(P0B!"($(@3:O`CNJ'P1 M`A$"$0+50@1W5+X(@0B!"(%J(8([*E^$0(1`A$"U$,$=E2]"($(@0J!F'/!< M3D9VYBG[12[U7#1U6^&BO1?F;M>?O+WTO;T'+D/NE"*G907P@T#8\"-+-9BN MQ(,;3=L^@T>V6Z270:?9%[]6ZL2P2S2LWHBAA(8E>KDI5-Q00X8F7^N\AC8U M328?82-AXX)4W.\<&\A'D+AE_$AV(45;UAEMV2T9)%BKD[@2K)%)MP(:-L:D M(Q#<%I*2NTO8N!4T;`PV=HY,O:H)$K>,'\DN)'>7W%VR].I.TJJ%"!5J"ZAY M-%63$>!3-=D60'M3B4<(1`A$"$0(5'<&(P0B!"($(@3:O`CNJ'P1`A$"$0+5 M0@1W5+X(@0B!"(%J(8([*E^$0(1`A$!TKIDZ35?GEG-L(IV>5#9/X.+ZUM18 MVDQ2:BI-*J].%"*51RJ/$&CURR<$(@0RT8@0:&TBN*/R10A$"$0(5`L1W%'Y M(@0B!"($JH4([JA\$0(1`A$"U4($=U2^"($(@0B!FG*6<\%SM`>C)U.FM')F M=&;"T)RJG9[4O.3MWLG<[.W)\^>X8L:ZY.EUP.:W"\_VA]QB#TRXK.=R*_0M M^&3H>Y9J,#WP78<'TAJYD9R5;6921D/NP+/>`_Q>^)YI^:,BH:U?Z:2?CZL+UO(EZMM;U1#S56J`D3 M"1.WA(K-P,1.I]4Y[AC)1[A8'Y8D7"1FRYY>0#_"1<+%>I&/<)%P<7$/ MVF@L$BING"'GU5SH[S'#KGX"_^H%WR5_K=_UUY-37W`7[M0N7,(NW$SO0K>P M"TL>O+#%9SP(F?",&^*EUVU/7:IM"6DQ+Q1[#IYR%P_R_:'(^Y)%@K?@W_(T.K[ M@=6/PBC@EN3!@X!Q8+*1&TH@#0YI\!8'XY$/WX3"9B[\>A0%]H!)#F^UY(#! MXQ9_LCEWDDDS.XR8:YZ1%PU[/,@]&OI6CUN:;N]R$I3^[0J&#.(*$A,S:$,D_"[=U8DE M]7W7]1^1QR6WHT"$`D9\Y,!KGA]BU9,;.<`F,6[;=+@"VG4L@]*GI]M0RVA,'&6/]'`BSN((J44L7T4@80D[^=:MG.= M@_3*L"F252L^76.?(!MT*P^J^7TKWMV[0/)#6A8>`_`L#<\7: M[[2JA7^67$#Z'']H,=?'*&];+6[S/!\"]1IBUT04!MC%"L#%$J MZI%M(Q,)!`D$"41U95I8RA(ZI5=+\!]U*]_2O$%#]L](AJ(_GH\?*^:,WU@0 M,"],#\J;#>G0M]*D;#Y-.3,55&"7>IV7;QI@4^.:)5%H+HE*.M>LFTK[K:/V M0>OXT'@ZJ=:E54TU&0B87B!V!$P$3`1,6Q?Q(KO[^5VNTEK.&64&DU6>E?B" M#.[ZH#;IM:;H-4VEXVZG8R83Z38RNNM"%0*G'0.GD^/6^_81X=*F^8L"X\TQ MT,]45]A0X/&W4EI9UBC@?1X$LRQT,M#KB_"D`YNB`SO[QZV#=MNL!$D+DG5> M%ZH0,A$R$3+5TC[7W]>PXT$%H_@9VU"3`]&S2U#RI2=I!D'+M$KJV/+#?WKN]]_AI^+$&9KYU;[ M0IZ\X7C2P!V;>?*KE!$>K/< M/ZR$'=;FK9U(?GWDOB%@P5HC14DT8/I_>?K*$9H>,!:Q;!!H6.&;4 ML*QO(X>%W'JCWWAZ^TW_Y:UUZ;]3H^^UNZVB[GL.^^>C&<-1P`?VVWUIIUJ,+$C'R`[4X`-U3U16FY'8=D!V722GZ`HAR%87J M`=N.AI'N%\ MA:DYCL`YMG*+$R6$CLG@Z-5S"3]O65RH:?FJUX[59VF?F9(9@4X,%2A9CP/5 M:X2'R2J$3(;%U0;E_7NP-5'(95,DD2.N*VZ\:`` M@&#PH6H\E%M6#^?@N4#7672)&Q\59B]D1O/(MLGG@"6OC@HP* M[-/IV4]?;JZ^79[OG5W]?'7SP?I77_V9HPL:`<8:` M'W?:DK%:1G3\D7E*EW=:)C:>.MP)S.(HYE8F/[-`DP"E8,<%O-9&0$'1,_.R M#9X!'J]5P-87'@/!AR=3Y)7S_8-I-W4[;,)F&X3:ARRQ!D&&,VON<*G6'$`R M![J7B>%9%"#2C6%^88@W(<8FW?%^T:2[!@P'+LM)C&F1.;,V:3UVIM4T:MD[ M<(ZEJ\VJ4P?C%,C193/#IH2`)*`!?#`4$M&,>QY:MU%/"D>P`!N?P:N^@"\] MDCE[86)B4G+01H]@\,##S(JI8EUHS>"K)H"@*;YZ6&BG3!S\G7FPXL/3)B>H MK$#TE>5AW4<@RZA)@!XE:*2T$RY#*0J;8_0"1L&K*6&F``AAX+NNHFF"!R4C M*;"&^:NY6S(AD5H?IHU':I5%4I21OQ\O,M:=8/!YUIO.6XV-QI'-Q(I?ASTG ML2DEJ)^^"+$KHWB(*<_`RI+`LQ*83RG;DM4!>=2RF*O,5)@\SB-4U`TX@"17 M*(E#JFLZQ_B-B4OA81\5+[CD]TQ:0Z%,,AT"EF_5YV^Z:J6!,FR9V53(&#O, M,39+&=OJ,5=-#DC@PZYE]9M32\/-T-M?)/L,>?PD_(@1_5D#\D#YVEUC%@A?KQ M./VITI3PCQO>___^AAW5S.ZG\WS5^G\&`^K*CLECT['CHVQZ1ZAS+9T`K%F]RG M!DH;'EL`Q&`?JF4*+[=L>&Z>YHZ9-8.\6>@U`73?)+_J7P!K(=!+@K:U<_[+ M'>]OJBF]T6Q+-_;YME]-X7`WN[‡B.JV/P%6"APH&`QT-0(?//)8Y[)^F M#;+\0!RP_^:)4L?R-E3HH9)P8"[:+`E=RPFKX=3@!]810="L#!7,%ZPM5A#P7',$@68M>U&HH(:8"H MRD!Z,BI=&D=Q\WK*3"/C9B53,JP+/GO@7L2-\5M\CC_A+1RJ:1 MA9UT?,GO@2CP$%-_P,&A'RAKRR"G.ADL`JP.C)0H,3O.>(%%Q;Q[/.@0"V$N M5S0MI_>^[SP*UVWAO1*/'*PS=;^$#YHQDAF$.3"I0%E9FAK3`^6E/+D"!6`+ M0X'X`3BQGA9:G?0S&IGLB9LS:+^".>E'L@!P.)9._/7!2/0#5Z97E6Z5<9I`1/B"VR,B\)XR0O,(:4\3^884:KI6Q@!Q&\UK@'6(X^F M&5"C_K$&0L*ZU2T[B&A@<:M0)@P0![]2L+-+L94#_/I#>"_\OTY[EB]5W].3 MWO\S9&/3+CH"E$Z0AC_`#^^,"=46G*@U0N6D@1F MF4Z#,GJ67#D;/1X^HB.AALID$V==O)FH&$Y25&@E`9J$*ABYAKV("PA1M-+4 M?V$/E6;F,_6,T4,INAT?XUFE7HFNL;EC3UL:>IE06HV*NWPM(%^1G>X0^\CF MV$Z;(XF,Q(G0?Q1XJQ(>I=+BPAF$ET1+C@T*(KZL3>GR0HZVH#&K*Q/Y).O42URW@J4+4I8=*+948'2IMA`E#O,F+ MS1E5XDD#(0=HRV$FUN-H%V`"5KW'B6PT0>)MR59J]+]"OU#.F)]Q#PPS5Z._ M:]2_F&?%[2U5XP9NA>G`P![OBS+;56EM3)'HW#X^,/*E-AC2\CL1HCTS]`-D M]+]X606=RA)C#B51V(7A$IUIR4CBN[!ZT#.P!7]BJ3&G:PAQ&,64$0B2OG"M MI1C1B>LG32+$[8&G3"ATO[7^QJ&2V>2H:-W%,RU2:B+'%`M78C@;?5=%3(G' M$=CT&"D=D*N&ZCI'S#+EEF&Y++C'&H)X(HJ.I@@I)O3O@1]"A3Y`]+[HAV/T M<#$5IO=(#'P-.CV>JW8W,90N]TB8#PT>'^^3FZ918M@9(J:H=9X3S1@JD47CHL"4]`KX MY_[$^18E">@"H[6LA]C7EO&_\1W]0H5:?H`_HT!(1]BS/<=<78;G6Z[OW9>4 M$,%"_E012U]7Y_:YHPI_"L*T)I'&_-K".XZ-Z[\T._$%PFE1SBI6U+NT?37.K=V,SGIWBQ$J5=\_P1@+ MNYIEON3'"9_S,Q,!&DO@F'Y.U-U7#U`P4NI./TT.Z.8=4-RH:>[^-0DAIIMG MY7:/?-+M5!$V"P)U+7@N+S(WA&TDCLB8(7_LP&9RH(.-^)?:+Z3Q]. MC9SS77,0H'DH#@,4:L$+ MG*<.ZF&Q=,KP)5ZB,VE[!K<.Q+XJ,F*[V8?G'+'8?\+@0*(WT3=(C#E1IWU25 M3F(6%N-Z/AY<4:M$Z`:O\R_\V/6E5!$]TYS\*+`H$$KCM?C&0W5[$6%II+@&RS=$%=-K-5N^_O/[Z[>?7IGW>*N MHA:X]D5Z_!Y^T/F^Q)@S+3-10>#$#\%%5A-!VY0K>U0?$`+'%2:&:A5/FFJ% M:HHC`U,7EFF-7'58'SBSA%,FNBY,'580>+H`=S/R$AZ.&;O(]DRF>0531%H! MX;S(3,$=4*QK9E7@J_ODE(32U4K?H2F@CF;IN*L^S81!4H.W:8/B\8=X_%Q5 MR:E2.\6[4J<25$6'"E;'!77QH2\#S56E%T8_J%BKWCA^6BBCF$`MQ=!I@=`$ M8S.=.5/YHYZ`:SXJ@JSF^1XH-'#4 M540#?/2]:&3U.9=&;U]D\*T5=)9#]!_BL@&L*YL1?LRP3H MW7!@EIILZQN/`6UA[`NE>&C#`^&7JG$9AIJ1:!F_^)A2:+QD?<3V96P/9L26BI[I"'&0Q]R>!XOD8!$4+*F] MY"XPN.GQQ+`T,8$]4(EWJR=<5QNK1=8/>"'DMJ"V.M,L.E$2C*9?''@QGD4M MQ/BP]AE3S?H=BYQ<(9[=),_&]EZ!#_I_:0[*V0>+E;X&@#;V#QIBEMM M>$Y'WN(*FC2QC".#WQD7$9L3C_JL?^(?YGIUZ3H<*/SA M?^SM6?_WMU]^/?A___?_V*/HZ7?O\,3YY^CA_O>Q]^T\>OQR%)P<_=3]\]O= M6+I'#_8_;??'\/C;V<_7SN__=?\'?Q^%[M-E=.@,.H/.SX/N[]'@ MRX_#>_:E[0[;Q^$_H?/7?\-#^[_O?^I_8C?B._\_O?_\YQO[Z5?[:G0FY<67 MH_]GG=W>[.U-QEPOXGJ7:Q[<8I_8+8VX-CFQ_+6L0A7VS%*;1OJGSOKG$^"G M;38NL/1DA,4R`Z9;[6#H+XI5!FR(4&Y/*3+')369D?W`A*O\(DQ%Y9H]8R\E M;&Z5;P=9=`XP#,2=/09.$3I?7J3:V>1Z1L=-I+/&T,8`;G;D;T:7Q'/A1F%6 M/ITGP/34DG,_6"(ID\'GSM=,K^E%3,^X%7!RZAI+I7?C>:O@\%"%`HT):=UZ1162ZH,[/+"%3M;G MEYQTZ4Y.>1I84_6/"F1\E&OBWAX*"-8;;TJK5@PL.X?S#$B1,(]J)MK/#%PV M&H'6*QSH#`.5\#86TNM7Z%,91I#XEA[K2(8I/&/H1)D5]D+*=^MG M#7\P!BFPO:FQMCN<2*!C)'[,PWSP*#D@G:M=,1ZOR!>1I[4DF1TMO'Q#U!$3 MSIZYR:O-1FA69%DX]H@9DQY'!,48EXKCJAJ?@.N3G&5-7GOQX5-U<"*]+D!# MS%S1)LFNI63W?3Q$HQ09JG^03M<%'8:'>^(V`&A6I,*)'IU=YG)1WN&G;T2)O@5!C22\!C0@?\*$5&XXAX7L[8>E\)M:LV5SUQVA-'GW M,=G;,7_@-Q*<]^EO"I>\M-NF:UX6NHRE[(.2YR<9-4^[I=PYGE_(]>GY^=?+ M+WN?KN[NKG[Y8'5'3W,$Y=GB4N-;D7:5(K:/(I"0I-N-R5&-4)^N;LXO;E(Z M]5P&>ABH9:G>(M,T,Y-L@^$!/)'%`\/F&J:ZXOV]&P3__E%Y8ZL"P_M M@_3B'7,RQ$SGI=V6^9QKLV:?4JHD<5LMG/._"HQNARBJ^#FVE'3 M<`NBF9(509,T4O;J-Y?1$'OO^<';Y1&8M!(AZ*XB*$&*JEZ2JX#K6FJG-^=< ME[J78"C9]G7&#$+128K4`D5K*>G7N1922 MDDM*"$H(NM4(2I!"+BFYI%N#&82BDQ2I!8K64M+))6TB%%3-/!>6T@/&O@]@ MGYT]D!<_^&#]ZZS]&?Y\/Y\Z\5Z9SUR4;]0*7)J]"N=&]$^6<6?[6GBC[*AH M\N?B^O;#\DR3%VN9>3/8$AEZKO)H#(BL#($KZLQM(Q,)!`D$"00)!`D$"00) M!`D$"00)!`D$"00)!`D$"<1J`I@58I+EY,SW^=@_,+7YF!\[/A@]F1*@+[]" M,UO#RZ_YW#N9&Q(]>?X<5\Q8EV5][I(_<4^:>6WNUA\AS3.>NE%AKH`7.L^8 M&-+`?I7Y:$M$?T'!-9*IV>"X((6.YU%(\:81VC;/6Z\/V\8#K^M4NPNS6TUI MN2(N))@CF*L!A;8:YCKMUO'[BB?[">H(ZK:3?"\@D[$*"VAE.7X$-G_L\,S" MPAVCHA$.%Z)BCL$W%GUZW7[7/MQXW(50D5!QT_),!F"C#<#7W6/R<^O-A01S M!',UH-!6PURGTVJ_/R$_M^:<2%!'?NZ64+$Y?JXY_$>HN&F&K%J+L.S#5`L6 M+C2O1&8Q1MU1[UN.<*-0/'!+W4E:M1"A0FT!-8^F:C("?*HFVP)H;RKQ"($(@0B! M"('JSF"$0(1`A$"$0)L7P1V5+T(@0B!"H%J(X([*%R$0(1`A4"U$<$?EBQ"( M$(@0B,XU4Z?IZMQRCDVDTY/*Y@E<7-^:&DN;24I-I4GEU8E"I/)(Y1$"K7[Y MA$"$0"8:$0*M301W5+X(@0B!"(%J(8([*E^$0(1`A$"U$,$=E2]"($(@0J!: MB.".RA([V8/1DRI16SHS.3!B:4[73DYJ7O-T[F9N]/7G^ M'%?,6)<\O0[8_';AV?Z06^R!"9?U7&Z%O@6?#'W/4@VF![[K\$!:(S>2L[+- M3,IHR!UXUGN`WPO?D^O/_:ZA2\U!\XY^+T-C&SNL`*TLQX^`JRJUJ=DI*E;O M4U-&1:/:7S,)7Q^V]TW$J[6V-^JAQ@HU82)AXI90L1F8V.FT.L<=(_D(%^O# MDH2+A(M;0L5FX.+K]KOVP?;%A@@5"14)%6M(Q8:@8O>8/.AZLR-A(F'BEE"Q M&9@('G3WP'39TPOH1[A(N%@O\A$N$BXN[D$;C45"Q8TSY+R:"_T]9MC53^!? MO>"[Y*_UN_YZ:%8L_!4^[B@5O1R/?,R,E&(W#?T(ENKWS6/9_G#$/XF`\\N&;4-C,A5^/HL`>,,GAK98<,'C:(JPFXRT)5AY+5L"@RFHDUXH&`+=(4D6H$_L0# M6P#!U+COBN`PJZ2E4,I2=P%OB(3?I;LZL:2^[[K^(_*XY'84B%#`B(\<>,WS M0ZQZS<(N`E-N$A.)FD",%)7>#$'-DF M.*F?\*S#XMM8DF7=R-NTA2X(J(T1BI4A2D4]LFUD(H$@@2"!J*Y,"TM90J?T M:@G^HV[E6YHW:,C^&E!>;,A'?I6FI3-IREGIH(* M[%*O\_)-`VQJ7+,D"LTE44GGFG53:;]UU#YH'1\:3R?5NK2JJ28#`=,+Q(Z` MB8")@&GK(EYD=S^_RU5:RSFCS&"RRK,27Y#!71_4)KW6%+VFJ73<[73,9"+= M1D9W7:A"X+1CX'1RW'K?/B)H*&PH\_E9**\L:!;S/@V"6 MA4X&>GT1GG1@4W1@9_^X==!NFY4@:4&RSNM"%4(F0B9"IEK:Y_K[&G8\J&`4 M/V,;:G(@>G8)2K[T)$TN)6?[_7[QU+PZ+0VD)V>7'U,=HN9/(Q&H#@AXT!H\N?N!=3H*A&MU]>B'1=Z=^D?L M"?SP723W[AD;?;A@@0?3E-<\N,6%7ONNL,=W_"G\A%ST,272#\D39RZ3\JH? MD_(JN$'HNU2M$*[ZM^EQ\C/FNMSY-$Y('O]06I$GPAO>__"E&".]3 MG]F=/TYA\/T.T`R)].)V/4^L#/CJU M;6Q%`72Y#GP/_FKS(79CT,29(%%Q_D=_?`:@Z?S(/)S^G9^MY..&O=T)D%V[ M#.M?W_W^,_QR%\KU#2^(6#!6B-M232P^G]Y^LH1FAXP% MK%L$:A8X9M2UK&\CAX7<>J/?>'K[3?_EK77IOU.C[[6[K:+M\!S6ST>#AJ.` M#[@GQ0,OF=17?2_1FSM_)&RKVVV_M=*L41>D8>0':G&@M$Y55YV2VXE`;A`^ M15\`4:ZB4#U@V]$PTGUB=+^:ZC,JR$<+%6J`S6RPAXUG@32)<*RT;.`_"*>D M-PG>NM3W@Z%N],-ZH$QS[8$DC)B;LQ_E&@851V&Y=?A)WYUL'B[AYRV+"S4M7_4JLOHL[=-3,B.P M*4(%2M;C0/5JX6&R"B&387&U07G_(VSM%'+9LB0@!-#0!F58@;3/)FY^.9,D MD2-NJVY&*``@&'RH&C?EEM7#.7@NT'467>+&4879"YG1//(!0B4SKKCM&IOP,.Z]W(]G1<`#V)YA9)HS$5C\F&N'B MXE9619(:6U992<>?9"6%=19E(R\&QE7:@2_EGHIS<]7@RH_7XPAIN[Z,T!(O MSKD,MK.5(`EBQ$EEEKE@6(8,#.<$8'Q9BD.AP+S.(HYE8N$[-`DP"E8,<% MO-9&0$'1,_,RV/+J>+("MK[P&`@^/)DBKYS;\-67P(]&,FW9B4T]0/WT18E=+\1!3GH&5)8%G)3"?4K8EJP/RJ&4Q5YFI,'F< M1ZBH&W``2:Y0$H=4UYR.\1L3E\+#/BI><,GOF;2&0IED.H0NWZK/WW352@-E MV#*SJ9`Q=IAC;)8RMM5CKIH6AINAM[](]CD:_S`S]R=8*K$" M*JG[4FZ:,`(64_C32M*XF@L6P,12[2M*3^?!RXU7.7S*KRB(XW^)1B\X M;_EH7FH;(O`%)E<+O^QQ5_`'&`?\5Y@0N]=>-VJ%,I-RFLI*^QHLW=A/M[+F MQ9-Z)3]*-)K.=% MQ!O3JM58?O>BBKI=[3I%%)FDR$27C)4VXJI?G6:-.G%1MU;JW46P_CR&)(I, M4J0(ZYTVP?J&8)WZM6ZC^!"@3%*$`*4^@$(=6[=%?,CJ(Y"N;\O+U335KH*; M:T=-0Q&9F9(509,T4O;J-Y?1D`47-*MP0Q"T4F*U`)%:RGIY)(V$0JJ9IZ7W<75 M?%JDVK5[2[(_]BJ<>-$_6P*P0DZQVE\#^097+!*9C MQP>C)U,"M'+"\QD1T.E)S8V)GLP-B9X\?XXK9JQ+7MI+3O^).Y^R!R9[7E6NICQS4>+#%Y6U7$EW-YS,RDW4&#DW9TR\QR*'1'[:- M!U[7J7879K>:TK+6=V01S!',[2[,==JMX_<53_83U!'4;2?Y7D`F8Q46T,IR M_`AL_MCAF7GOVVY1T0B'"U'1>/?@NLV_]KOVX5*I1ZA(J%@O\I$!2`;@]Z^[ MQ^3GUIL+">8(YFI`H:V&N4ZGU7Y_0GYNS3F1H([\W"VA8G/\7'/XCU!QTPQ9 MM19AV8>I%BQ<:%Z)S&*,NJ/F(!G,RS&8FRI$:]$#324>(1`A$"$0(5#=&8P0 MB!"($(@0:/,BN*/R10A$"$0(5`L1W%'Y(@0B!"($JH4([JA\$0(1`A$"U?8< M]**]&>=E&KW?MQSA1J%XX);D=A2(4'!I:N$X MO=TI4ZR\C2.I-E)MI-I(M=6$P0B!"($(@0B!-B^".RI?A$"$0(1`M1#!'94O M0B!"($*@6HC@CLH7(1`A$"%0+41P1^6+$(@0B!"H&0<\EY.1G7G*?I%+/1=- MW5:X:.^%N=OU)V\O?6_O@R"\G=)7>7++VZD[1J(4*%V@)J'DW59`3X5$VV!=#> M5.(1`A$"$0(1`M6=P0B!"($(@0B!-B^".RI?A$"$0(1`M1#!'94O0B!"($*@ M6HC@CLH7(1`A$"$0G6NF3M/5N>4AL8V=E@!6EF.'P%7 M56I3LU-4K-ZGIHR*1K6_9A*^/FSOFXA7:VUOU$.-%6K"1,+$+:%B,S"QTVEU MCCM&\A$NUH$BLW`Q=?M=^V#[8L-$2H2*A(JUI"*#4'%[C%YT/5F M1\)$PL0MH6(S,!$\Z.Z!Z;*G%]"/<)%PL5[D(UPD7%S<@S8:BX2*&V?(>347 M^GO,L.-/?O@NDGOWC(T^W-H#[D0NO^I?L,`3WKV\YL'M@`7\$Y/"/O6<^*CU M'3Y[QY_"3UB`\%$-_D,RRJD7"@=_)Q[X+;>C0(2"RXLGVXT<[GP&4ISYPU$4 MLE#XWO2K3H=^!%2./!'>\/Z_7TG\4+["9'X(;U2?V>__P'$Z/S*OV^YT[_S] MSB\LP+^^LAQNBR%SY;]?[>V_^KC?.6ZWV]D2ES*YCPE!U[KFH_R:][,U[T^N MN7-TLHXU7_+PJRK8^-F7\C2IV;CSSU3%QFVN8"/FFFQ]D72>NZ&'[?W"XA:> MQ<<5KJ+R%H&CO=159)+[PLU.A;KJPCXJ]%;5.C9WW1%S'!@OAL=VC,CXC1PQ M>_J;`H"WVR8(7PA2RSXH>7XN\B^A.&V63=G`RQN((J44L7V4@H0D[^=:-W,- MQ/3:J"F252M`7&.O&)L#G`35;/\5[^[=(."\E$Z6]0N\>""M"P\`TP*LFXJ[;>. MV@>MXT/C"95:E]!L+&DK,S<7GFTF?3:\T6"]%IC])JFTG&WTS&3B70;&=UUH0J!TXZ!T\EQ MZWW[B'!IT_Q%@?'F&.AGJC-H*/`(5"FM+&L4\#X/@ED6.AGH]45XTH%-T8&= M_>/60;MM5H*D!#_)'D;]>?G[U+#T\^+KIT"W[)3RSE!@OY0"-VFV09TF M+Z'$R?'[]M'R.P>LGQ`'I<*0<_VN$_=.D20_KQ+R`-@?K*:SP@9(=%C**]M` MHG,A;=>740"XC2-P3ZHA;KC+@,G/?!G*I'4)=Z[9>,B]4+ZDO4'9216KYP<. M#^)O\BT/%FV&()SX@P'S[@7^QX'W[!WLFS1\'9HE&,-?!0LE]$>&64Y'G"I' MP_+#_/;U_.X_,,"Q\7Z;BM&O95WYLZP@UITB^B40_69>-<:[]0>DJE(XSP,F M6W/MQ+J]NSK[:>_3Z>W%^:R(W]G5+]<7E[>G=U^O+JN%W)=#W\6,5_Q7+_@N M^>NB`5T4F&5%=.<[$LO>UFY!_%;*,ZCS]GJH0$P+LW-JQ^)/^'>\LBID+GUS_H^X$5#F`8[%%A#74G"E[L1&&A M'5,8ZH7D+L7YZ5.0%0;/'J_0,P/LDA&WT3APQ^]R_F#ZMTO?"MF3U>,>[XM0 M6H\\`%4<@BW;B[+ZFHE10U\146;[5]RL'K=9!)O%4%E%ZC,#>C+7]1^99W/K MD4EKR(07PG]A+-PD&?5D""Z%@%^-\:=`OW!:LITD@8"+8%+R4+Z;HF@YA!>@ MI>Y"WQ"IOQMP,U?U?60(L,LL;1#*:#AD@?@'QD5N0RN4>>.TEN3H>YFK\3+P MEV)/BR'WBW#\83ELT9A67$LO9]S5C@)$D4F*-*''0I7@+;PL(^`+[=>-EP[4 MJ#F$BBMLX$I1Z@WQ`N(1#$Y2I`DPV``T^2UTWI4'14X?[DUA'D+Q%]/]"V:$ M]L[!0:^8O"4:+TSCSTP$Y;S]*SC?1N*3'JV=UJA:_?H2%VUGBH&:MM`%&QLW M1BA6AB@5#:@M(5-5[%AVY;PY9/G\@OK::?JJ55PKYI9+K!?(3KN:WL]"ZYS; MJF0@36%L0/-3T:J)*E2TNF-%J]WWG=;[PY);[:AHEK>JN0F7174W07=9&I(Y,1.+U`]`B< M")P(G"@@3L;X@OSRJXZ'+ZUP@[0=:;L:4&A;M-V;PT[K_7L*<#^'=F^7:Q\0 M(KU`W@B1FH)(97%MPJ+ZF=UKLZ275GI.)G?X_6<_Z'-1$@'?DACXSIY%>`&9 M9A]%B!E_)JCM%@U?3$2C1J5PU@)ZM6+!>$/XDJ"17(4Z4*B:JU!5-@GQ"/$: M%=:?";`'*W1&=K4@OM#09[^:4&^?U[((YVR)G*_,:P%:68X?]5Q>R6W9+2J^ MG(SF4."Z:^_;)ZV3DZUL&#VMQ)LLW(2-Y+;4@4+/=5O,S$5Y#P*Z_-?4N1(Z)Q M9X_!O]D]MT8\$+Z#5.B\:QOG,^8LH,::]>9MX^"?3L]^^G)S]>WR?._LZN>K MFP_6O_KJ3XZDDWUEKTS=6D^C^TB&%HH&'BYOE?;D_.2S0/'2N0#6"_U`FH6% M1>'`#Q1?YH9JJ8:=WKT%K!\&\$;.53]8FP?8'1;&-B;/G]OH`?MA2C M2PY#\.'(]<><2Q1HD!5N1R'VI;V)W)(NI)UV[W"O8XU/M<= MA'6S?UP?OA4D?I@VMS5(,,R8V;8?.+K/K0@'UGTD'(X$EQ;VYA5]`12(/`=$ M,SD_T#;%R,OS,R=[I?(U_"5HU\5]@X M4,#O8=.0['K:8<``QFS$,9EO&VP:\P[FE)(9ENBZ"#E0"8!P\&7%TOH`%,]VY&1#*#>8_?"P]O.8@QO7.88#H@Z8-P M%,.Q$&^_)T5'76ZW6=H(CYJ"1V51;<*B^AG=:[.CEU9X M3@8W=;E=#Y7KIP^IR^T2-"9UN5VG7MV)GH\$C1N'1G(5J,LM(5[M_(MZ!O67 MUH^/RN&IRVVC^\.MS&NA+K?-[W)[@O?O'31"A3=9M`D9R6FI`X6VN\?M5F8] M=@+HYODJ^GOJ<;M#/6[#`9=IUT?L32BQC:UYK(G>MIU.ITISV\(0"W6W[;X[ M,I)&]9*\/Z_7T72 M>04[Y84PGOK`?O_'9X"&SH_,PR/3=_Y^!Y@!__K*Y2?[GXVW?V)Z>XO8[H7<:_/6QX\")N;G[UC3Y^XQ_LBQ)FM MB/JYI2QG4NM?:M6=J\=2TQC+J8*J.P3$_/>!@'V8T8L_S2>@GI*UCC7%3J-[#2*=_?BO>7;Z>OGYU<=.NPB+*YCLQRF*;$;>"N(V MB3%@4*Q-LM9&C@K"58[!'Z^[OW2URT#5?(4T?KY5@2U-&:.EHWJ-9W MGK!2"2]UM%X3H:D`K=X4VI8#]MWWG=;[P^.*?D^M"LZ::D$0,KU`[@B9FH), MK]O4T7KSW+5$9[^>-G@3>WI01^M:R`[IKEW57=M]ZKQA*HS`B<")P(G`J99, M1@'QIAOCU-&Z!F)&VFY7M=V;0^P<00%NZFF]W?)&B-041"J+:Q,6U<_L7ILE M33VME\@KU--Z'52NGSZDGM9+T)C4TWJ=>G4G.KP2-&X<&LE5H)[6A'BU\R_J M&=:GGM;4TYHZMRY$/NIIO6GUO7T]K;OMD];)27L;4Q,[T>R5L''CV$AN2W.Z M6F]EWF,G@&Z>MZ*_SW>U;E!WN>?F?:B+$%%D'D6:T%>IHA--[>6HO=Q.M\4A M&&PT##8`3:B]W&;H3NWE5D]C:B_7%#VZQ-*\G>FZMC,+I?9RU%ZNL6GW><)* MV71J+[-06/RJ+:A$7U,[K79D=3<[DE\@HU MEUL'E>NG#ZFYW!(T)C676Z=>W8E62P2-&X=&5^^"Z2>_>,C3[Z<^<,1]R0+A>^=!@'S[OF0>^&G!<_!W!X%\]>'&$'\JK<,"#NP'SKD8XA$PG=QFI$Z<13.J&]__] M2JK.3:\L&\@'TU*?V9V3/T[E57^_<\YM/)?ZQ\22?E''5E]9#K?%D+GRWZ^^ M7GY^];'[OO/^\#A'FW4MYV,JR^LDY6\2NP-=K`Q9=(;D&SE9@O7?8>?]^ M+6!=7-?&"+IY%E\C<"^X]+6A3EJ4T"``GUK3!LRZY3!WMQW;(K6C\2*&2$V- MZL6)JXWJ]LG)R7IIO'RC.G[#513*D'G8AWMB'R^>>&`+R:^!(*OBU>7![V++ MJ2]'=B9<#Z!UWP_`[;:Y[NA;PI.=-O[9#$]N*;(^@]3`KYT:^GGUM(>[W5)# MH2I7[QWO[[_?C$&\S1;QRRB_1B9?V":N*VSO3VB^J@Q^`A[?P490N[Y6Q#-H MN3R67=R.F&!)>-]0A&H/3CUXNQ?"&-RS!9?G0MJN+Z,@"S<7EU[J6;WZJ+(+ MZN:4GA\X/(@C]_E+4Q:]3D4X\0?`)?<"_^/`K/<.#DQ9BZ!1PR M#:Y_???[S_!S$<)D[=QB7\H>H#O!``G,Z?ROH&&&8`*,BXPSS4790P7>>=FN MKOE$V?HW=EF;>"J-"PHX&)D!=ZS>V`+KTCKW_6`O]/?P_ZU;YL+HIW8(+[=N M_2@<6#_Y`6^5)R*<'2L9@)K`I/>F'`8#%J MT%_T%Z?PQ5EN2*7!\+^FP1)!L-[@4I/*^&[[^]P(Z:>=[]_F]6'ZM[L!-XV= MSDYR&XQ):8VT`6N%ON4(#+GUHM`/D)Z*T/P!OC1N:3A@86$OA`0;79F9,-8H M\!^$PV'C^Y'G2/C(.$C^E>9EC$?"9JX[;BD>`C=$J@V.QS7O*ACGL"X@N0,\ M9X?N.&&[9*K,ML$2QMV$J889I2;W0?TZ/9IP]#V8F.A-N)H_O7@6P!T`A### MQX&P!^:Q8@&0FFSQ<^F*>MR240]L?_`5%-\HZ@><3ZNS(6S@P$RKTV152*W\ M-`B!#OH1#;.-8P"$+`>NCN6CQ,3TJ", M-!'P#:`9I`4_@DW%O9M^(7\"-A;@V'#C.LXY>%UJ=WS-A%(!Q(/O@E2TLOTR M[!4`PABIF>(-[*_P;-@LR2U8%+A]^N_9IA*/[48`(#_=_`8JIFT-!X*P%F90:HK_H+/!K[OX`;HV2JT&H"`3J\T@=@4=5%^"V@>\X0H MT\Y#X.!W\RRKPE-+-*[6ZNDTRV:^X?>XS2I"9=S:.#YEY<)75F8D?"16ES6PWLVDY;=)&!-:V4<-]Z8(%0_K$1/<"R0*!]X$$HT/QS>`\FIJS+`7M0-K,'$X89W^-/ M^\PVSBU3DZ\/6MU#=8-#"^Q4L$#WQIP%UB,+5+670KH(5`N3YAEU6@MWO:'H.I@(X$=6YE]5!C/]WCY#,K>-@OR9\P@;Q(\,ABL!WS/ MTL-V!G9X(]YF>]<7L`%HR&6X`"/#\XI7;!\V*58D)9H`%7I"K\2^\70>`SY- M\`:W^18]"!$*7F*%OX'9.QSXB#MOM6H#4P/4;&SF@NJ]O3BSOD3"46X;_'Q: MLZ7/CP(!.@U6>PE+&!;8M7.,]D7[J`64R)/"9I%)6>+"2L@#P_>0?4%;HNW( M^WUN*V=KFB5B(]T&G@?WTY(C;HN^@(=&*AVEF0!$7MG#,"^8V+0I'SNOVM%* M7N:A61=O@'F>ANF`X`AP/UVW9(=0$,&1Y=S#EA=."VUA,)6GYX2>"/Q`K0], MG=CH1KY0U1B8WT#.5P"%]+J)7*,P=PX.WOSU-C-"\W,Y+9C4UEV.XY%D[MBP M0.1K)W&>YO)V)HF&H?+REC,@U7,9="468TJX:5H!CR`&.PHVU.-30)$?Q40F M\(30U"\SH'%,)(F&!0/0E-GVY2LTX>DC!Z?$\TV,I5=8QE6X[N3AQ&(']\\K MP2IX?=Y@L6Z3S3.N_ZN2@3%Z\T:L`H]9H@/MH8-?99Z@>4!(2NQ[C9LJ@S2? MOX9J0TJU;$K8V!OE<=Y/@=Z0,T\).`-O1`[`?3(;YY"+"2VNEG.ZJ[@7LVUN[,D]6*IXNFB%)7C M/U6N]J7O)4YYFF/_*WB<3*T?3*36=0CL4R0%:JQ;?H^3F4ZO[[U/"LP*-6;& M]T_6@\V99"2=)4VRC=44B\_O+#-ZSWEO]LP.XYF!M8W&RA^WB,._`PS_%O.Q M<58'8`<7YC7QRJFJEC.727A//.A5<(.I9UVW<=7/$/$,3`7N?!HG+X]_*.?5 MJKS/KZ+3KK(*76((F@L45VX=+YOG-$.O>.%'$PN_\OAFEKW.11^K17>.P>96 M/'OIA^=*S^;4;/8638,-LD2!-#?<175RS8)P?`<_E$Q;K\LII"F[CGSU%3:' M]:RP*6D%M-H:F^JU-!5K,J;#DI7C4_->M^+:BL-WLP-Y1L/BA:4P52D\+W*W M=F+=7/Q\>G=Q/J/2RK*N3V_N?K?N;DXO;T_/[KY>79HK5AI1L[+ZT&PS(K-? MS3'VS[P71"P8QUY&(?.*JD&YQ)BS@Q>,F5M6BW":AG317?U9@%X!UTR%=S\% M/G/&UG\X/#VP;FV5.Y4MZ^=W/[\[>V6%Q]EMYEE[4 MQS1BH(-5<0#0D"96Z)^DA6VEALV;62'CD4]A8-`ZGN#!'_U.YJ2H%':!M$^G\ MFGI50@WXP#@?X(B.IFH:K+`P]J)B]#JS'@_&=:N3DO!$?I/>P.^5:YK[T'G; M@G\&?W%8LQB._"!L&=;%G_`;/1\P/(I+>/0#UP&K@K>KD-R9 MU7A6PFGF8)]GG8X"X<:$R_^TH^>RK?D61-,NB($25!D#@>60`1`XIH`8JKJ)+TP)3ZU+2/_F@VXWZ^SQ&TZ0T"%[MPZ!JS7$=3#\" M<"B.,+&P;!#4II[%'&O@VPH\$<0RU6AB^"@8^25$_8;Q:`EFI#9+IK1X><67 M*O13.-#1.(!D?=T]U'^7L3+'+,!<):VQ!X@\TJDX=VR#Z=GOWTY>;J MV^7YWMG5SU@+%4I:`L MW(*KIC12B8-E*CG-7*Y5>5BW/BZHR*:9VFY-@X_.6><5:0]6Y*7&0URRT/>C M`%;\-_B^H5)`AN4AI&8E2LHXD1(3J]JN+C%M4GO%G/B-IY%W7[0I,%!JM\P< M,"?JL%JFBK^G5F*N#YIT[LJJ&R;8#N=78L0%/FA*/%#@81&[M"-]]D#5`P`- MX_RQJHX1N0J5,C;-3^@T-*_8`Y]!K;HUW]<"UK0C5U64ZY*,O(Y-*94I*V,6 M>%I]@0^*>>S0#W'I>8UE&.!UMW6`.FP)1:M9#F*!K$&<;_`&H3WZZT-L1MY@ M@5N:50%5R"=S*B?Y]$('TPNZAT3G#^WWZAA/$N+Y^>>SZ?3)/G8^:7O&K;TC[,2/[L"59+^%S$+B%2/;^COP$FY1^9E;S=[^A-`P\5 M%PN;UH[_6GW=*IE;2.6^<,)3.QUS0?S\S&3T$I@0UJ-RT[GU%-YO.-Y>?8+[ MA284W6R"BQ%\T0F>:J/[)D&S,YWV/_6<:N4'^Y/M!Q:9[%%AKE6FDG+`@ABT M#.I6PJ!%YW50.J]+'JI3@G&.>350N0!_'I8V25F(/P_FL&=A>K>IE7&!A_+D M=N:OW]=U,9V#EI'[:/Y!V9,*3T\S"NM4W!;>9^KM(LN/5>EX?')H#0) M[N%QT]Q1V?Q(4V7!\+=\7JZ*MT>QM_JR6S-Q=%4X7\N^YDUT')ZW#DT/CN2Y#6*3T M5%=RS&,:,R,O/1M@#(5=>=8O;&P=E)#-N+")7@<""_9Q$$4JV(8'M,.Y:OJ6 MT?NY).JVVH#DE=]U6M6=XK[ MJBC946QP(83U9]ETUQ(A"R MVJ+@?5T)W4U67'E!6.V[JF+?%2]9UT$?++;B+@C&?F$37[[D'[Y[Z@6NYN#_ M#U!+`P04````"``N@*A"MVT=D*P)``#7;@``%P`<`&YH=&-P:RTR,#$S,#,S M,5]C86PN>&UL550)``,8KXI1&*^*475X"P`!!"4.```$.0$``.U=VU+CN!9] MGZKS#S[,RTQ-I1T':"X%5(4`&=+<#@G-96IJRK&56"#+09)#PMVMK2S('_RT4M"K`@)@,V%JSK\'*;\S]72MH%<_MU"VH MG6/&?VLQV`7\&NX"PG_FOW<8Z^SK^MO;VS>+WTHM2`#U?&(!*BYHA<*1)O[] MYY<#`5(A0$#L:_<&P'I-@KYYI*V7BL5-/;IQ8W#G?D]SM[>G!;S]NI3#I M1MZLH3]<7M0M![AF`6+*3&P)``KW:7#QPK-,!CT\@UV:]`[Q4R&ZK2`N%8Q2 M8=/XUJ/VQM&`.4T[(!X"MZ"E!:;OLWX''&Y0Z':0L"BXYA#0.MS`#K,Z+P7! M8G%ST,JO@VO_<-6HAZ`M^#\VD7B:N@,`V]!$XW>WYQ_/@4WF$Q,YP$3,801@ MFUH>Z0@]=7&O+FU*/U)D\#GFX*#.^&<7X$5M'FU-5T:T%C4Y:D:/8@$WU3*1Y:/`@2ZX83&308_Q%H$=&2U:S*!W M?J)S?.19,4PDO-DC$20RFP`=;OBTT#;-SC]E2@&C%9^0H/<-S<(%KY@"B M/,HFH*Q!=T_B)N1^*Y-./FA;W;`VU"OR(S@QD"22.AK34P_%-\3K\(E2_X8G M(8R/*6(\Z8B,4U$PF8BW*AT]28?)1,D">EI9JIYGOT&$5$CPT?8JT_U)@"2$ MIZ;V%E!&H!4F_>-IU)6'+77A?0[TU1AJD\29AT+9*)!2O:&!1JU0R4"K.DI( M:`G)WQXC/Q7W%]!L0@09!"H3H`241=P]2L1OS+[(PI[]FDD(%K+C&634TF5U<7*56A(CN9U-7JS+->'`_Q)JF8P;&^ M"BT24!8K6H5]-FA7V6I1$DS.+BV7*UZK2N!'6CE,MX3GN:Z'U?(_AI'O['LV M[L>)R;HV6+9M*$PUT8T)^?R@8G8@,Y64"F50^>OJN(`38?'"%%E1429R*NA;!:A;VI!E[VOENA!`,L@G[52X\2L\\ MPL'P8-RU^@UB8AHR:#_[E(7%_^L6SYP4S90S-W-M'%>%1+)JZ*+%T#*VEY-& M3<52;2-SVU M69?'3+IKPN:1`WUD<^#1,K<,CFX.33T25@D/HC?$:ZE)48:;3^N^=1,!&M:, MQ*(P5;0Q(1$G]X)G@D"Q7IM(CFRFES)\4CY^!HW7N7NH"9EQB%5G?8R2\3!8 M6*A(UA&G''B8/>UU>,:C9IP:!TEO<-`-@X&"4LZLB+IG0(W9,JC\1QVI:F,. MF\14EAE/'2!^N3TX+8,X1-EV(8:4"?NZ(+1/B3JS(7^(%1RX^>O^\N?6WW\] M6!V_]XBW]^SWG6[[L8_O3ORWZ@[9V_E1>KYK]"G:Z5KO151CNW>5BQO[\0EM M;N.'YG7EY+Q?;;PV7?^9_BCMZ/?O-<.M(ZM7\^O/;A-?H>9/_=7X_F?3;]!+ M=FS[UF/WQ^W7G<8ZEWYV[9C.,:% M4WKTG6K-;9O5(G*+N^R=V2]/;-MZ^OZC=?QX=]9\J%*C_]2P\66S_GS\^M)Z M^%NKU&_#8T4KWHEG[%^2[##ER@Z?_UDPL)]_1B"@A4.['F'P/;BN9H%G!MQ\ MZY(S:38;?UDO8$>6?<[8E0YE0S`YE[XF/'ELE^-PHC%Y"%CAITCH@!EG1)_X M_!/R;8YU(_HMYX(Q`IL^$YN6&I[8^\9GJ/P!46`U`P1018.PU#U8Y[G*2H0R:#RG\W-(E@"1?)Q+Z485X!]]HYRUX1H MT!6&EIG#JN6Q2:&E0J1Y3]%2%^6'6M+Y5KT)+A_Q__I/7X&N983?^9=31?OTPD* M!4O?_J#(TGQGU'/V`U5J33Y`DG.4C%[%DK)2*-ZSP)O@+B1&"/NX?T?%BNG' M_+0LWA`5+`XK2I9F1?\W;LZ4*)@^R*QTAEDDB0UEL<&7U9'[KGPQ8!'.8$#/X_QR,'3A55%Z:`KL14:`'Y M9J!5LG4V.Q5'#JDN6T\)_)=45D9UED?HI,!#N^J6*NXP;K[)NR)%8\1*C]ME MI:;D<.QR))6!?RU=I13+3NYE)N[(&=OEB#H*^O5"[QBMH9"[:@+N8-8_V`N? MCXLF@']!%TVB.%1V3YF+CK\88]!? MS#DE_$:R;F;EIA*[16R@N17OD]`7*-Z;_>`T7<,K6Z\^)$#Z9E$EQ?W9T5>T MLCFA+\1J_W/0/+XVD&EPBK\N60>@,8A-;>06A)/3% M@]"91VY!QR>6PVF];@UMP%$9?":@KN:X.4'ZI)@SB559K,GT3VG<``(]>]1M ME&P,F@<_9W'3<#4L[SQ)U92=[U_H\1-C^)0_J'35@M8[+IU MVN/Q!+?!K37R2:N(WJX.,/K@5$_1]02P,$%``` M``@`+H"H0CY;'3)V'```^QX"`!<`'`!N:'1C<&LM,C`Q,S`S,S%?9&5F+GAM M;%54"0`#&*^*41BOBE%U>`L``00E#@``!#D!``#M75MSVSBR?C]5YS]XO2]G MZY1'MI-,+I5LE6S9'B>.Y6,[\29;6U,4"4G(4*0,@+*57W\`7F12X@4DT2+I M8%[&L25TXVN@T>@;WO]M;V_G##F(&`Q9.Z/E#C[^'S;[Q\[>SK$[F]^8>.?< M8?RO)L,+Q'_G+!#A_^9_GS(V?]?K/3P\_&;RCU(3$T1=CYB(BE_L[.W]OSM\]>[PY9S9#OVP&R/V."+V;RZ9]`[W]U_TH@_N!I]\]RA^D?C\PPO_TP=O MW[[M^7]=?93BM`_R80]Z__I\<6-.T]+$]\:N]@\.]%P>_/5)KQ2+_C,569.(#O.H%?]SU`=O9>4]<&UVC M\8X_QW=L.4S6W!NO^[*4'C#[O.E)GSO_8$W/LO`G)_#W[W)QXH,FTT908Y%39?,A>![XK.]S*%Z M_]R!9_C/*X/SQ*:(8=.PJ4+^UT<&F\ZYPWE!-XS_/.,$:TYA?32?[6WPK582 M!8/#S4HH0X*FR*%<#09T^U&4Y&J87:78UK%ZZK`J: M_M>4[C\QXGY%3O8A4-FOS,V^TL44#%F=F7W%6S,JV:G#S[[:I=PW M3==S&'8F5WS[FAC1HZ7_T[("CSF#J5YEM\;(1E6.B=B7`39B,')5^4;?5@G6 MD4'YH>=8`VQ[JY/Q"I&;*3\3?8(5F)485.TJY8O*$K3X&7B#3(]@QA?7R:-I M>Q:R3HD[XX?[(/S`L6&;GNT;WK3J!&L25*O%KA%E!)L4.IUC;#1`SL%UQ.X1?!MBFP>Z,73+SU5<%-G.'BZU$@YBR7&>X M0B)/AO"!O/*G8N&9N!>YSIZ%QH9G\]MO2"8^A=48V&$]_I5>^)G>YM>CU0G, MK#LSL%.9U^#;P-!.^1#$]$9H;T6Y',-I`\27,`C$/C1[,S0;(5(2W\17GU0! M!)N&;9=C3GSAB26^6+&#Q?ZZX,03;*%'QGW9L8QOS/E0N&LXK.^8\T%3-_YF.#COSIAU_FX!T<]I#- M:/0;H<@.]_8/0N_GWW.HQ)9:=:9#"PN0X2=S,>3T2;A]DN29+X:(E7!=R"V< M\#MC;K/*R(6YV4"XQ$+DPRX_S8(E_8I;EY''%D4>$(.L+1X9?*2^-&>H_8I"EE$D+3$:IFC979HEE&9=7-E"; MD@.0S+%M4#H(#S=HT<2)]>(*2JUT-D_M--$4K=!L(24P*Y9259662?3/_:V+ M"EI.D2D()BB!62BJ@QQ1E1)4>&VX=9EA?P[M%\FK1OP[8%IJS;0JQC9%&0AP MT^8IL>RK8'F#"$:T'\:B,=>9*PY]QT=)F"6'`UO@:@4@"X[$.J^HDOJ4(D;[ M(\I$U@"$%EJCT.3>D+.WUB%1#WX4]/.("(CFB2`O9)CZ[2;A39](;+EG3!C( M+!(!T+[CQT%/[CV\,&Q.F_;9L4'($CN3KX;M@=PKY`C'-6J+1%42/9G-44TQ M!5$L>HU,Q*ESU7B)6+B`0-14'KWD)F^AM/+1"H5TJ/[X..<'E\/_O+Q$(%)) MC-_R'9/$(L3\A?*-,6131`)N`+=#"I76;X(T9$(QO(2RG"`U4K?03P?^%<0M MVIUS:WEY91M!P(,?3W-AU0'IH%QZK1=+/EJAE'Y7+Z4SU[4>\)/G4Z5$5F.W M'OTG%$*D7ZM'^BF3(-UFNW0=$TY+E:#>\O.[#(ZA--]`GNZPX&-$;;]E"Z^V7Q_U]2U.34J-AU; M0CJEI&E#!C54.:SD@2R\"-9P8\6YJ.C+2ANB28=6V16ZZ>I*!46UIWW="7!E M+(4'8`O.DC5*C1[P5815A!R@W]TT^1!ASNZM\8A`;Y*9Q)I5;S5%E@6@A+NK MCLQB7,/++(58YV66!J"$NZR&/;U-P150[*[TBJ"4<+55$N$@C(A>HP5R/,AC M+8-29X^U+.3@?',11:Z0M[/;\@EVS7B4A+'8:U==5VY1269JQT[*+!.]0L]? MW=LSH)R>EXARI)/MR:N6>^#.9IC-_)"Y8QV[?CDFN1A* M./TJYYUOTQ&5[WKJHM@D_$_YSL2:N;4^?;#W MQ'!HT**B;_WP*`OS<(9C?M$'43(56<\*E,.$./B5=!+.Q,MB6A.,E.BBF!67%F9Q7#(DFV/YD0-.'L M7N![3_A2.$HI<>(,\DR431'HD!-NU+I=.'JF`Y0H4`JFKN4#<<^E1O7!KJ`)$ET000;L,#X MD<^(2^D5<<0:'L[%N]G\7G+R..>J-*M-C:("UTQB7=@! M.5`5^H*K'PM^P1\59YS(`3Q%,+626:0:OFX7KLZ-0R(-KD+KJIITD,U_/0E> MGK?75LZM+GCQ4Y"1:&Q;3PA/Y2*@8HB1:?_+ M&:G@P#6^]6MX+EW'39(%/(X**';"M"L`#:8?QM."X#_9GN4_3DY\.0Q MX>N[=45?5]=A?,JVSQI#!%&@EP5J<=0!K5@7&:.^*6$-`=.(M4 M)T)KF3B!=M$05W"H4RTV>A=491P,B;88U>QQO,"6"$XF3#F!_H+?T2;HTA-S&(XW$JP@`QBE>>B$ M&5$>6:D>,K!B!M.6Y1AH]F"KNB>J2%]6]ZJ4>JA3MI)V6I:%1JU*0,%G8RY9 ME]RRO-64AB,ZC56GL>HT5IW&:N@T5IW&JM-8E:6QAE=T9(D>@GQ&8(D3&90Z MX.C+PJ@CME5*<\C=JOE3VI[2]I2VI[0]I>TI;4]I>RI%3CKOH"#O0(T/,HQ\ MY#6_CAI;EPZ'EAJTQ>9K)8PDGARMD>-8HD\YYR9(2=YZKWD@3IN+W5;9)1N9 ME@"B`SHJ4SB%7"YYY%JL':30DGS,MO$;KD&GI[;[L*OBEJBOMOIJJZ^V^FJK MK[;Z:JNOMD]WK>B0I:>HO@M9.R]RSI`5N=D%4:'>U[J'>;*;L. M"QP2JK19]*C;ZIY#;]UKQ,T.$]MHE2I^Z_(?Q0PX)Z(.P#I:JMA*:JEV3KPP MV*M^TB%:A/'::XB-FAB_D1LHY%[(JF(':QGQ2P;(MR7!RJ'U2A;,U'`FB)X[ M?4J1_Q9[_+&VTN:+U&A=U:626$FXBZN6UA+$E\4`!?_G?)BFZ_%UR%8\N75L'SE()3U^"@1Z[BRX7G'%LS/;D62<8!,M*$!DF$`1IJ75)M$@ M(."[_%F@'[8CP12ZSV4OID$J\2B"2H&*]@D-R72#]+/9GQG(PCR9D*WBKXSE M]H_,B&BSU9$P9^8*4+BN0*G$^:#6JI\&VKI<,\@_,PEG@2SS7(-B6<>L[JT* M.4[WN9RQ:9`"]@9*.PF:DFH6\>FG_$+%$9\R%0@1EZ#>I+>WCI3+ M`"S5!ZE^C%JX1JC*&'7>@)V+4>>B(Y,%7#%&;2S#<$+?O/V MP:_'CG7"?SL/4[/4Q[#EJ;=F(THLXT2(NP3`8%E7FSK_FL^!8#-,UMS..;I& MLZL2+083[#'O#*V>,H$M'IMIU+LJVS(`*R_-2./_%#N&8RH\-/,&[-RAF8N. M1.BLYJ%YZI)K-/>(.>5J8#B.-9J$/"QSJ+;%32^Q:M/.R#P\8;)),O9["O]; M5*AIU%NC4$N*M@S`8,?FR7B,3#8TO\3]A@RT,6ZQ! M"#F7HM_1/5P.8YB'S]*I72&"76O=:H.0ARE`.P<($EN;J#2]=AG9KU"'I\D)=7JC+"W5YH2XOU.6%NKPP M14Y''N4JF-(!HB;!\["%A.A@38?C*X(H9]VO#KCEBO;(!G)Z5."B"YUXJH`K M58/1E"FVKWL]:&-,&V/:&-/&F#;&M#&FVAB[P1.'$S-%RD"0\>X_NFEC$R,* M:H!)4FYUZ+`LBK*!B,:,K7W=,%I;6MK2TI:6MK2TI:4M+966U@!3,99'@@24 M50^,:V0'CS=01I^Z9*RR.R%-L+HL=<(VJXU[^XVV??UNFC;;M-GV3,VV]W_; MV]OY]]WGKR__\^]_F7/O\9OSZJWU\_5B\FWI?!EX#V>OR=O7GPY_?+E=4OOU MPORY;W]D;[X<7UQ9W[[;+UXY_QH-CP?GR[/;^]',^T$_';[NW?W\>#"[L/+-V=W8WS\\^79S^^(OCT;WLV< MZ<''"?KX.#ZR3P[GUZ>+V?VA^P,=_77_>?#FY^A@-N@-;T=?O]_][_GT[<%W M?^:V8^7WBMK>C`]N)@>?O.F9Q]G$^-LWY[MOV$_ MF?77=_;*_/[[I_'1Z/23_7GX`K^:X.']W>P/NV>\0:?_V3F^N=[;4VXK:7-6 MF[/:G"W9?'^&@XYQ(M_+]5U>R!$.KR>+"]1Z+7>H%4: MA&ZU7:KM4FV7/D.[5-M?VO[2]E=3]E?HOKHR"(L_QK0MXZL,^4ZX"4OAV0&7 M8&A]:?-+FU_:_-+FES:_M/FES2^%>7/>B*)[CS-XL@"/TV83ZT))0@Y4K:T\ MV,SB.UKZ/RUU@IPVJ;1)I4TJ;5)IDTJ;5&HCBM%#SWPJP6$+'#_,H=<)GU4^ M8F!=C[Z('EHGE.$99Q+D^%FCT$1'FW*26(<$KJ_JZKF"+>R03%KM%T@V3'#= M^TX-3/S^-L-QV/O(L,\=RL?U@_KA_0%`3G*$.]`]2!)!R>Y!%6(J?OMY\?[A M)$!G"YNLF&@GSB()["2>N:K8AL\@#K^JBV9A?B;W%J161++UV4:%F!6^7%6U M,>9#S+E"7(?_:*+8]MZ"\$KST(D=6!Y9F2>MF@QC^K=\JAN`:*^;]KIIKYOV MNFFOF_:Z*0]DFE-D>;9P7ZQ9A*)IF-EWK`&V/88L?_/#ACDKLM*)(&A5F*5" MI#6DWN?FHB5(XP6Z0:9'_$;-)X^F[7';3?1Q%D6S7M`T;I/[+2T(95QVP`D" M(1L)?V3SAKYN/J.M?&WE:RM?6_G:RM=6/I"5?^GZ3XZ)MW:CM^7\AY"^<,QH M^%+'TM[_=N*L;JM!&'6E<'IGQRZ[$3;<=J.TW:.\0GDRYH=I?(&),T*4G9C8<^^8J'7J, M,F[,8F<")MQR#'0AE%$24IB7&E.C*!#R2R?4^@MH!C[%F9-5CJ7HB=;!1JRB M]$$E,52+U5\)/,"2(6L&C?HSD4$&L9/4,-:$X5)ZF<=WHB)YR-S.*FW>T)-3 MQ:I,^6IK%6/.;(LS7:%-RY"K9HW+B(GV7@UJ`"N3ZJK4P@PI;UA%6[0Q,UEH M\0E:&=50P&]4;^)U?0RX5;-(=2+[/!.G4#!OBPR=1MH\%)[-;(JBX_[8L$W/ M]H]INHITZ#B'CG,T$^>H:5<>+=,'@(J60++;@9@+J+3`(C?I1"^-&8(+X!32 M!+1>I,(X6]AXQ2LG+H/&Q`\3'));`/!+("].U+(U(!=TJG:],0@Q'/8Y82`J MO;PD"#1LZ\HJO,15)8F0Q&ZL6)R>R!^"$T@ZH08=.U6$DH&6VAABZ%,Z%BE> MA&%^]%]Q.2!"0JIQQM/DE>-:*S-F1T13!:WBL*#VD;?#1U[N#J76*5Z<:-&$ M4=/HE)HR%7;"JNG1N./ MD?:%"3D)FG4<+3>>(_4Y>V+/L:YLPX&]AH/P"7&,YS[P'V*4Z)3=\J7XS,[]LI/[I0__TBM!HJBF98O]JV_<=%/OKO'^*^O= M=3%*E)2T?"D^,[U;=G*_M-XMO1(DJFM:MMA/73)&N+.J=Y/]7WK!IDA3LAZH MJ8ZG`\0,;.NG#70BB&Z6U>JD$-TL2S?+TLVR@$14JEE6LT>U;DZNSVE]3NMS M6I_3^IS6Y[3:A[]M@]+A.*RC&Y)KX6]:M95;58<<T\4VNMA&%]MT:C'I8AM=;-.AFHPM M%]OT;?_O87/"C?F=/(H?0(+'!8S;/! MQJWQ>(0H*,F-.71+^2GSNH%-++GT&ST:A M*11J8=Y_(X50R7SN,^)2&'\:`)N=,)Y`Y"/[4$733MY]W5-)NWD;=/.F1E.@ M7+[9Q`!/0X7>WQRPH.[GJ23A7+IYY)KN8%RX5`M%!>UMS2$*XS0M%%>SSD]5 M$H/S9Z[V_!ER)\283[%IV.!92AO$NJ'^IP9H,<4C<5V,"D<,&3+_R!D@$8@)PN"-3I M2)V.U#44J0O>#G]B67Q8``3DR\DC!Q<)4NC>R<5+O<%;0!;.:YU/L&$?DL2B ME9`9<,5M+E48%W:QT)KU6JF4&VP9[C6R1>+UE4'8\I8;%]0P_:R@HV7\+V`> M;WGJG5":9=#C%Q7%) MJ/-':13Y;#4<@[L`!:BHRK6[Y!27UYQ!^D85\WV-:QAF8;=WHC MBNX]/O#)0C`#V`8JBU1'&D)E(@64:;U)#C`?/I-8\_GP^0NT0$)E$E?5B@DH M(3Y/4(TFQ"L0DYQ[K-ZQ$Z8Q^!UWP*M_-HAUK/IG$RRH#+97#22"?4Y'6]R#[-.?+!0@:KI>+GHHIM'JX7OZT(/:?4 M0Q9(3Z$"BMU)X,TTH?-Y&Y*VHGS>O'!%8UZV@6OZ#_'U'>O$87XX9NR2 MF1]._D7:\%@(_QG,/:JXK$& MP`-$38+]UH\*<8Z/VFZK)1V($/3?%5HMH61I?7=MS MF$&6I]C.38`L)X;U8;NQ"S;`")%_JWX7^!2..5L3ERC3/0[W]SU!:610Y"/P_U!+`P04````"``N@*A"%^\KTV@W M```-Z0(`%P`<`&YH=&-P:RTR,#$S,#,S,5]L86(N>&UL550)``,8KXI1&*^* M475X"P`!!"4.```$.0$``.U]^W/<-I+P[U_5_0^X[-:572?%DIV7O;NI&KV\ M2A1)*\GV)JZM+8K$:)APR#'!D37^ZP\/D@.2``CP`5#Z]NKNK$A`=Z.[V6AT M-QI__>_=7?`6QC#U,AB`VPT(#Y]ER^=@%QPFR]6U'X+3.,-_];/P'N+?Q?

/YQ=N`O1_`_O=O7G[[YN4WX-W-(7BYM_^*3<(SHC#^X]9#$#PLHQC] M[2L.V<-M&GV=I',4>;%/D&`PC>(_O(L\;TL3&(-NH!T!/FOW6+8+OG5 M[O[+W5?[7S^@X*L?&><`^&N:1/`*S@$E_4VV6<&_?87"Y2HB%-'?+5(X%U,2 MI>D+,O]%#.\(\PF6UP3+_G<$RY_R7Y]YMS#Z"I"1[ZY.I8MZ78'%)KVP2N@- M3!'L1"TWDR,Y(K\XPZ15B(8/&8P#&!1D$S@*25,T5*]*P`1TXE>`1D1EDK2` M23'_[:MXD?FK/_Z-/RN41&%`*#WP(J)NUPL(,_0N]M9!B'\[NT49^0BKK&33 M=\F7L_>*:`,@A``8"/"N!//_K"XJW,$3;%<[2JGB\U"\HQ3^V+#$?\<)/,-95MAOQ M"YVGR;*'8+.D*Y-&$&,TE`3WNHL0?"P`_6LKS:]+ M;!I@FL+@71QFZ##R$#I*EEX8"\TP94)SD,S)O]ER]@E*'B-\3&O-S= MV\_WIS^U([.DCJV$2`Q(.1[0"3N`3@$?V:2MJMG4-&T)$LW26_B+'SMJT0PA MK)[B;6<8U:EA>/&CK3U(3(!$3V;7U\#T0K.9%D]Y1O\$F"2*[ MSSCJW*SWX2PUT)THTR9VZ*'%+`[(/\>?UN&]%V$4:)8= M>FFZ">.[]UZT%I].>^YM>H@K"QO=.FO1)/N,\23@Q0'PR0]P.]VM[3:2+V_2 M]7EA:NC+305]B.'?1O`<9KF2C^)-J?!9=P04Q,C\K'P*2,LYCOT" M#0%6O(2V-7#QHJZ6I"+;`%3MA^.:#<$6&Q;BR8)$DV@`X%?<70<:X-<2+Q.2%;8W2*, MKA;C:T269%[4?CQ7:\0-`3(MC6A5AB'UX#)-5C#--I>8*QEV:(@SLUIBN"/M M%$I\MNV&BAAIU(]-H;XL+,;7MQ4WBJ,CRVK@KV7YW=7J;9($G\,H&D.%2MBV MU:5`+%&-XL].([]UQO/RKM#?7;97$)^M0S^#@?@0=(ZI'&]?,<`^O"/:&A'6 MITZB1%L`]*3L]@1C+FE>W0QY,8"7.Z[FB1&]^-&)G]NJ2,S5G81#HY20Q,MM M*D<_3W<\%W=P#=#T:Y4.[23D7N5\TX/M*]FST+L-HS##YWIL7:ZSQ/]CD40! MMM'$RF2;,7./VKAMUL:8$B=1H;/3V<'IV>G-Z?$UF)T?@>N;B\.?_WYQ=G1\ M=?T_?_KAY?[W?P''_WAW>O.KV^W)5/Z\!AJQR$K*I@MEHC2.OO2$&9ZG+TP>2 M8++K`XF)D&A/,1BD;+1C'T@M*EYA%*OLZ@,5(/&V:,?ZJ!%:#;`H26G3'>P/ ME6>PC=-=3$N$(C62K[O/I2%JU2SN9-(MS/(>9KAY%94FW#E^"MD9@YU+I3M] MP_@C*HTE?6E-WFCK2[4R:3KZHJP3IQ#>.[9!9DD@CPV?QFS;/ZBGD($GC/7JA#'2)G2(9[9Z6"(W5TXR`@-8+ MZX@,W0%_WOMZ;V\?K+P4W)-Y?P'?[NSM[9'_`VCA84J!M\X621I^@<%?P/[. M]]_M[[S>_C&`*+R+:?>%:TAN5X`9V6M(?Y_P-H)@54>X_^J'G6^V\T.$2!R' M;%').B--<@)LWX&7@2/HP^4M=I=?[>^0MCXOZ:!?L"(NBE^]V@'>W5U*F[-@ M[PAK3T`[ZK"E@&0._OSJU2O'-DJAA,(;^#49]M%_LGO?QF9^^;'Z@&TO]\M?/JN]=#Z3"&L8*T-5:T<7P54J(P M=8>LP?,^M7E!$)*/UHLNO3`XC0^]58A//:-D4B2HK-]L%-,A2Z.4H['.AL%N M&`.?37!=L=,BNDH*1;'D/F7HF1?&,#CVTAA_\9,8=FQ5E1I0)F^KH M"&X"%:.VI=BS(DV.B-6E$'0G20KQ08K%2?W-3>K%***'F5GP^QIE^96\B_F- M]S!2D11^;]#E0II.0-(PXP="A7LAPN.RC\/;`R+E(,9Z6,,;_>Y]$:\R*=%.A&.LG M"K'>8`P;,@X^^!"A`BR)2F*B4$:=\#*.3?[$HHU?`P4+0D1'!N&\^,TMS#Y# M&#/8%?IX$.1[E6!'-?1.=N8^=FPI>G?I1<&DHW M*40T*[,PZ3T ME.S&,!+L$[`203^E&4Y;1B+'9C.1+"?#T#*P7/`T&O]+!=BF3-S*>R1V19`O MMOEQ6]K$HW2M4APMAGK%%19,3KD$0FW3L#HC[#X[8W`:T-IV5$5(G*OZ_,F? MG?;ZV`NNL,3FT4D'K65?58,DK4HG[0.3XUHCD\.2+F\Z7Y_D$-@X):G0V;]D M(*%$2]M49R/'"J;C5;C=O]9J$PBYWDR&M7B/;?RH'LS,^XY0;J+TI*%B_G%BKSC M2S(HPSP]Y#U*$_Y9[;+6C<;6 MIT9UA"RJE/O_3=A](I'77@11WO""]"U'([U'(,1C^S:@@`:)L<%_`8@,=YU[ M4,FG4J\C6UN/,QK*+N84UG42C>1+5U%8#P%4T$OW'901^U-7!S>.C5`F55^F MN:C..O`V31"Z3)/Y.)<\>/#6NWMSR&4/39`18$6'.!:\0!"5%R=J:^D1(:5?3DR%^V\I=3(.LT4X\L6:6]<;Q>MTJNTF5&NU^KU*B4I(D=1 MP'O7KN#P,NCMV!UN.T'.XN`$CM/#18;*=BA#0H>LU=@$.V:V"*WA\$D6VT-K M8(1_??<6QE@M(PQS%BS#F'#*(W>GFTQI0 MKP*@-%\D?>1':WJKG4;6=F\]1%XG2I9D`$MWYH-IUX67>Q3B7_N/&AGIGJ53T%?1MV_C".X2J$?4CG@ MGR-(+]5@7,LDS<(OE6+L81LZ:N"U67.A0Y"TN^-V*OL6N#G.%=!$PM5^CYH, M&=(KM^*-N[@?TR!">2$F:;B!TW+]M%R^?L^R%="VEP!'U0T.S?#)!&WEV%*A M;JM/Q%,HB6OG3B$IH7K4UMB[:>QY$B=5V".ZY4;F M>>T=6F?M9%M%VN@JJUY_YT#A5E=/"R_VDNQ^>"/,V"F+7/:Z2`OG20H+/::/C3B.:`ZC,;Q^#\"_KIMP^?9) M_C$=X*/(2#%S&2K;!V,)':VOW)!X^GU(0A;@V2V;\WP2JBB57E/'Q*ON]3@\ M!C*6Z\9!'V/;;3-K6_2*7"LS3,Z/@$U!U-YQYU?2_?&0\#X,8!R@:M7W*-$# M":I!K<5KI@DQ+5D/5+H@(4?OG@8(BMG.]:1%@I7H@&+)W2T&_F:VV]WLW@LC MMK=QE6QYYX0##X7^&*IE2H(#C\J0Q%;[!+P"!L@2FC0HRB!S,,X5LZ->\`K; MA6D=>W(P/,65`N,"2,ETFV=+)25J7ZB\(N*JP;N6$+CJ-,4B[5XMDQ,BRA0W MV#V%/N[#\;Y?]_:BFV;3=0HS(9MY"2('D$Z5_:^V`X<;$*T7&&W+Y@GLD M(NI`C\)HG8USTT:&RO9)5T*'M*R`_K5=>::@.S7IJ;2'7W5WO_4##.\6I'SY M'J;>'3Q?D\[M%_/&K8LQB\Z,:1BEX6!;M-J42HDZ%F!V/08'Q!00+6AM7-QQ M7K[653UXQ>W$.+NW0+N0*')MS(0[E?HX5T+N=7%>%^%H#I09`2[R:T84MCI> M;)KC?F.=I-Y%3ZN^V9`:FN_;5BZVFI(P0DBHHY+*2-1P\NJ*.B$];9.]AJ8J M&=/Y7<#\.`*#0ZZZ<0R-E&"RN]V+B5`]!*BJ_61EHOBO6/=0K8WM"M001Z2$]_5GM#M71,- MT;C&J\U:6Q&.@>@UO,C=I@L3BL].3#'V[#]D6\UYBR0M2-]//77?Y5Y5+D+5 MXQO%PQK&FX<14(M..BJ)*\N(1JZBD;="]!V=AJ!XRYKYR8W;9 M\48[4B>\?&DD3==Q)S=2[15M,GWBQ_/S.R?6W[0:B5*;B<%QEM#O52OGA23C M:F"C+'T<]O=KE%HG:,S/2(7.0>&4@AQY3[C&9N#\G>4V"=9ZP"F7/'3PP4.+ MDRCY/$+_-P7H204:I&1V""]@6(`">P1!A5;)ZYP8U@$U.D29S,`,VN_PY.SBX^7(.3 MJXM?P,7E\=7LYO3\+9@=WIR^/[TY/;Y^X_*(8RI-7N],6&/;O!C0)C0J.G(3 M&Y*G*\3A8XFJ,U8U_K;_-,*(^]W#B-L#"[I)KB`A+(Q@67I_D^`?B30OR66Y M``8'FR&,\[!8'=39#[H`B97G<)!;'FF!A8:TB@NT"?TOG[@DJQP7N-UP[2B\ M$MT;-\>@,16-?^-]<(G8O4LP./VB#6APE9)XO?_1+QWY]+DOP??Z&2,.5('O MH#R*Q]^KB9/K!DZBW;NQ..O95'EQB\ALR$J!W,;5ABCEV3,O70V_4JYI^/?.(^4F`B1/]]H M<\6N$Z%-E_!TVBHNX6[_%,76;V_&'D$*L;4Y@NQ?C,_WDS7V'+#?`,-[],@7-G&YN_0V]CV[`JF3J^&M9+4Y="LVS/5M;VV9ZCES_.*[=R@0 MPD_7,"A;_T'K*B=!/QWE$Q/8V@L2BE1Q,IJH%GJK3BIX,H)V M3M6A2FX+R4`0M+P",RUU%$A92P_K_!C>(72EAC+D$]!%"6EJ=S!7R\9K!E-1 MQ!9A:[B&-E3R*&^UF3^(:4<5ZT@GLCW7R))F]?)6JRD;-CW?4")3M<:)%C_D M[LL?N-W8/@'RJ=B^)FE:,1DN]>$TG6PL;?W8S(#&KU'_\`X1OU-0!3&&4AI@ M=]/_5Y,Z1>M?K8HNMO4U>^C?S/ZW# M%&(;A:U2MKG$7,]F<7",?[LB0\;8W`RP#[BYZ;^FH$^?[($%3-3"(X^/)G.R MQ=')M/P$%C-K"5E'SW(8JT&E:-^,33W>`*IY?%>0Q)9\+$7RM=@Y$]1P.M'+ M-JJD1U`VG%1"I>4$ZG]-[!P@%JS:_1>PH*NF2?PU@16VZ/*+L$_'Y1=09^+R M/ULCVG#O.?Z_'-#DG7^%.F@X_S*&#>'\GX2Q%_L#.O\J@,Z=?P5QFL[_R>GY M[/RPZD0Z+^$U%*C,=6SCCDO_OX4V'?]?)+K)E//:$6%_[_\D2:_@*O=5:;>\ MXB&B,;U^!=:Q*HYTG'TY61)KLAU-O'S^T2JW24Y]Z8J<^18V]"DUDNR(`C6W MZ%Z)L$_'O1)0U^9>Y1X5F!=3Q0[5E#PJA09H>%0R'G6UCL?S.?2SB_GQ@T_O M5UQA"W(1$\SX2$O^(R\B7\L8BFJ$?_"GXD5[>!?*)&K*0!"#"7,@(,50 M$,"VDZHO"9+0'^`6EEM[VD4?*@_^F'*MCXT5@[V$:9@$];/S&,IKA']PY6WO MOV9`GOK5RC*BHJ&UCJQM%UVH=&XS9=889XH517>=>6EF+M@9WC#2=(/WAO=> MQ*H4I(>+V?D1H#\<_^/=Z?O9V?'YS?4.N(5W84S>ZZ*17$K+1.5:6ZN^0(5, M&OS39+P[CI6^N#:!HD8W"BE"_'D*Y/2E`$K/+R10X^3T/WFDLH[]*<-&-GASMZM";HQW#,^I`A8O'QLS)E+TXE@," M'"2YDH./!!Z@`)VUWNFO,+S![LC)KL;[.KR+PWGHD]0KN[B#-X7+)`I]?"#N M;K`-P0[OTK=8:3/Z5);Y);;,U^OETDLW1#LYP&`+&12@7=8(=1,U9X@[,*WS M\WEZN,:PN)J8G923Z]$F>\I,K9H26^JDIY&1\"L]CO09U+E9Y%&(_"A!V!=C M3P45G92N8$2R!H<)RM"VUU)9[M+9E@Z%S[J1'8APE?5]1:PO[DVCI@Z@%U.*%M_+=RAPPH)!WV'.I M>5.[`KK,JW;21'`8/:OT'1R`Y9TW#Y(9#5D#31*62>@&!6.R/6WIZKY7=`1O M_Q&S;H2JMH)O\%90@>.\)J>7J"N/$'3F5??+=69(1TD*F5%@_9J=&7WRAWH* M(#3,40$#.#L^I4A'-]VH/>]CRKL.E_+R[RFO%O5@UB<+O`MNZ(=R!2 M96F_Q9:V<",H3,`#=6UV>TB;L[E=6=;9H39`.(:Q-4'OQ%$V(%!:>2=360T[ MZ\+,=E`)WL::A%Y90F-'7,`#PKYCM^J]%(BKH)JK$;TO=*.;9=9-%-*SY-FM(3W8IY?:/*B MTQCOG&L:6V7HQM`M/<0.GDS3(DRB=F0NH).)_2JG`VZ^[E;H1"6-M('73WVF M=3WEYQT?R9.!V.FSY(FU(W44RFPA2QK`I/,`-W'2ZJ@M\VK44H@AFTHK610P4<*=T+G\9YZ5$DP].!M]VL+)=(9_O("@B"\A]?07Z>TQ<3Q@Q^M`QB0 M1CVD]G#-[O(T:;3TB0Q&I8.3WO"KT/BN>%1@BPL4R`#19\"A$W^,ZB_/\:\E;60[7$GTY77G67R*YM?YM:`YR-%J M$2:[N=SPKO(H=FGT75=&&@F1OX"OS16[I1#:=(DRZNWBFDICR-'%UBV]SF,Y M7ID7US0F6B^+KE.@_+"/+[D7'EQ^P`)>UX5>7Y.5=F\*`N3?'^'JI+XS<^[N MN3C[G,.,?<]G"4*S>R^,Z&Z?<(TW%TD48#"49)D0\JYDQ.QY!1"0)96VI#D< M\"R,P5$215Z*GKL^JQ@N7QP@Z\!!JWT3/\#P;H$-]^P>IMX=/%\O;V%Z,:?F M&UVL,Y3AW0L?B8:2L&NA&JU7)-(.#'/PZ0JC40-_H*1G&4`$NJM*3N5J==(O M=2%U\TZ*+II'C4"#L;^B`.VGE1?:-S6K,F)X46D M\(7T:!)]]VKQB%^L>FJRVNN3;NT979PM2>ILC`#?,(0-[HC@+?,V46]<@U`N MO2X5[^:!/NZMH5I;?+SBO_[W[B[X^.&7]]_\Z^,__=7ZX=?XV]?!E^_O[W[= MQ.^.UI_??I^^_O[GE[^_N]F@Z/M[_\M>]%/VP[O#L\O@U]^B5]_&_[R].#PZ MW;R]^72[7/^.?G[Y_8L/7W[:7UY'_L-/Z^O?E[?Q>73[_L6G_>_^?KN^0;]D M!_L??OKIFQ_>?IB'AU^^>?OE-XA>O[WXL(P7^S_=P9\>Y@?1\G7XY^^'*[OSQZ<7%S^_ZW#_][NGB]_YL_]__QT^\_75\_^+]^]^LW MG[[/HH?S];?!8G^Q?[9X^>MZ\?:GY9WW=B]:[OV0?O@->QI8LI$&WA/&]%&_;C MXO%>]YRX_DD[1SU.Z9,I$?:+Y(UI5/>:USHTKJ(U`AY"ZR5YVX_DE5)$K\3+ MPCT3C_?45*A;Q(=G[Q@E;56F!%0(-L`4$!'/#0G6:0!M,9SAT;AL^6WVTNI'9+`V7]4 M98CW(<7HS[TE/$J67AC;BZ9Q..W$>W7),;-Y.X#,!!_97/?W$G0%W![-J7'$ MQOE]\/"2@7ER[$%//U1G;G3*-GV5`LBB]K%#&TIMOSCU+4_(*)KW` M=K!IM.>>??;2@/Z_&XQB%@>76`KCNAZCT&FUP&B,%<@\'#(!D!DB=\9)>?Z( M:E:IVA^+R7W:AK02):.)O"&8;;C6$!?XK)7>++SX@CY5AIT=1HWUPCX(=2X[CP(U! MJ2Y/VZMX6B9`K)]VOG"!`*;I5%0)?6).A>GB[)8V3&;=__$G1OM.7%B;Q^I/ MG"3I'(:/UJ5HDO]4S$EC9;H.Q=,R`5+]M/.1BZ5@OS_=1$*LHM*0_X32GUXH M?81K(XX/9X)TI?"!LJHU?:*Z.9%\\:CE53)"U*U+^+X`:9^B.!E&OK3 M.GH9DC[&98EQOV*S!?[G!-51F0?YX#O(JOO7?AAY"%W,/WB$KNPBO2*8RL98 M9621029.??#Q(4D`G[``&F_R- MN^7$P(/;33$!E3/834ZV"[O])@=2N)V;K!RXF,PT=O>63`?\?)`#<%Y&8";]RNT8?0[U>,YJN8J2#837 M,+W'VX48U8WW<`!C.`^SXDZ.!>4=B#(7S[(,0[JL\UX.'.30I9_`#GG_$N0X MMN]*3.X+&58%*U?[AY-#YPI;+1K*,QKU\-!-DGD1__?#!&7G2?8KS/)W[;Z, MT^5F/&(==,,8:RW]O\OMJQ0,+?Y2">+JYTE0XY$9V,`,;+$[?A=O;&TV_GP[ M2[!/AGHTREBL^R1)N?P61WX<&6Z-8J[`!&%)B3`]V6K"=J+92? MB143(M,H,KD-W"T=+P;Y"IT=JLQ%)28ABZ; M][LG$X247])N6W_G\B-X1[3V+4SN4F^U"'TO&K$A@129I6>Y6@F1F5?\I.ABPT?1`DH^GWL6')';?V%.X'-&' MI%BWHY:\4HKV3271Z*O\."6QWRL&UUA72.W/\2QDE*J[`Q[R#*+C['F(>+ M<'4),>_CS+N#!QOB^R9QABG'(.[8D#$,07=B''29Z$RL_!TX;B@HP.Z`$C#8 M0B;^56T"&^;6Q>JM3;RUZL?@KG%+WD;>8&\->3Y74(-H*_GMK]&',%OP4\;> M'[N0Y"1%U9-HK>V7`[!3U(0A5B[&PP:?,7!0F3JI#;N'FLEV]ZX<[YY`RG>D M$:LJ:QCLQR.K!+0X$((212=Z)A1+16V:J^IS9)CY?KJ&`8-*SKXL:#:+@V:H M;=""<1V\UB_AZE`E*Q1G4T$YU_53"@:"K=2"Z[)@A!!ED/CT9B$]$VL="82- M[/-/.L5COGX\AX)>5R77MPA^6F/6'=_C_T=:<8^8O94BLYV]E1$BR]Z6XP&= M(.WR[BA[VR;$2O96N?;.Y\L\0DJ?2QB]G(3'8CN"U"2AK7R$/8HQI9H1@90$ MT>[Z$GL4'96O,>906178*4)XPQBE=K@%H[LLF8PD9=*,3"HU:2>OH0-LIFO' M4T^VS42:DA'="U2;UFWV$(Y39"I!9=L@2>@PV\K(#+>FJ45R+5M8N>(>KE"1 M6[GV8>RE83*:X@@1V7P@3DB!3&'R(9/0$96(*AHB7>#P2=BQU$2%SF[IK((2 M\_QK58NFE7Z5J5,;`SK7SA80^5K*T,$(DR54MF)Z$_K8(3&B/A M>CN[.I=8-V":PH"ZZ[-?X%B/48D1V=ROA!1(M*4<"]@!;`8^LO&.WB#4$A>O M+O+%]MB[2J#OXI`\QT8>6AO+T$AQ62T;DE'1JC9T/,V[TI>))V%OVL0GU!_1 MPOM$_/.JMO$,316![7-4!;NL?UA>&]DT*6[T0B@27AF:B^K1)*C?4\@'&S&` ML\5>LP>ZM]"B=`"SHXX.O?K;SOL:,+2Y+'^I;DR"R?':2$F-_A MK&WLDZE4E^FB>NF=CQ&2:A+L./!_&4NQ#+#;C7GH$Z970#P!;3.7M$;5D8PA MW_0-YE?L1F45O5,=/!502V@Q<5[+)C'1DCS/>Z^OB%0JF< MOQK+&B"_RY>WC)YL:2!SE6RI$Z)9M>3>0+3*39AK$2YWJ+*2\;Q2,2*KM0$B M"G2+22;AE2J%I:@C&2C3`M-YDBZ].&_EAT9,S$E0V=Y\)'3(,BW;T44EFRB< M[B;/HA9>)CL[-#P)OE$'2J(E)4Y5VIE@\7ZY+DVB MK]9,,D]"-/7^.8,(1^/>6"MAHM9H1O)Y"M*I7ZDPE"YI8N>JD^R> MJ/"Z>V,7,>QQ*!+/MMDO5DB!Y'O'8R?HCBLEP&F#?*76>T!)21%VE6WG^J-D M^]X('JV&TR2E1]A'%O-^0WC_.1_N]NY];Y[O=X__G,/LVHO$,4.%A:M-LWJP MK.*6];R"&:"C)F',Q%SF1"M8D_V#89,(D>%2WK60U-50ZP&QZ9CH$2?OX98#-!=SD2KWT M)+Y(`_GQ2J3+&.M^G2YE0FO9069/4&B.O$)=\H1VV%QR3T]N/3Q+^F*B>UEKPY.)-0M8"TGV_IBK-O+&@$BLRAGY^3YV:7Y60[IYR2%7GRP M1F$,$./(Y-.51IOY^W:&G[()3(O)(P.R-![>J26'EUD<'&/0I!<]+>ZC77YNB4?N9]J&1`N8 M37]:AR")[2BF`B\.`)L,N-G@8S'?K9J9R(_3+VW&6'U<4G+1\BA$?I2@=0IO MX$-V$)'/@*-1V-#8')3;ML?F]`JDVIF!5O,FM>)SI"W4UHE.RS;;B!-5$.AQ MPNHW6.VP+0I(<4,>3ZOP?;LZ?I@LEV%&+"S")A;OYED8W\'8#V$7:]8-FMM3 M;#>:A:Y0=U;:#41LR;F8\Z_>YV;Y,$$9:CQZKV_^!@+OUET99@TBCV9(YMLM M4,\#!4<0^6FXHBY8'&`R0W0QQ]X_*G(+VIK2':++';0[U0)UZ,M4FWON=7@7 MA_/0][`_[OO)FEJXRR0*B8W3]XZ,H+BMES4B5>0X=>"8W2XZQ\M5E&P@O(;I M?9A?E*.6A[=--][#`8SA/,R*AEK%7[BWBD2R+J"#'#R[3KA[2Q``'LX.P#A` MCH2]&\;_N?&&DXNKA\.PBM>2,81@O?%T"C&E1Y#]>QJSA]K92T-GH7<;1C1% M*M.0`@!X5H!X#L(8Y"_7YP\O<7"<7T#57K%(T(;LLGU-F"/@;AIM-FYE<4"<,7:PSE'EQ@%?Q`9)&?C"8W>-EW<'C!YCZ M(8*7*;;54B]'LM$!C@+2PI@?EU,!*!D[("<$_[`E90<4Q("<&E"0`R@]KC]" M2VP7:9U5B=MN$J/E2&JXW&`['13SP4<"`5`0KFH*S!8J%+\!BRQ+;]M<[]!# M"Q(=PO\8*RNR"92Y,]]`<.R@[8PIE(T\&VY8KD:,HL MJ[O*.\QU5C?9GX6WBL=7E*N3B57P""[P#," M!ON]ST$)"6Q!N;;I^HL6R=.49<89X@"&99[P$J9A$AS'P1$7;6]V]$'0__HN MN7^!I[)F/OB'>@\?.5A+UD-*0%LFF`T&>#0XXI,?-G6G52A$1=0KM-E32Z*D MI2/;^[O>NO&3_ZX%BS;XKJ4L>U3>_UMZ8_`T9EKY-DV05/!#>OH,+0F`,,3D M-QBU:Y]L>&:.X;]+96;9V\/?P<7\&.]M2VS)I&J#1Y$FCN6X'>:.;\#'_%^Q M3^Y$`:HK$LE.M&:;]EOL*C)-J`?=I-EKN6.=[ZB"8*7C3]-DW2*YF?/-:J?+ MKA:!K(74BN&3!'4N$`VSWBR\.+<5YPEU/V%0.^E3&T(\D!,O3-][T5I:73*` MV6=4`H[,/.Z=84*WFT))JR#X0^FE7AX@%`-*\F/=+@:4VJ#[R^#:9-45:N8< MCO)"W2O2EV\MM8>2U$PQ&^33'6M;Z_+T\C!"GEAV'&8(P:PM\\(&32;I4J%9 MQ&K!HFR_2+2M43^"MXKBM6W9/AGG^.&A*M'"O5NT+MMO\-"OY0KZR5T<$EO( MG-?6B'0^$7`SM1Q@-^',ED6*HYA:G+'^-,D"!NL(^^KEEE5[^(4^29D?W3W8A!TJ.,R58T'@/A[W:68`&'RGP*9UR>C%'Z'#TYW:7&W@DJC;#?DI` M?)63R+OK'P>M@K-C8QIX98]F%&,`&>3(&Y'RO`AS-E=BN[@#;Q<(FZ#`,S#3 ME3FZ$0I7^Z5T=9+-LX4;MDVS[(Y%^RT3]K2#)(T[@?<=6O*VZH7;=6BV)KOG MPZ)&NZ;L.=<"V[8@,L='(X>+^1'1/.S;T>=&N'HB61"Q$<]C M@.CK3NSAE4KM5P[>[W,9>>PV M,O[M:JF(TQ000):`'`8H@.`/E(#987>V"TB./TW])8M$:LHPQR'0O$(,X?,Y M#._)KFD8!2T`@"T$U^=7G57J!4-EW.EZ&F57]P^Q\%,O.HT#^/`SW/0_E8K! M6JS.$1(@.:;FK1GRP8".!GBXL^H;96<(,$-2(/$#59UP,,!6T"RZFQ7<1:3M8LC+^;2VK;3L+8PX0. M4`Y80II^.:!@T2*QFK+,L0-(4_AY5K+O-<4&QMX^HPF'+N.B1T^(^TIDLH[8CB!&XLB%FXJQYEVW:NY8_=+R MSE,ZEM^D3ZLJG3Z[@K[8\LQA7A2>6 M<[Y'$'^.?DB/MM)N6MP8Y\K/$R-B2?*D^=5!YI-=2X]]<(D52RMK#!_?6'KFI^$$3[V>1F\2]+!`O95 MH/9/7Q7\ZN,6'0J*L8Y#]4)A5(]2S:7UNDU]$B+?B\@;BB?X-ZB_`L@`VZLH ME%#0=J6:#6!!VO"6A9C5 MUH`-!'2DFQH,I02JIJ"^JDGTA3OL'4(Y%,=/IAEF-0Z@"/AC._5Q%)+X?1R@ MZGL.\F:_^?"=^EL7SF4C68GPW*):M.U"X-&N*58OR&O=51RIX8'FS==F.P3C M"[!/[0JLH0Q%RCX9XAQ$"`XC#Z&+>?XD^$5Z14@LZ@^W]<*'7A21'&;Q='@^ M$,DB!A0L.5?F$T"2`CICAZ_HW!9V,_CD(RE?LR]FN-_3>O)(>$X=@NW6F[9I M/U+2\KH+H#``#T2GOL/-74?M10M#WZ8\FX9,BS:EY'H`3_:',%OP4XSEO%,V M;657."HJ\!E#!Y6ICJ^Y]N*-@3J8L;O#P^C;4]#[)%K'F9>RR,@`$0PQ6.LU MIS4"U.?6.4V6"!8@^4^DZ MK3([+R!(JL2T9(?+NHJD(8!\YG.G1E6]*J$P-/A@-Y;#U7O-XH#/`+$#@4:/ M^/*B"[?'N7)QVI8C$HH>"QY'A\/64]Q[6H%=G.+<1P$8/=LH@-OK;[;X;O?D M+I*Y3>M_8/P,4MN;4H`#16EW5U'G`!KA?7>] MK40L5@3H3:N?6<3_"JZ2E.SVUU@T0V1:E=#MI5M59+14.N>)GG(28+,F<'A1 MRZQ6W"Q?NOU++9^YAQ%2[&*N\6+I=L#NU&LV',!P*J](5"!-MHN7Z>K%M5%= M.-@K@'$%[T+R.ERU?XFE7SH5%I)N"WA&="Z4/$3DJ'^C% M(7&9P0!,MVQ*"BI.DA0[,1CRPD.,_*(E.A'-_W M6",#;_^.@802]5F'3-K]@\P"Q31V-25U?NQI$5SU_*-:O/N^7^2E96;=;[P' MV/%.9+X[4@C->Y'3J$26KE5R@#%CE>VJ6.VT(S_R?[Q5@OY2))I:+G"[22=I MY1]5&4>;,?N(&OB\16-CHVG)U9>SI5Y"XY*WDZB_UB*%60$#]M@/"-4^;_+^ M9HSW:O.F-]Q,U]Z^*1M]R')&.?ORO*\KM]Y+!?A^MY; M[D9U[S&6`Y!U%YN&V6VNTLC);&LI-KYGP^A@K5O(383\(EX6>23V> MR4ARK1O6>"\\1]H5O-V]M[Q7>#'/NXZ2EM4EQ:PV0V8^MI='27ZJG,_KUV1+ M6[06+E('`X[9CMNQF)-F1=(V&C?AIT]DBY*7$\@88/4)YO)EG?H[++3]$_8- M\A28^5N!HH=K*%!:KIN#G?0[@48L$=KC/MQU?;+9OF5(&C\;GFJXYR')[(DU M0JTN3>\H(V+'$[D14KW7[_Y&2+TOQ%.]$5+ENUV'3B1SFQO/+V&,]SLL&B)E*(=O,_LN(D,13BTL.?'NY8^+\X"D.<_YM M0BJ"K(W=5618+#KR55P2Y2C')0?D1P_ M^2L42+6&H;&H+E?G&N#.PAB>XA\5)F(`+=ABL1ZL;9#0KA!D**!CW5]JE0M* MJ!W5599GW'P9^*]_%$O!O\+_1 M``!Y*@(`%P`<`&YH=&-P:RTR,#$S,#,S,5]P&UL550)``,8KXI1&*^* M475X"P`!!"4.```$.0$``.U=6W/;N))^WZK]#SXY+[NUY5AVDLFE9J9*MFR/ M$\?66'9\DE.G4A0)24PH4"%(V\JO7X`7FY0(BK@1H,)Y&<>6T(VO&XWN1J/Q M^S]V=W=.`02!%0)G9[S<<8_^)YS_[\[NSI$_7XQL=^<,AOBO=NC>`?P[>`<" M_&_\]UD8+M[M[=W?WS^W\4>1[08`^5%@`T1^L;.[^^<.^>^__^MW0N0H`(3$ MNYU;3.>CM=SIO=G9?_WNX-6[@Y<[-]='.P>]_1?)E_`W/!=^'UL([#S,/8C^ M>)8C]C`.O.=^,-T[Z/5>[&4??)9\\MT#^47A\_]0_,MSW[9"UX[^P>Z+_>^!*S#9B5E_%RX7X(]GR)TO/,)1_+M9`"9_ M/(.ST%Y\WR4H]EXDH_PS^=U7+#7D>ZY#\#^T/#*;T0R`\-D.&?SFZNQQ'M`* MH\#R9L#RPED8`.@@VP\61)Y[Y+-[U*'V_FR`X:]#"_,4SD#HVI:')/*_.K*R MZ9Q!S`L8A?CG.28H.(75T?:4Z`&8`(6[>$"\&IE(VX M]ZU&6LV'V,H,MA]4+/^1!,_Z:U/5'1NQQ5&5* MAN1GIB=Y:::C"C`4G)5N6_;?@1#%TZ'>/G:+D"'R_BG)0>/%8/) MUK)K:^P!GFTB]V4%"S$9F5>^V;=E@G5H(;SI06?@>M'CSC@$P6B&]\28(`>S M-0:5JZ58J1Q""^^!(V!'@1MBY3I^L+W(`7;DQ?XTXIV@ M($&Y5NP*H#!P;0ST*/3M[WT2.KGADG=NE<-)MG8#$%JNQ[DA[)M_A!1LZSQL#[XQEM''0#K-L4?K%/WGR:-_DFA M(,XI5@!PAG]$2KE]HI);.RNJV`^*$[`".^,)_UC0P_6,6_J)O46<7MBU9Z[W MJ,(3["/PJ%3HTR7K!PX(_GBV_SQOXYFE,,18@R``S@UT0^RA7UAST']PE@0#[Z_WT>,'%0G[D.W9Z&250<[B"/A@J MF[K(Y-1<2&Q2C-219R$T\.>6"]5;J3RQ-DBT!F2I,`^>]_0;D,VVM\Q-6)T! MEU+U$<);;[D3)T>35B@8LLNMN5MYM%=!T6*OCZ*`S*9*0%5>=NFWM6MZ^6P( M]I3I:H$^XY:YA#UPR,K")8NG'ZRO$A)=%&/<'[5&R5+ M1OSX]U7O:4OEM7])?AY=`1M@!K'YO0!AJHM*K&$5/8.79SV\(_[R\`$JD5AC?^&571".5R0L=J^LRG($@85CAFBJATH*55(9-*JN73:\? MY2)JG73*!?.*PPTA@;^8&S(,_`4.3)=#STJ2RG@O71`G5I&UJZ37`ME5XY6* M\K>FU]BI[SOWKN>ID-CCV"V0SA,.J21>-RV)I]/><@?UPH>V.E/(0-UX3X,% MR53:;\2S9^+.B%H)EQ-ZTE8C14E!)Y7:6S'O4<`I4>>-F"Z1;/Y9>,R3`RDX M']R2.'>ML>O%]3YXC<OA4F7ZL#9MW7GI>JG%^E!*.VW@R3KF MV>1,/98-H=T]8=7D7&:R%!)9Z4FQY-706I),3`-IJQ5*FAT4'FENPDY",I)7 MED&4U8U>6P]`:3A.):;;B@J*E`:AA,2D0(:9<)6;F'K!EA#;`L&602@GNRD0 M3S0IW0T4VRSB36!*R(SRRGF04KL"=P!&*G=9"J46[[(T[/CSJ6*[;,8/WAV: M6;+5!/460\@0+`5("4E6$:OBY4DCRBD6NT'4?'+)"J6.N(L0`@M%P+GV`H@ MWKU1W[:C.;DN#QP<5[FVJZCP8"/5]AK<.I!F$F\RB93C(XZL"KV+SGW$?KQ6 M?\16KEL&P#)Y\E3ER;B05&82EY,3^WUOM:=']@<-O3Y66SQVK3^ZUA]=ZX^N]<>:A>U:?W2M M/[K6'UWKCXW$VB#1&I!UK3]*SBBPLW@9Q+2<..6=M2Y5?]9#I6R.<-8\-/I9 M#QU'?M,O?A&[R&/,$.I'X

$2[#IN,SA4*Y/FUIT>B M[18G08V_3GSMDJ(TN9XA%#6W1E-J+95FAI64LG!I$KR,0O+`C>/":5-BS)-L MJ2P+J$FI_V82:)&E_G0:@"F>RKG[(R(9#(Q@22%%1=14=SR#I54;$@GEW>)U M+DUZM'7(ML/EJ06@C/)N4?$VX<16D=-\+,(L3:KW*E31+4N.ZIP<&JF61)=4 MI/B+N<7#R36F%'LXE?3:*L@R_T:PSX89AY"K+^:QFXG\:(_CH,O)Y8(\HDD> ME9%S"%EW;)&UTAU(MN-`DE'/6$XFQ:0QL@&T`M=7=2I93LB,,&1S5KR(3A%Y M/MS3`6\@6@#;G;C`47?60B=F3+10IGX%2=#QRF6\33_A5G;*,K(\@-+KSZ3U M'5+4M+&4CC%*5.D9E4,DX[B$T[E%X>4D9F3D>XIBDB*)=LAI#1AMQQ^G@8_0 M,/`G:FY*Y(:$TGI42B]2BW3,`UX=2V)0X`)F>[,8#X9P_$2&(^YWX0 MNC_3MRSE2[L6W19LHO7P:_X8DJJMC6RH[3CE*,%&5L-^87$]W2=3*K`<&4-" M[7H2R\/#?ZHHX9&%^";@A0_](F<*]\D-%%OBPFZ`C?^,488?^Z1=^"O$4,&V`%+TD),11*\RQ*.K2VE0):4,:9LQ943TI+7J5:^_(JBH"/G(I84>0U<+PK5U#W22&G;`/GE]HB2KL9*69C M0'>0PKMT>%1$V+[+V)(IS*8VK)%R:586-+O'"E6$CKJ\C@Y&%EVO-W]B=5FZ M&NRN!KNKP>YJL+L:;/TBZ&JPQ99Q&OP#A[1Z!1`IJX:A4&I%_I&&DKQTB78G MJ:33[S-FK:)M6"6#R_>0:A&1L.%UCE)K'"46O6/PF#J'J7.8.H?)A,GH:`W8 ME5!4EU`TG%RL>J<@>X.`V<=@&M0,TUHJ)C9P-+=R97UQ`O.<%*(W_FZ((DZU M*!+/^EDK8D\?[:7WLR-TE M#T@Q;UEU!S3:`ZH/B[3(N$M:4+8^1@V5G\+@"SJ>`A]T[5\!VX>VZX''G,.EC.4GEZH><\@C<6UT3'8FODG#? MB`X`UJH!2/Z/&;9M/\)JC)48N'>JTB2UZ&H)?$5\L7IHP;O,"@^>3BO&9GG";9G;=<$D*.C4*68)0DY.?"(CS3"Q#@U(^L2NENPOLO0 MY.A0U,SZSEJZV)JDOT9Z&]8\!52.ED=-K/YL/QI:R^:W]HRHOB,&)7O[(Y;2 M6B+)%'<095>(KJT'T+C@*>2W1P5H^`KT.E*K#+E`I%$MR-/=@IV_#$W^YDB2 M>J*5[4VZQ$XCO@6RI^(JTH9)1@W:.JN#E(>T"W\SHE\ENB76?@U+GI9-JO,W M^8A$SYHO(;XM:[X,5Y%F33+6_%IF^081CZ1DPBIT@(&ZIM2\B!JP8"O2,$JH MNV5A@B0%A636-U0-V)[ZADI8)'>,8*]OL);IR5'?_A&Y`<#ZAC4L7`X]"X9] MZ!SCWR[B%_=4U#_4IV[""JZAX(7R"`9L.4Y/J0T8I>WG5WBV@6NGU;O-;.,K M-%LH]LTXF=N-""ML1]NVK`]NS; ME;!(/#T7VK=/_.`*+*+`GF%+$U_;SMJZJMRO*Z@:<*Y20Y_+MNDJ*"5NSS+- M=,\F?!5L!=E]'J_'@R`79X.3E^L.,BGRNL6I>0<(^]2?(_ MXE'>61Y19Q6*P$2_?9:`#5[^+<`3=M_*>1J"P/6=5?]3A2(PT6^?(K#!*_"L MHEC']&IV^]BL!<$23_J3Y:E)O]#(_T9?(O=CN!ZT:[F3?>&'I#T9D]8=1@B#B-``(#MP%VD7`M(8&5U.ACE> MKS%OAWB,[\SQHP`)@2BJNY-M[IUL<:5CZ>3:7<_NKF=WU[-_M>O9V<#LMD:% MGG%P88P"5GI9//!*;8FFS=/J,;>[&;E3B->G34X(DR+?^*5+S[5QS,KO7S$. MV_7%WTZGBD^[NI;X9FQ[G1O5N5$FNU'UK(L2W:I'N259J;HXRFZYH,]-ZK%W MS!^XR/9\%`7)6>UC7X(KX"5=^5&(GCH7/-9B<7M0LNAUKM5VNE:2];'SNV*M]<-^_\?N[LZ_;S]^>OF??__+7D0/G^&K MM\[/UW?3STMX,XCN3U\';U]_./AV<[U$WNL[^V?/>Q^^N3DZ'SJ?OW@O7L%_ MC2^/!F?+T^L?XWGT#7TX>+UW^_/]_GSDV0_OH]&W^1A>>.-/>S_V?_MK'%VC MC^'A_NW[]R_?G-Y.W*.?+T]_?@'H[>GE[1S.]M]/P?N'R:%W?+"X.KF;_SCP MOX'#[S\^#M[\'._/!WN7U^-/7V[_[VSV=O^+/;'_?O_M_6CT8'_^[?/+'Z]# M[^$B>N7,]F?[Y[.#S]'L]/U\:IWVO'GO3?@S=+Y_"5_97W[[,#FT;D;?QP]_ M__V7_66T.+VY?PE?HH_3_^P>?FNR?LME>)05K;!R8$9A6 M>IZLF,IS-'6[F:F?R::*J4,^M((P_Y".%"^39^PN`[B=;J:`GG79/C-VO\Z; MZKPID[TI!A.C0L%8R+$Z#9E[&)?BJTT+1HC\"/";!W?B9VE;AZI*^K? M2A>IM@IUM?NF;&&=2]2Y1":[1%23HD2=J,2,4:=*;Z<"K/87W*_7RATNXY^6 M[-5EE25XK?%X6!2)R>OIG)[.Z>F<'A,FH^-4+7NP&D\WV>,4 MGZ%5T&M)IJ<:,^W/%]Z0IF/'*'3G>#)*3/(*!4,63Z7,5D&1U2Z7MT%J\M1& M`PN.2JL-4J,#):MM(I?\3BPWB!NZ7$[2?E"6=P:Q!Q;%1^EIJ*!`F/4(MZ)- M4DT,!5IB26F/F3Z30%Y#Q>YW0YOD9J(MV2EKH,??#TG2=GEL!1!'4J0I6UQD MW8!\-Y$T([BIE.Q&U#@>$)3[H,1]+DH.?(A_M$'.M#0@9F8>6K*JV;'E>$C0 MS./..$!#72^.+C/8ELQ@5REF>$:GRQ!V&4*3,X0C>P:1![[):RI/33E9,485:QTJ[B!EGK@*J`??;SQ.(1%]PZ,@!T%<7OLXP?; MB[#31;IGD]NM40+]^BP;4AUI7+8BS:)".I*?&M/LS'<=8[H`H.4!0-9[ MF$D4,Z^F=H"-A58D(YEQE9QI9%:$6^!.9W@O[]^!P)J"BV@^!L'E)-[1T644 MHA"[HBZ<*E,#-@:,L?F56L`(JHS74:44ABD36677&M+\#"J/R=5+BK6HAS&]'BK]1=`?A%+$@6_ MTX:W@;'/6Y*?!ML\CG+)5\W>0,OF*JW,5K&CG/*NUU7.F#`DF)3D*S]"*ZO* M5J:KG#*WYMPUZ"Q366A%S,2,:ZH%KQLVQ#2?4.'"IY$R/.&Q$:E4@F]:72V_ MV:T(9R#S5(XLSXZ\F`V4'>*PNI:;"5Z7$V1V',0I22B=Z`Z`C#L`DJ:!#(=# M.J*OPV7Y`*H.F%2R:T883SU64"HI"8==MU806##\"(A7HL2G*Q#0OK,WL'(* MSE\1WI7S,-X]9*5D1)WPR@EI77(-"Y`"M5`5Y1$I_0E"%YN,8>8=QJ/G62L3 M:N4;1_7'U)TD:4B$3##+:D?!O:;+YW1AS8&ZXH.--#4'V`VO]`>F>ISN#L]V)@]JZH_R MNSG]>RMPKO$'E47S!0+:([H:,7@1$2DH_](A6)F&U0^:1*-?O(E-_&!N01LD MIR?JP*>1TJ[T&T5`!4E&^O'I*F+^LF*?I#JF21NAP^7:=<68Y2>^H3/T+*@V MOE'"IU[W<*/@U[579?;!"T-V>,?$?8$X!E M\=@IM*5ZO7E>IMA$W1I?0P/X;P24+P9SET.R_+_V6JKU3]:\4^R<+/D/"A+] M/8:.-E.>SBI7;;:R8(\?0&"["`QQ]&:6M69D77N`IEAS627)?Z.C3&M-,[GQ M/H/.X##FU2B]9>6]#8M#AW0109>388YE_M;9`B1D]-[K"NV,*[035SJFWHU= M\\:N>6/7O-&(R0B7_&C>7SE>JN@>GNNV4G4KK'MXKML\N\VSVSS5U,L>>1;" M+GEZ!_XRN"+1]&.WT,=;:T>6YP'G<)E^#J4?5++@15EJ26Y$&'G9'9QU.UX] MCGY$W2-AG;-FDK/6MD?"NHN(JS!W%Q&WZB)B=PW.7,DKO0:WNF*--#;JVG]X M\=_3WJ5K&!\_D!^5^`XU*9NS$U0ZZ75QU/Z:RO%\X?E+`$8@N'/3^\1K[%Y; M#X<`@HD;9MU'&E`(29P9DW"HU!=98I#V)HLZ97H\@8^-,;KV0\O+_YWXNCBZ M^PS"*V#[4^C^5-2@6!FSAB2%Q!6.3U2RVJV9I8));=2)'Z2_(I_;;Y5>EL]@ MB^RC1+%*>R5'RR7`XKV#T\!':A(H"MALB7^G1$+RGOTQ)#';X^G51M[0<,,X MC,-1VI$?GUL"2$XMG[)D_)E8SN&YC]VZI*NQ25='5&+&K)`J.=;` M3((O=D6B.E4VZFEP0]8-U2+E8*`URZ]9^`SN`/P,K"`K3F(T/K3OZU;9-3TA MZ%$GJ\G,7$(@`'WYM[7[K:7(4V8JZXR$K0,]8;#,C%=UF\]]QTR$"[/:DCZR M+X7#&!)[3(APDBBI(C5>1,\9BH048E5B)OM5R`<&1Y[$=0Q:]IC15JZ%%\U+0R M4[V'2A2FU65GJPGJS1?6E&!-[&0\742SFX?+_%^4Y7'K4S?>LQ M%?B6L_PK]M=&M@N@#=#Y^1&C7:L>1:N98U=)(H8-L.@U@GG&U5F^$BK:`RT^ M85;A5GHV9:1%J$B8ON!R**_\)5;OY14>MGZ0E/N.=FVH#KL+T]-^R^>C"_T@ M;HR(!P0HO+R'>."9NQB"P":X3<'ADF3T?!ABNGB(:?(1%4N;GQE3]LW*1(L` MUM)N[\AUH-+;18C<.LK;O5LWG.6_TJ!759LEP\V$-.2EI76Y=2`HO!*Y0 M,*1:HEJL*Z#(NE;"=[?7MH,(.`E/)-6;'-_TH:/VI+(673/;.P:-HC,"/"'-W?`>$VN9L'JGK`[R5*?#:*M1$N]\B+RJ[WM!(F>/% MT`-$&DIRJL:+HZOKA%-.2._N5*U_%4*0W1-GG1&%A596KO"@FK_RR5YZ*.1MT'0F4P42S1V:O9EG9Z&*Y',)S3>&);_&C,X1P MY*>DW<<&BL;(HC(TW@2;@7=!NZ+#%A4=RJHKUI).&?AV_!95'SK',(Q/!B9^ M,(])\33(J!J/O3%QG<%XW"('N%^3$;-;XC`D[1;IJPD!^_G4O]O#WTP6$OYA M=?U01]63#681!5D7=%`$!F@-M.CYB]T.?E@EIT>+#G$MQ&84HM*#CPJDL M2U))HU7RJ(/9ZBTW7LD,H['GVB>>;U4<&K$)(C]D:RQ."1JY5]RYS$X?\^`0 M/DX\2X*6%X?35$/!`^T*#KF7QMD#O,)XN=<%)<*;'[4][D@Y*+F7J\6/GJ+3$HU2KGG?ODL3#+\)]^+,`3!\L3U*FOHV-!?';9].K\&3!;U M<"5]G\:-ASO"CN?4#Z29F.*@+?0#5U#)L!8),9.!;X'G?8#^/1P!"_D0.'&> MK^*L@PUXVO`M%`$5J4P8O(=.^5@WZ2$K+30M'[9-QH8"3(;Y"UYCDXW[%.^> MX-](L.^T@5NTL5*QR5`7"#B+8V<=NQ4@GQ^Z/1Y\!3P9^*^>G$I*"OSW/3+F MV$(@_N?_`U!+`P04````"``N@*A"1-N&1DX*``#H6P``$P`<`&YH=&-P:RTR M,#$S,#,S,2YX7U]_6B(KLS`%#''HP9BL@&4RZ=`_OOW MOSY)(0V*I(AC<"_D7,,IJ!Z"VL%Q?>^XO@ON^@U0K]9V_$%BQ(0=,V.,;`@F MMD78\61`+7Q2BLB4+1\=.JK4J]6="B:,0V*@4M"?>'9Z;Y/3"I^ZJ")Z((J- M$N"0CA"_@39B+C30;!B!W*/0&B-H\3&GB)C,<*@K=:M(K-6=G5HH;L)BTEYW M0F2URK?KJY[29`9MS`WWQUIBB$-R*.:0\DPY?YS'RO+1'.00LH$:%3Z1HNKE M:JT:6K6CHZ.*>AIV3?2,DR,?#R`3Y"`+V8CPSPZUFV@(/8N?E)X] M:.$A1F8IPK7)9_-%Y]JK^`]+:I4`(-<)),3AD&.'G`*_-6AW74R&SFG8)EHE MD.,031<-@=+B6%K@I,2P[5IR`:FV,47#DY+/53GDX;L%!Q\%R+`3I`9U+*0W M4L6ECBN8`:V?KIB0:7A6!FEQU63_OE`&R!]WW5:N<*>$ MB!3#'`N;,EF<0TL&]=X8(5X"V`S-\#VS4PQ*"&9.R*F(R")U]<3*4X%(I;GY M5""8"ZC)&/AP1Z!G8O'DMT^5Q:D28CR&S`XY5;\7%W@P/.B2A!@=&U\_BR-3 M](L.7N!H8?2,I$J,I>32W#Q_WV^AZ,W'B&.!D>6B`'T>B[<7C<"57#\NKH0+#2Q,RP'.91 M)/Z0XX"LB&^D2+0032&1-1/#BK+;B+6WH70EJJH)KJK+?.DPE2E5W7JV#>E4 M4M+#(X*'(KL)=SLS#,<- M&'KV9&EW\2+KN&UZR4_,/#N'R?E\JGY-8TQINBU+0_+L+,Y<2D7P/WG`YT\H M7H^#QO07XRV1F1[6AP,+L82+!G3PI?YT MUY\RZ^#%>*M:;7YXU[BZ-1\>K9T]\FW0:31;T\O^\\#VGMB7^D'E_JU=LWN6 M,6E[O2=[0&ZLP=?*7MX/<>-M]_+M$;&CR\Z]3<:U M]@BU)\-SZZ+N=C^_V,]UYPF=_WB^;AZ^#6IVL]+I#[X^WO^W-3ZJ/1I#XX_V M4[O7FQ@/^P^[SP?^:X-JY=C>L/WOBR;8_@9=6RJX?\C9L_'OF>\;C_ M97@^^*/5'MTT.@]G;ZW)+G/WJ3LYO_L+-'K=X$+#YA9Q$W&(K<0:#IJ71)_] M#6T`@`^^O-1E_7=;TYOF+AF`PO:E`2A]`V?5[*'A;DM>*GG2"80]S2:VO-GQ MQBVBO3&D?OJ(<9JC^_)2?!-;0#.NQ2@%2KET`"O<0!?`@$+V#\E1FUD29\+2 MIC0D?D$]9'@4RWL5%Q/#\DQD?J:.S<>H&71HS-&RY')YYU0Y=D+2]ZC67TM1 MQ&`.&828@00-!&H0P@91W-LWCK7R1F;BR+,;5D_?#=,7K[I,L24LG;`N8IQB M0P189=7,6\VG2[;4=E^RDU=-WTG*QJ7;;0M%^=Q`*W]8$:SEFMF M)R5./?GMA>KE"B,X9E^-,ST:!%""+4N^"H1]F@73#U@M8>E3=HSQ@38PNE8"HP'7_^@"L,!]A26Q4%5"<-G4:G,T/D0D]5 MGAT^1C1V.?;*8852,3]8C<:W%`V1,%7POCP:4302,U[A9T\N=@'B*[0DKJB^ MMD-$94>G:1H/H<525?9S&0\?#7PG$J9``\S?8X>\*N2,1?-;M9WA_-RF\$$I M+VR-%>)[ZD52-`.9/M)F&"?E0OTO16XN_)73#*LD(X4_A8P7-XAWAGTX*9(5 M5L);.5UC.00W\7\M#]>@SJ1^-D8>)`0A@HR"7^\6#.U/3.?/,:5N?I. M%QD.,;"%Q)+QUT_?$3^EE%OJO&!3%'73@IMDLPKI0^<8DA%B+1)4@\0L:I67 M"ZA>U^A*:Y$7Q(J[!')CS1<#/F,B2K!?0UL=UDQMSSV&"6*LB9A!L2M%BB6B M;M]TAM&[-WTTX>>6K!X+I/\[T$#G+-Z%@H)7,!U18^ZN[:6<:%NB+I MF@_H<3VK2-HO@ZCQTJY\&6TZ-L0DU,3_WP6/3=6XTG;Y1G2) M`-+&QZXSA1:?=B&?[?1+V`*/(3K]?-P1.+IR!(D$_X`@O8=4%#><72-[@&@Q M;)\%3AGOZG9(3V1R8B!V==4HDEIZB)F.WQ,P1!H(_J]3+$3'3VV* MI&).K#HB.P05=5VF0]-&AQO$>]!"A5)C`5/FPKMQ>!.)!K.+1E@B$]+F2:U0 M&N5!JN6I[W!H%4FE*"`M\B\.19"$&UX]-)+/BJ2)#F!V.9@90J(E5I'47`6P MMI377%(L4K&7"V=0@:BK@/Y%*+_A_U!+`0(>`Q0````(`"Z`J$*T/7X`4'(` M`)MI!P`3`!@```````$```"D@0````!N:'1C<&LM,C`Q,S`S,S$N>&UL550% M``,8KXI1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`+H"H0K=M'9"L"0`` MUVX``!<`&````````0```*2!G7(``&YH=&-P:RTR,#$S,#,S,5]C86PN>&UL M550%``,8KXI1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`+H"H0CY;'3)V M'```^QX"`!<`&````````0```*2!FGP``&YH=&-P:RTR,#$S,#,S,5]D968N M>&UL550%``,8KXI1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`+H"H0A?O M*]-H-P``#>D"`!<`&````````0```*2!89D``&YH=&-P:RTR,#$S,#,S,5]L M86(N>&UL550%``,8KXI1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`+H"H M0E1B;V8&'@``>2H"`!<`&````````0```*2!&M$``&YH=&-P:RTR,#$S,#,S M,5]P&UL550%``,8KXI1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@` M+H"H0D3;AD9."@``Z%L``!,`&````````0```*2!<>\``&YH=&-P:RTR,#$S M,#,S,2YX`L``00E#@``!#D!``!02P4&``````8`!@`F )`@``#/H````` ` end XML 13 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 2 - Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2013
Significant Accounting Policies [Text Block]
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and all of its majority-owned subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period.

The most significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates associated with obsolete inventory and the fair value of acquired intangible assets, including goodwill, as well as those used in the determination of liabilities related to sales returns and income taxes.  Various assumptions and other factors prompt the determination of these significant estimates.  The process of determining significant estimates is fact specific and takes into account historical experience and current and expected economic conditions.  The actual results may differ materially and adversely from the Company’s estimates.  To the extent that there are material differences between the estimates and actual results, future results of operations will be affected.

Income Taxes

The Company recognizes income taxes under the liability method of accounting for income taxes.  Deferred income taxes are recognized for differences between the financial reporting and tax bases of assets and liabilities at enacted statutory tax rates in effect for the years in which the differences are expected to reverse.  Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized.  The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution.  The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense.  Deferred taxes are not provided on the portion of undistributed earnings of subsidiaries outside of the United States when these earnings are considered permanently reinvested. 

The Company and its subsidiaries file income tax returns in the United States, various states, and foreign jurisdictions.  The Company is no longer subject to U.S. federal income tax examinations for years prior to 2009, and is no longer subject to state income tax examinations for years prior to 2008.  No jurisdictions are currently examining any income tax returns of the Company or its subsidiaries.

Fair Value of Financial Instruments

The carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value because of their short maturities.  The carrying amount of the noncurrent restricted cash approximates fair value since, absent the restrictions, the underlying assets would be included in cash and cash equivalents.

Accounting standards permit companies, at their option, to choose to measure many financial instruments and certain other items at fair value.  The Company has elected to not fair value existing eligible items.

Revenue Recognition

Product sales are recorded when the products are shipped and title passes to independent distributors.  Product sales to distributors are made pursuant to a distributor agreement that provides for transfer of both title and risk of loss upon our delivery to the carrier that completes delivery to the distributors, which is commonly referred to as “F.O.B. Shipping Point.”  The Company primarily receives payment by credit card at the time distributors place orders.  Amounts received for unshipped product are recorded as deferred revenue.  The Company’s sales arrangements do not contain right of inspection or customer acceptance provisions other than general rights of return.

Actual product returns are recorded as a reduction to net sales.  The Company estimates and accrues a reserve for product returns based on its return policies and historical experience.

Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized over the term of the arrangement, generally twelve months.  Enrollment packages provide distributors access to both a personalized marketing website and a business management system.  No upfront costs are deferred as the amount is nominal.

Shipping charges billed to distributors are included in net sales.  Costs associated with shipments are included in cost of sales.

Various taxes on the sale of products and enrollment packages to distributors are collected by the Company as an agent and remitted to the respective taxing authority.  These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority.

Income Per Share

Basic income per share is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding during the period.  Diluted income per share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of non-vested restricted stock and shares that might be issued upon the exercise of outstanding warrants and the conversion of preferred stock.

The dilutive effect of non-vested restricted stock and warrants is reflected by application of the treasury stock method.  Under the treasury stock method, the amount of compensation cost for future service that the Company has not yet recognized and the amount of tax benefit that would be recorded in additional paid-in capital when the award becomes deductible are assumed to be used to repurchase shares.

The following tables illustrate the computation of basic and diluted income per share for the periods indicated (in thousands, except per share data):

   
Three Months Ended March 31,
 
   
2012
   
2013
 
   
Income
(Numerator)
   
Shares
(Denominator)
   
Per Share Amount
   
Income
(Numerator)
   
Shares
(Denominator)
   
Per Share Amount
 
Basic EPS:
                                   
Net income available to common stockholders
    $503       10,863       $0.05       $283       11,069       $0.03  
                                                 
Effect of dilutive securities:
                                               
Non-vested restricted stock
            318                       179          
                                                 
Diluted EPS:
                                               
Net income available to common stockholders plus assumed conversions
    $503       11,181       $0.04       $283       11,248       $0.03  

Certain non-vested restricted stock is anti-dilutive upon applying the treasury stock method since the amount of compensation cost for future service results in the hypothetical repurchase of shares exceeding the actual number of shares to be vested.  Other common stock equivalents are also anti-dilutive since the average market price of the related common stock for the period exceeds the exercise price.

The following securities were not included for the time periods indicated as their effect would have been anti-dilutive:

   
Three Months Ended March 31,
 
   
2012
   
2013
 
             
Warrants to purchase common stock
    3,704,854       3,704,854  
Non-vested restricted stock
          98,607  
Convertible preferred stock
    138,400       138,400  

Warrants to purchase 3,704,854 shares of common stock were still outstanding at March 31, 2013.  Such warrants have expirations through April 21, 2015.

Recently Issued and Adopted Accounting Pronouncements

In February 2013, the FASB issued Accounting Standards Update ("ASU") No. 2013-02, Comprehensive Income (Topic 220) —Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, to require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component.  In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items in net income but only if the amount reclassified is required under U.S. generally accepted accounting principles ("GAAP") to be reclassified to net income in its entirety in the same reporting period.  For other amounts that are not required under U.S. GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under U.S. GAAP that provide additional detail about those amounts.  ASU 2013-02 is effective prospectively for reporting periods, including interim periods, beginning after December 15, 2012.  The Company’s adoption of the standard on January 1, 2013 did not have a material impact on its consolidated financial statements.

In March 2013, the FASB issued ASU No. 2013-05, Foreign Currency Matters (Topic 830) —Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity, to clarify the guidance for entities that cease to hold a controlling financial interest in a subsidiary or group of assets within a foreign entity when (1) the subsidiary or group of assets is a nonprofit activity or a business (other than a sale of in substance real estate or conveyance of oil and gas mineral rights) and (2) there is a cumulative translation adjustment balance associated with that foreign entity.  ASU 2013-05 is effective prospectively for reporting periods, including interim periods, beginning after December 15, 2013.  Early adoption is permitted.  The Company is currently evaluating the impact of adopting ASU 2013-05.

Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

EXCEL 14 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\T.#'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;G-O;&ED871E9%]3=&%T96UE;G1S7V]F7T]P M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I7;W)K#I7;W)K5]O9E]3:6=N M:69I8V%N=%\\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?-E]3=6)S97%U96YT7T5V96YT#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,E]3=6UM87)Y7V]F7U-I9VYI9FEC86YT M7S$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/DYO=&5?,E]3=6UM87)Y7V]F7U-I9VYI9FEC86YT7S,\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K5]O9E]3 M:6=N:69I8V%N=%\T/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,U]3=&]C:T)A M#I7;W)K#I7;W)K5]4#I%>&-E;%=O#I%>&-E;%=O#I!8W1I=F53:&5E M=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,3`M43QS<&%N/CPO'0^ M+2TQ,BTS,3QS<&%N/CPO'0^9F%L2!#96YT3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^,#`P,#DQ,C`V,3QS<&%N/CPO'0^3F\\2!6;VQU;G1A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\T.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6%B;&4\+W1D/@T*("`@ M("`@("`\=&0@8VQA3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA&-E<'0@4VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA&-E<'0@4&5R(%-H87)E(&1A=&$L('5N;&5S'!E;G-E2D\+W1D/@T*("`@("`@ M("`\=&0@8VQAF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XQ,CQS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T.#'0O:'1M;#L@8VAA'!E;G-E(&EN8VQU9&5D(&EN('-E;&QI M;F'!E;G-E/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,P/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!O<&5R871I;F<@86-T:79I=&EE&5S('!A>6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA M2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T*("`@("`@ M("`\=&0@8VQA2`H=7-E9"!I;BD@:6YV97-T:6YG(&%C M=&EV:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0@0FQO8VM=/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@86QI9VX],T1C96YT M97(@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P M(&ED/3-$:&%N9VEN9VEN9&5N="TT,"!W:61T:#TS1#$P,"4@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`@#0H@("`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`@ M#0H@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL M93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN92<^3F%T M=7)E(&]F#0H@(`T*("`@("`@("`@($]P97)A=&EO;G,\+V9O;G0^/"]F;VYT M/CPO9F]N=#X-"B`@("`@#0H@("`@("`@(#PO9&EV/CQB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,G!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE28C.#(R,3LI+"!A M#0H@("`@#0H@("`@("`@("`@1&5L87=A2!H96%D<75A&%S+B8C,38P.R8C,38P.U-U8G-I9&EA M2!O9@T*(`T*("`@("`@("`@(&QI9F4F(S@R,C$[('!R;V1U8W1S M('5N9&5R('1H92`F(S@R,C`[3DA4($=L;V)A;"8C.#(R,3L-"B`@(`T*("`@ M("`@("`@(&)R86YD+B8C,38P.R8C,38P.TEN(&UO2UO=VYE M9"!S=6)S:61I87)I97,@:&%V92!A;B!A8W1I=F4@<&AY6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E. M1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@("`@#0H@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4-"B`@("`@#0H@("`@ M("`@("`@=6YA=61I=&5D(&EN=&5R:6T@8V]N2!A8V-E<'1E9"!I;B!T:&4@56YI M=&5D(%-T871E65A&-H86YG92!#;VUM:7-S M:6]N("A314,I(&]N($UA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T.#'0O M:'1M;#L@8VAA'0^/'1A8FQE(&%L:6=N/3-$8V5N=&5R(&)O6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+CPO9F]N=#X-"B`@#0H@("`@("`@ M("`@("`@("`@/"]D:78^#0H@("`@#0H@("`@("`@("`@("`@(#PO=&0^#0H@ M#0H@("`@("`@("`@("`@(#QT9#X-"B`@("`@#0H@("`@("`@("`@("`@("`@ M/&1I=B!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE M3X-"B`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY4:&4-"B`@("`@#0H@("`@("`@("`@8V]N2!A;F0@86QL(&]F(&ET2UO=VYE9"!S=6)S:61I87)I97,N#0H@#0H@("`@("`@("`@06QL('-I9VYI M9FEC86YT(&EN=&5R+6-O;7!A;GD@8F%L86YC97,@86YD('1R86YS86-T:6]N M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=& M3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN92<^57-E(&]F#0H@ M("`@#0H@("`@("`@("`@17-T:6UA=&5S/"]F;VYT/CPO9F]N=#X\+V9O;G0^ M#0H@("`@#0H@("`@("`@(#PO9&EV/CQB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,G!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!4:6UE2!A;F0- M"B`@#0H@("`@("`@("`@=&AE(&9A:7(@=F%L=64@;V8@86-Q=6ER960@:6YT M86YG:6)L92!A'!E'!E8W1E M9`T*("`@("`-"B`@("`@("`@("!E8V]N;VUI8R!C;VYD:71I;VYS+B8C,38P M.R8C,38P.U1H92!A8W1U86P@28C.#(Q-SMS#0H@#0H@("`@("`@("`@97-T:6UA=&5S+B8C,38P.R8C M,38P.U1O('1H92!E>'1E;G0@=&AA="!T:&5R92!A&5S('5N9&5R('1H92!L:6%B:6QI='D-"B`@#0H@("`@("`@("`@ M;65T:&]D(&]F(&%C8V]U;G1I;F<@9F]R(&EN8V]M90T*("`-"B`@("`@("`@ M("!T87AE`T*("`-"B`@("`@("`@("!R871E0T*("`@#0H@("`@("`@ M("`@"!P;W-I=&EO M;B!W:6QL(&)E('-U&%M:6YA M=&EO;B!B>2!T:&4@=&%X:6YG(&%U=&AO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q! M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M)SX-"B`@("`-"B`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE"!R971U"!E>&%M:6YA=&EO;G,@9F]R('EE87)S('!R:6]R('1O(#(P,#@N M)B,Q-C`[)B,Q-C`[3F\-"B`@("`-"B`@("`@("`@("!J=7)I2!I;F-O;64@=&%X#0H@("`- M"B`@("`@("`@("!R971U6EN9R!A;6]U;G1S(&]F('1H92!#;VUP86YY)B,X,C$W.W,@9FEN M86YC:6%L#0H@("`@#0H@("`@("`@("`@:6YS=')U;65N=',L(&EN8VQU9&EN M9R!C87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S+`T*("`@("`-"B`@("`@("`@ M("!A8V-O=6YT6EN9R!A;6]U M;G0@;V8@=&AE#0H@("`-"B`@("`@("`@("!N;VYC=7)R96YT(')E6EN9R!A&ES=&EN9R!E;&EG M:6)L92!I=&5M6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X-"B`-"B`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!4:6UE2!T;R!T:&4@8V%R2!T;PT*("`@("`-"B`@("`@("`@("!T:&4@9&ES=')I8G5T M;W)S+"!W:&EC:"!I2!R969E2!P28C.#(Q-SMS('-A;&5S#0H@("`-"B`@("`@("`@("!A6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,3AP=#L@ M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@("`@#0H@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY!8W1U86P-"B`@(`T*("`@("`@("`@('!R;V1U M8W0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,G!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UEF5D(&]V97(@=&AE('1E7-T M96TN)B,Q-C`[)B,Q-C`[3F\-"B`@("`-"B`@("`@("`@("!U<&9R;VYT(&-O M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,G!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,G!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE&5S(&]N('1H92!S86QE(&]F('!R;V1U8W1S(&%N9"!E;G)O M;&QM96YT('!A8VMA9V5S('1O#0H@(`T*("`@("`@("`@(&1I&5S(&%R92!P2X\+V9O;G0^/"]F;VYT/@T*("`@("`-"B`@("`@ M("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`@ M(`T*("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,G!T M)SX\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY);F-O;64-"B`@(`T*("`@("`@("`@(%!E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,G!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!D:79I9&EN9R!N970-"B`@("`@#0H@ M("`@("`@("`@:6YC;VUE)B,Q-C`[879A:6QA8FQE('1O(&-O;6UO;B!S=&]C M:VAO;&1E&5R8VES92!O9B!O=71S=&%N9&EN M9R!W87)R86YT2!A<'!L:6-A=&EO;B!O9B!T:&4@=')E87-U2!H87,@;F]T('EE="!R M96-O9VYI>F5D(&%N9"!T:&4@86UO=6YT(&]F('1A>`T*("`-"B`@("`@("`@ M("!B96YE9FET('1H870@=V]U;&0@8F4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,G!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE"<^ M#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R,B!V86QI9VX],T1B;W1T;VT@ M"<^#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^ M#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D(&-O;'-P86X],T0Q,"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&-O;'-P86X],T0Q,"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$8V5N=&5R/@T*("`@("`-"B`@("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH3G5M97)A=&]R*3PO M9F]N=#X-"B`-"B`@("`@("`@("`@("`@("`\+V1I=CX-"B`@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@"<^#0H@("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@(`T*("`@("`@("`@("`@("`@(#QD M:78@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@(`T*("`@("`@ M("`@("`@("`@(#QD:78@86QI9VX],T1C96YT97(^#0H@("`-"B`@("`@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY) M;F-O;64\+V9O;G0^#0H@#0H@("`@("`@("`@("`@("`@/"]D:78^#0H@("`@ M#0H@("`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@ M,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@ M6QE/3-$)TQ) M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$8V5N=&5R/@T*("`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY3:&%R97,\+V9O;G0^#0H@ M#0H@("`@("`@("`@("`@("`@/"]D:78^#0H@("`@#0H@("`@("`@("`@("`@ M("`@/&1I=B!A;&EG;CTS1&-E;G1E"<^#0H@("`-"B`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@(`T*("`@("`@("`@ M("`@("`@(#QD:78@86QI9VX],T1C96YT97(^#0H@("`-"B`@("`@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY097(- M"B`@("`@#0H@("`@("`@("`@("`@("`@("!3:&%R92!!;6]U;G0\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@("`@("`@/"]D:78^#0H@("`@#0H@("`@("`@ M("`@("`@(#PO=&0^#0H@#0H@("`@("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R M('9A;&EG;CTS1&)O='1O;3X-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;3X-"B`@(`T* M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`-"B`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T* M("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q) M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@+3EP=#L@1$E34$Q!63H@ M8FQO8VL[($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@,'!T)SX- M"B`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY.970-"B`@("`@#0H@("`@("`@("`@("`@("`@("!I M;F-O;64@879A:6QA8FQE('1O(&-O;6UO;B!S=&]C:VAO;&1E6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@("`-"B`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&%L:6=N M/3-$"<^#0H@("`@#0H@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M"<^#0H@("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M(&%L:6=N/3-$"<^#0H@("`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@("`-"B`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D(&%L:6=N/3-$"<^#0H@("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX- M"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A M8VMG6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX- M"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`-"B`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)TQ)3D4M2$5) M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X-"B`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T* M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@ M("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)V)A M8VMG6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!4 M15A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@("`@ M#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/ M5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/ M5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@ M("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`-"B`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T* M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T* M("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$:6QU=&5D#0H@ M("`@#0H@("`@("`@("`@("`@("`@("!%4%,Z/"]F;VYT/@T*(`T*("`@("`@ M("`@("`@("`@(#PO9&EV/@T*("`@(`T*("`@("`@("`@("`@("`\+W1D/@T* M(`T*("`@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^#0H@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@ M("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T* M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@ M("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5. M5#H@+3EP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`Y<'0[($U! M4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.970-"B`@("`@#0H@ M("`@("`@("`@("`@("`@("!I;F-O;64@879A:6QA8FQE('1O(&-O;6UO;B!S M=&]C:VAO;&1E6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD-3`S/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<^#0H@("`@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD,C@S/"]F;VYT/@T*("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#97)T M86EN#0H@("`@#0H@("`@("`@("`@;F]N+79E6EN9R!T:&4@=')E87-U&-E961I M;F<@=&AE(&%C='5A;`T*("`@("`-"B`@("`@("`@("!N=6UB97(@;V8@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,G!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE"<^#0H@("`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&-O M;'-P86X],T0V('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`R<'@@6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@("`-"B`@("`@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4 M:')E90T*("`-"B`@("`@("`@("`@("`@("`@($UO;G1H6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`-"B`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@(`T*("`@("`@("`@("`@ M("`@(#QD:78@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$Q)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4 M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X-"B`-"B`@ M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY.;VXM=F5S=&5D#0H@(`T*("`@("`@("`@("`@("`@("`@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@(#PO M='(^#0H@("`@#0H@("`@("`@("`@("`\='(@6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X-"B`-"B`@("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY#;VYV97)T:6)L90T*("`@#0H@("`@("`@("`@("`@("`@("!P6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ,S@L-#`P/"]F;VYT/@T*("`@("`-"B`@ M("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@(#PO M='(^#0H@("`@#0H@("`@("`@("`@/"]T86)L93X\8G(O/CQD:78@3X-"B`-"B`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE'!I6QE/3-$)T9/3E0M M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E)E8V5N=&QY#0H@ M("`@(`T*("`@("`@("`@($ES6QE/3-$)TQ)3D4M M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG M;CTS1&QE9G0^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2`R,#$S+"!T:&4@ M1D%30B!I6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE M)SY#;VUP0T*("`@(`T*("`@("`@ M("`@("`@8V]M<&]N96YT+B8C,38P.R8C,38P.TEN(&%D9&ET:6]N+"!A;B!E M;G1I='D@:7,-"B`@(`T*("`@("`@("`@("`@2!I9B!T:&4-"B`@("`-"B`@("`@("`@("`@ M(&%M;W5N="!R96-L87-S:69I960@:7,@28C.#(Q-SMS(&%D;W!T:6]N(&]F('1H92!S=&%N9&%R M9"!O;B!*86YU87)Y(#$L#0H@#0H@("`@("`@("`@("`R,#$S/"]F;VYT/B!D M:60@;F]T(&AA=F4@82!M871E6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,3AP M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL M:6YE)SY&;W)E:6=N#0H@("`@(`T*("`@("`@("`@("`@0W5R2!O6%N8V4-"B`-"B`@("`@("`@("`@(&]F(&]I;"!A;F0@9V%S(&UI;F5R M86P@6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8[($1) M4U!,05DZ(&EN;&EN92<^5&AE#0H@("`@#0H@("`@("`@("`@("!#;VUP86YY M(&ES(&-U2!E=F%L=6%T:6YG('1H92!I;7!A8W0@;V8@861O<'1I M;F<-"B`@#0H@("`@("`@("`@("!!4U4@,C`Q,RTP-2X\+V9O;G0^/"]F;VYT M/CPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+V1I=CX\8G(O/CQD:78@2!M86YA9V5M96YT('1O M(&AA=F4@82!M871E28C.#(Q-SMS('!R97-E;G0@;W(@9G5T=7)E(&9I;F%N8VEA;`T* M("`-"B`@("`@("`@("!S=&%T96UE;G1S+CPO9F]N=#X\+V9O;G0^#0H@("`- M"B`@("`@("`@/"]D:78^/&)R+SX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M/'1A8FQE(&%L:6=N/3-$8V5N=&5R(&)O6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXS+CPO9F]N=#X-"B`@#0H@("`@("`@("`@ M("`@("`@/"]D:78^#0H@("`@#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@ M("`@("`@("`@("`@(#QT9#X-"B`@("`@#0H@("`@("`@("`@("`@("`@/&1I M=B!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY3=&]C:RUB87-E M9`T*("`@#0H@("`@("`@("`@8V]M<&5N6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^+#PO M9F]N=#X-"B`@("`-"B`@("`@("`@("!R97-P96-T:79E;'DN)B,Q-C`[)B,Q M-C`[3F\@=&%X(&)E;F5F:71S('=E28C.#(Q-SMS(')E6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)TQ)3D4M2$5) M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M8V5N=&5R/@T*("`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY3:&%R97,\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`@("`@/"]D:78^#0H@("`@#0H@("`@("`@("`@("`@(#PO=&0^ M#0H@#0H@("`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@ M6QE/3-$)TQ) M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$8V5N=&5R/@T*("`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY7=&0N#0H@#0H@("`@("`@ M("`@("`@("`@("!!=F"<^#0H@("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D(&-O;'-P86X],T0V('9A;&EG;CTS1&)O='1O;3X-"B`@(`T* M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@(#PO='(^#0H@("`@#0H@("`@("`@("`@("`\='(@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR-C$L-C4X/"]F;VYT/@T*("`@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$Q)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY' M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S@R,3$[/"]F;VYT/@T*("`@(`T*("`@("`@ M("`@("`@("`\+W1D/@T*(`T*("`@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$Q)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C,W/"]F;VYT/@T*("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@(#PO='(^ M#0H@("`@#0H@("`@("`@("`@("`\='(^#0H@("`-"B`@("`@("`@("`@("`@ M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,B4@ M"<^#0H@("`@#0H@("`@("`@ M("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$58 M5"U)3D1%3E0Z(#$X<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*("`@(`T* M("`@("`@("`@("`@("`@("`@/&9O;G0@"<^#0H@("`@ M#0H@("`@("`@("`@("`@("`@/&9O;G0@"<^#0H@("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/ M33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@"<^#0H@ M("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y% M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG M;CTS1&QE9G0^#0H@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.;VYV97-T960-"B`-"B`@("`@("`@ M("`@("`@("`@(&%T($UA6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1% M6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$Q)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@("`@(`T*("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C,W/"]F M;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/ M33H@-'!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)TQ)3D4M2$5) M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO8VL[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS M1&QE9G0^#0H@("`-"B`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,G!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!4:6UE&5C=71E(&$@4G5L90T*("`@("`-"B`@("`@("`@("`Q,&(U+3$@<&QA;B!T M;R!P=7)C:&%S92`Q,#`L,#`P('-H87)E2!I;F-R96UE;G1S(&]V97(@=&AR964@>65A2!A6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)TQ)3D4M2$5)1TA4.B`Q M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R M/@T*("`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY3:&%R97,\+V9O;G0^#0H@#0H@("`@("`@("`@ M("`@("`@/"]D:78^#0H@("`@#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@ M("`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)TQ)3D4M2$5) M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M8V5N=&5R/@T*("`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY7=&0N#0H@#0H@("`@("`@("`@("`@ M("`@("!!=F"<^#0H@("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D(&-O;'-P86X],T0V('9A;&EG;CTS1&)O='1O;3X-"B`@(`T*("`@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@(#PO='(^#0H@("`@#0H@("`@("`@("`@("`\='(@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ,#`L,#`P/"]F;VYT/@T*("`@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY'6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!S='EL93TS M1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S@R,3$[/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@ M("`\+W1D/@T*(`T*("`@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@("`\+W1D/@T* M(`T*("`@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY& M;W)F96ET960\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`@("`@/"]D:78^ M#0H@("`@#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@("`@("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S@R,3$[/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@("`\+W1D M/@T*(`T*("`@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D(&%L:6=N/3-$"<^#0H@("`@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!S='EL M93TS1"=415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^ M#0H@("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S@R,3$[/"]F;VYT/@T*("`@(`T*("`@("`@("`@ M("`@("`\+W1D/@T*(`T*("`@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@(#PO='(^#0H@("`@#0H@("`@("`@("`@("`\='(@6QE/3-$)U!!1$1)3D"<^#0H@ M("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=. M.B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXY,2PV-C0\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@("`@(#PO=&0^#0H@#0H@("`@("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^#0H@("`@ M#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y' M+4)/5%1/33H@-'!X)SX-"B`@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@(#PO='(^#0H@("`@#0H@("`@("`@("`@ M/"]T86)L93X\8G(O/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,G!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UEF5D('-T;V-K+6)A'!E;G-E(')E;&%T960@=&\@=&AE'!E8W1E9"!T;R!B90T*("`@#0H@("`@("`@("`@65A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\=&%B;&4@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@8V5L;'-P M86-I;F<],T0P(&ED/3-$:&%N9VEN9VEN9&5N="TT-"!W:61T:#TS1#$P,"4@ M6QE/3-$)U=)1%1(.B`Q.'!T M)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X-"B`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,G!T)SX\9F]N="!S M='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY#;VYS=6UE<@T*("`@("`-"B`@("`@("`@("!);F1E;6YI='D\+V9O;G0^ M/"]F;VYT/@T*(`T*("`@("`@("`\+V1I=CX\8G(O/CQD:78@0T*("`@("`-"B`@("`@("`@("!C;&%I M;7,@=VET:"!A(&UU='5A;"!A:60@8V]O<&5R871I=F4@8GD@<&]S2!I2!E2!A;F0@:71S(&AI'!E M2!B92!R97%U:7)E M9"!T;R!I;F-R96%S92!O2!C;W5L9"!B92!R97%U:7)E9`T*(`T* M("`@("`@("`@('1O(&UA:V4@=&\@861D6EN9PT*(`T*("`@("`@("`@('1H92!C;VYTF5D(&)Y('1H92!#;V]P97)A=&EV92!T;PT*("`@#0H@("`@ M("`@("`@9G5N9"!A;GD@;W5T6QE/3-$)TQ) M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@ M8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A M;&EG;CTS1&QE9G0^#0H@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY0=7)S=6%N=`T*("`@("`-"B`@("`@("`@("!T;R!T:&4@86=R M965M96YT('=I=&@@=&AE(&EN=F5S=&]R0T*(`T*("`@("`@("`@ M(&)E('-O;&0@=VET:&]U="!V;VQU;64@0T*("`-"B`@ M("`@("`@("!F:6QE9"!T:&%T(')E9VES=')A=&EO;B!S=&%T96UE;G0@8V]V M97)I;F<@=&AE('-H87)E6EN9R!T:&4@9&5B96YT=7)E2!D965M960@4F5G:7-T&5R M8VES92X@5&AE(&UA>&EM=6T@;G5M8F5R(&]F('-H87)E&5R8VES92!O9B!T:&4@=V%R7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^/'1A8FQE(&%L:6=N/3-$8V5N M=&5R(&)O6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXU+CPO9F]N=#X-"B`@#0H@("`@("`@("`@("`@("`@/"]D:78^#0H@("`@ M#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@("`@("`@("`@("`@(#QT9#X- M"B`@("`@#0H@("`@("`@("`@("`@("`@/&1I=B!A;&EG;CTS1&QE9G0^#0H@ M#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,G!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2`R,#$S+"!T:&4@0V]M<&%N>2!E;G1E6%L='D@;V8@,BXU)2!O9B!S86QE&-L=7-I=F4@;W5T0T*("`-"B`@("`@ M("`@("!C;VUP86YY+B8C,38P.R!$=7)I;F<@,C`Q,2!A;F0@,C`Q,BP@0DA3 M('!E6QE/3-$)T9/3E0M M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY297-T;W(F(S@T.#([ M/"]F;VYT/@T*(`T*("`@("`@("`@('!R;V1U8W0N)B,Q-C`[)B,Q-C`[26X@ M07!R:6P@,C`Q,BP@=&AE($-O;7!A;GD@28C.#(Q-SMS(&)E:&%L9BXF(S$V,#LF(S$V,#M4;PT*("`@("`-"B`@ M("`@("`@("!P97)M:70@=&AE($-O;7!A;GD@=&\@8V]N=&EN=64@2!!9W)E96UE;G0@86YD($QI8V5NF5D(&%N9"!A<'!R;W9E9"!B M>2!T:&4-"B`@#0H@("`@("`@("`@2!T:&4@9G5L;"!";V%R M9"!O9@T*("`@(`T*("`@("`@("`@($1I2XF(S$V,#LF(S$V,#M2/&9O;G0@6%L=&EE2`D-RPP,#`N)B,Q-C`[)B,Q-C`[ M/"]F;VYT/E1H92!#;VUP86YY#0H@("`@(`T*("`@("`@("`@(&ES(&YO="!R M97%U:7)E9"!T;R!P=7)C:&%S92!A;GD@<')O9'5C="!U;F1E2!A(')O>6%L='D@;V8@,BXU M)2!O9B!S86QE2!I6%L='D@;V8@,BXU M)2!O9B!N970@7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV+CPO9F]N=#X- M"B`@#0H@("`@("`@("`@("`@("`@/"]D:78^#0H@("`@#0H@("`@("`@("`@ M("`@(#PO=&0^#0H@#0H@("`@("`@("`@("`@(#QT9#X-"B`@("`@#0H@("`@ M("`@("`@("`@("`@/&1I=B!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/;@T* M("`@(`T*("`@("`@("`@($%P6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E. M1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@("`@#0H@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/;@T*("`@(`T*("`@("`@ M("`@($%P28C M.#(Q-SMS(&-O;6UO;B!S=&]C:R!E>'!I&5R8VES960N)B,Q-C`[)B,Q-C`[3VX@36%Y(#0L(#(P,3,L('=A'!I7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2`H4&]L:6-I97,I/&)R M/CPO2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4 M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S M=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!4:6UE2!B86QA;F-E2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D#0H@("`@(`T*("`@("`@ M("`@(%-T871E'!E;G-E6QE/3-$ M)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q! M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M)R!A;&EG;CTS1&QE9G0^#0H@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY4:&4-"B`@("`@#0H@("`@("`@("`@;6]S="!S:6=N:69I M8V%N="!A8V-O=6YT:6YG(&5S=&EM871E28C.#(Q M-SMS(&9I;F%N8VEA;"!S=&%T96UE;G1S#0H@("`@(`T*("`@("`@("`@(&EN M8VQU9&4@97-T:6UA=&5S(&%S&5S+B8C,38P.R8C,38P.U9A2!A;F0@861V97)S96QY(&9R M;VT@=&AE($-O;7!A;GDF(S@R,3<["P@4&]L:6-Y(%M0;VQI8WD@5&5X="!";&]C:UT\+W1D/@T*("`@ M("`@("`\=&0@8VQA6QE/3-$)TQ)3D4M M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG M;CTS1&QE9G0^#0H@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY4:&4-"B`@("`@#0H@("`@("`@("`@0V]M<&%N>2!R96-O9VYI>F5S M(&EN8V]M92!T87AE&5S M(&%R92!R96-O9VYI>F5D#0H@("`-"B`@("`@("`@("!F;W(@9&EF9F5R96YC M97,@8F5T=V5E;B!T:&4@9FEN86YC:6%L(')E<&]R=&EN9R!A;F0@=&%X#0H@ M#0H@("`@("`@("`@8F%S97,@;V8@87-S971S(&%N9"!L:6%B:6QI=&EE65A'!E8W1E9"!T;R!R979E2!T;R!R961U M8V4@9&5F97)R960@=&%X#0H@("`@#0H@("`@("`@("`@87-S971S('1O('1H M92!A;6]U;G1S(&5X<&5C=&5D('1O(&)E('5L=&EM871E;'D-"B`@(`T*("`@ M("`@("`@(')E86QI>F5D+B8C,38P.R8C,38P.U1H92!#;VUP86YY(')E8V]G M;FEZ97,@=&%X(&)E;F5F:71S#0H@("`@(`T*("`@("`@("`@(&9R;VT@=6YC M97)T86EN('1A>"!P;W-I=&EO;G,@;VYL>2!I9B!I="!I0T*("`@("`-"B`@("`@("`@("!T:&%N(&YO="!T:&%T('1H92!T87@@<&]S M:71I;VX@=VEL;"!B92!S=7-T86EN960@;VX-"B`@#0H@("`@("`@("`@97AA M;6EN871I;VX@8GD@=&AE('1A>&EN9R!A=71H;W)I=&EE0T*("`-"B`@("`@("`@ M("!R96-O9VYI>F5S(&EN=&5R97-T(&%N9"!P96YA;'1I97,@"!B96YE9FET6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY4:&4-"B`@("`@#0H@("`@("`@("`@0V]M<&%N>2!A;F0@:71S('-U8G-I M9&EA2!I65A`T* M("`@#0H@("`@("`@("`@2!O6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,G!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!4:6UE6%B;&4@86YD(&%C8W)U960-"B`@("`@#0H@("`@("`@("`@97AP M96YS97,L(&%P<')O>&EM871E(&9A:7(@=F%L=64@8F5C875S92!O9B!T:&5I M&EM871E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,G!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!F M:6YA;F-I86P@:6YS=')U;65N=',@86YD(&-E2!497AT M($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=B!S M='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@ M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M4U193$4Z(&ET86QI M8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E)E=F5N=64-"B`@(`T*("`@("`@("`@ M(%)E8V]G;FET:6]N/"]F;VYT/CPO9F]N=#X-"B`@(`T*("`@("`@("`\+V1I M=CX\8G(O/CQD:78@2!T;R!T:&4@8V%R M2!T;PT*("`@("`-"B`@("`@ M("`@("!T:&4@9&ES=')I8G5T;W)S+"!W:&EC:"!I2!R969E M2!P2!C28C.#(Q-SMS('-A;&5S#0H@("`-"B`@("`@ M("`@("!A6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!4 M15A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@("`@ M#0H@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!8W1U86P-"B`@ M(`T*("`@("`@("`@('!R;V1U8W0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,G!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!4:6UEF5D(&]V97(@=&AE('1E7-T96TN)B,Q-C`[)B,Q-C`[3F\-"B`@("`-"B`@ M("`@("`@("!U<&9R;VYT(&-O6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,G!T)SX\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,G!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!4:6UE&5S(&]N('1H92!S86QE(&]F M('!R;V1U8W1S(&%N9"!E;G)O;&QM96YT('!A8VMA9V5S('1O#0H@(`T*("`@ M("`@("`@(&1I&5S(&%R92!P2X\+V9O;G0^/"]F M;VYT/CPO9&EV/CQS<&%N/CPO2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET M86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DEN8V]M90T*("`-"B`@("`@("`@ M("!097(@4VAA6QE/3-$)TQ)3D4M M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG M;CTS1&QE9G0^#0H@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY4:&4-"B`@("`@#0H@("`@("`@("`@9&EL=71I=F4@969F96-T(&]F M(&YO;BUV97-T960@&-E<'0@<&5R('-H87)E(&1A=&$I.CPO M9F]N=#X\+V9O;G0^#0H@#0H@("`@("`@(#PO9&EV/CQB6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX- M"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9"<^#0H@("`-"B`@("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$8V5N=&5R/@T*("`@("`-"B`@("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:')E90T*("`-"B`@ M("`@("`@("`@("`@("`@($UO;G1H6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX- M"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9"<^#0H@("`-"B`@("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$8V5N=&5R/@T*("`@("`-"B`@("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$R/"]F;VYT/@T* M("`@(`T*("`@("`@("`@("`@("`@(#PO9&EV/@T*("`@(`T*("`@("`@("`@ M("`@("`\+W1D/@T*(`T*("`@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<^#0H@("`-"B`@("`@("`@("`@("`@("`\9&EV M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@("`-"B`@("`@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$S M/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@("`@(#PO9&EV/@T*("`@(`T* M("`@("`@("`@("`@("`\+W1D/@T*(`T*("`@("`@("`@("`@("`\=&0@;F]W M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@(#PO='(^#0H@("`@#0H@("`@("`@("`@("`\='(^#0H@("`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9"<^#0H@(`T*("`@("`@("`@("`@("`@(#QD:78@86QI M9VX],T1C96YT97(^#0H@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);F-O;64\+V9O;G0^#0H@#0H@ M("`@("`@("`@("`@("`@/"]D:78^#0H@("`@#0H@("`@("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T)R!A;&EG;CTS1&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@ M("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY3:&%R97,\+V9O;G0^#0H@#0H@("`@("`@("`@("`@("`@ M/"]D:78^#0H@("`@#0H@("`@("`@("`@("`@("`@/&1I=B!A;&EG;CTS1&-E M;G1E"<^#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<^#0H@(`T*("`@("`@("`@("`@("`@(#QD:78@86QI9VX] M,T1C96YT97(^#0H@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY097(-"B`@("`@#0H@("`@("`@("`@ M("`@("`@("!3:&%R92!!;6]U;G0\+V9O;G0^#0H@("`@#0H@("`@("`@("`@ M("`@("`@/"]D:78^#0H@("`@#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@ M("`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH1&5N;VUI;F%T;W(I/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`@ M("`@/"]D:78^#0H@("`@#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@("`@ M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@(#PO='(^#0H@("`@#0H@("`@("`@("`@("`\='(@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;3X- M"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&-O;'-P86X] M,T0R('9A;&EG;CTS1&)O='1O;3X-"B`@(`T*("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@(#PO='(^ M#0H@("`@#0H@("`@("`@("`@("`\='(^#0H@("`-"B`@("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,T)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^ M#0H@("`@#0H@("`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%, M24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z("TY M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@.7!T.R!-05)'24XM M4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD-3`S/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$ M24Y'+4)/5%1/33H@-'!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^#0H@("`@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M"<^#0H@("`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD,C@S/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@("`-"B`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@ M("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P M>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE"<^#0H@("`@ M#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@ M("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@(#PO='(^#0H@("`@#0H@("`@("`@("`@("`\='(^#0H@("`- M"B`@("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0S-"4^#0H@#0H@("`@("`@("`@("`@("`@/&1I=B!S='EL M93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E3 M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T)R!A;&EG;CTS1&QE9G0^#0H@("`-"B`@("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY%9F9E8W0-"B`@(`T* M("`@("`@("`@("`@("`@("`@;V8@9&EL=71I=F4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`-"B`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@ M#0H@("`@("`@("`@("`@("`@/&9O;G0@"<^ M#0H@("`@#0H@("`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A% M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#$X<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/@T*("`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@ M("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@ M("`@/&9O;G0@"<^#0H@("`@(`T*("`@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F M="<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$ M24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXQ-SD\+V9O;G0^#0H@#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@ M("`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@"<^#0H@("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@(#PO='(^#0H@("`@ M#0H@("`@("`@("`@("`\='(^#0H@("`-"B`@("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#,T)3X-"B`@(`T*("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`-"B`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@ M(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@ M("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@(#PO='(^#0H@("`@ M#0H@("`@("`@("`@("`\='(@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`-"B`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@(#PO='(^#0H@("`@#0H@("`@("`@("`@("`\='(^#0H@ M("`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#,T)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/ M33H@-'!X.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&1I M=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR M-3L@5$585"U)3D1%3E0Z("TY<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@.7!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@ M#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,2PQ.#$\+V9O;G0^#0H@("`@ M#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@("`@("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^ M#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD,"XP-#PO9F]N=#X- M"B`@(`T*("`@("`@("`@("`@("`\+W1D/@T*(`T*("`@("`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#@E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,2PR-#@\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@("`@("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M,"XP,SPO9F]N=#X-"B`@(`T*("`@("`@("`@("`@("`\+W1D/@T*(`T*("`@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@(#PO='(^ M#0H@("`@#0H@("`@("`@("`@/"]T86)L93X\8G(O/CQD:78@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,G!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE7!O=&AE=&EC86P@&-E961S('1H M92!E>&5R8VES92!P6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@(#PO='(^#0H@("`@#0H@("`@ M("`@("`@("`\='(^#0H@("`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@(`T*("`@("`@ M("`@("`@("`@(#QD:78@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)TQ)3D4M2$5)1TA4.B`Q M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R M/@T*("`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXR,#$S/"]F;VYT/@T*("`@(`T*("`@("`@("`@ M("`@("`@(#PO9&EV/@T*("`@(`T*("`@("`@("`@("`@("`\+W1D/@T*(`T* M("`@("`@("`@("`@("`\=&0@;F]W6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@(#PO='(^#0H@("`@#0H@ M("`@("`@("`@("`\='(^#0H@("`-"B`@("`@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;3X-"B`@(`T*("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M(#PO='(^#0H@("`@#0H@("`@("`@("`@("`\='(@6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4 M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X-"B`-"B`@ M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY787)R86YT6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$Q)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@ M#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS+#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$Q)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^ M#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY."PV,#<\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@("`@("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE M/3-$)V)A8VMG6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@ M("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$Q)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@ M("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5. M5#H@,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY787)R86YT0T*(`T*("`@("`@("`@($ES6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@ M,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE2`R,#$S+"!T:&4@1D%30B!I6QE/3-$)T9/3E0M4U193$4Z(&ET86QI M8SL@1$E34$Q!63H@:6YL:6YE)SY#;VUP0T*("`@(`T*("`@("`@("`@("`@8V]M<&]N96YT+B8C,38P.R8C,38P M.TEN(&%D9&ET:6]N+"!A;B!E;G1I='D@:7,-"B`@(`T*("`@("`@("`@("`@ M2!I9B!T:&4- M"B`@("`-"B`@("`@("`@("`@(&%M;W5N="!R96-L87-S:69I960@:7,@28C.#(Q-SMS(&%D;W!T M:6]N(&]F('1H92!S=&%N9&%R9"!O;B!*86YU87)Y(#$L#0H@#0H@("`@("`@ M("`@("`R,#$S/"]F;VYT/B!D:60@;F]T(&AA=F4@82!M871E6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U M.R!415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4U193$4Z(&ET M86QI8SL@1$E34$Q!63H@:6YL:6YE)SY&;W)E:6=N#0H@("`@(`T*("`@("`@ M("`@("`@0W5R2!O6%N8V4-"B`-"B`@("`@("`@("`@(&]F M(&]I;"!A;F0@9V%S(&UI;F5R86P@6QE/3-$)T)!0TM'4D]53D0M M0T],3U(Z("-F9F9F9F8[($1)4U!,05DZ(&EN;&EN92<^5&AE#0H@("`@#0H@ M("`@("`@("`@("!#;VUP86YY(&ES(&-U2!E=F%L=6%T:6YG('1H M92!I;7!A8W0@;V8@861O<'1I;F<-"B`@#0H@("`@("`@("`@("!!4U4@,C`Q M,RTP-2X\+V9O;G0^/"]F;VYT/CPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\ M+V1I=CX\8G(O/CQD:78@2!M86YA9V5M96YT('1O(&AA=F4@82!M871E28C.#(Q-SMS('!R97-E;G0@;W(@ M9G5T=7)E(&9I;F%N8VEA;`T*("`-"B`@("`@("`@("!S=&%T96UE;G1S+CPO M9F]N=#X\+V9O;G0^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\T.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL M6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@(#PO='(^#0H@("`@#0H@ M("`@("`@("`@("`\='(^#0H@("`-"B`@("`@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@ M("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@"<^#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@"<^#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXH1&5N;VUI;F%T;W(I/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`@("`@ M/"]D:78^#0H@("`@#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@("`@("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T* M("`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXH3G5M97)A=&]R*3PO9F]N=#X-"B`-"B`@("`@("`@ M("`@("`@("`\+V1I=CX-"B`@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@"<^#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@ M#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<^#0H@(`T*("`@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M"<^#0H@("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)V)A8VMG6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4 M+4E.1$5.5#H@+3$X<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,3AP=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@ M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY"87-I8PT*("`-"B`@("`@("`@("`@("`@("`@($504SH\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`@("`@/"]D:78^#0H@("`@#0H@("`@("`@("`@ M("`@(#PO=&0^#0H@#0H@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&-O;'-P86X] M,T0R('9A;&EG;CTS1&)O='1O;3X-"B`@(`T*("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;3X-"B`@ M(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`-"B`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@ M("`@("`@(#QD:78@"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@ M("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$ M24Y'+4)/5%1/33H@-'!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M"<^ M#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,"PX-C,\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@("`@("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD,"XP-3PO M9F]N=#X-"B`@(`T*("`@("`@("`@("`@("`\+W1D/@T*(`T*("`@("`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&%L:6=N M/3-$"<^#0H@("`@#0H@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@("`-"B`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M,2PP-CD\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@ M("`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD,"XP,SPO9F]N=#X-"B`@(`T*("`@("`@("`@("`@("`\+W1D/@T* M(`T*("`@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M(#PO='(^#0H@("`@#0H@("`@("`@("`@("`\='(@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@ M#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T* M("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@ M("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@ M(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T* M("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX- M"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M(#PO='(^#0H@("`@#0H@("`@("`@("`@("`\='(@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY.;VXM=F5S=&5D#0H@(`T*("`@("`@("`@("`@("`@("`@"<^#0H@("`@(`T*("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^ M#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y' M+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXS,3@\+V9O;G0^#0H@#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@("`@ M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M"<^#0H@("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U! M3$E'3CH@"<^ M#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#@E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@ M5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@ M("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`-"B`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE M/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$;&5F=#X-"B`@(`T*("`@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T* M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T* M("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX- M"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE#L@5$585"U)3D1% M3E0Z(#!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M/@T*("`@(`T*("`@("`@("`@("`@("`@(#QD:78@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D(&%L:6=N/3-$"<^#0H@("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX- M"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@("`@ M#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I M9VAT)SX-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@ M/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D(&%L:6=N/3-$"<^ M#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q) M1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1% M6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE&-L=61E9"!F"<^#0H@("`@#0H@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@(`T*("`@("`@("`@ M("`@("`@(#QD:78@"<^ M#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^#0H@("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@("`-"B`@ M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXR,#$R/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@("`@(#PO9&EV M/@T*("`@(`T*("`@("`@("`@("`@("`\+W1D/@T*(`T*("`@("`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<^#0H@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@ M("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A M;&EG;CTS1&)O='1O;3X-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)V)A8VMG6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@ M("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXS+#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M(#PO='(^#0H@("`@#0H@("`@("`@("`@("`\='(^#0H@("`-"B`@("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S@R,3$[/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@("`\ M+W1D/@T*(`T*("`@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T* M("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXQ,S@L-#`P/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L;'!A9&1I;F<],T0P M(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@"<^#0H@("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<^#0H@ M(`T*("`@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@("`-"B`@("`@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY'6QE/3-$)TQ)3D4M2$5) M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M8V5N=&5R/@T*("`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&86ER#0H@#0H@("`@("`@("`@("`@ M("`@("!686QU93PO9F]N=#X-"B`@#0H@("`@("`@("`@("`@("`@/"]D:78^ M#0H@("`@#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@("`@("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`@(`T*("`@("`@("`@("`@ M("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`- M"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD,"XS-SPO9F]N=#X-"B`@(`T*("`@("`@("`@("`@ M("`\+W1D/@T*(`T*("`@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U M.R!415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@ M("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S@R,3$[/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@("`\ M+W1D/@T*(`T*("`@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@(#PO='(^#0H@("`@#0H@("`@("`@("`@("`\='(@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY697-T960\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`@("`@/"]D:78^#0H@("`@#0H@("`@("`@("`@("`@(#PO=&0^ M#0H@#0H@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/@T*(`T*("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXH-3$L-C8X/"]F;VYT/@T*("`@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@(`T* M("`@("`@("`@("`@("`\+W1D/@T*(`T*("`@("`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`-"B`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY&;W)F96ET960\+V9O;G0^#0H@("`@#0H@ M("`@("`@("`@("`@("`@/"]D:78^#0H@("`@#0H@("`@("`@("`@("`@(#PO M=&0^#0H@#0H@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@ M("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58 M5"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3$[/"]F;VYT/@T*("`@ M(`T*("`@("`@("`@("`@("`\+W1D/@T*(`T*("`@("`@("`@("`@("`\=&0@ M;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@ M("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&%L:6=N/3-$"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$Q)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@ M4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3$[/"]F M;VYT/@T*("`@(`T*("`@("`@("`@("`@("`\+W1D/@T*(`T*("`@("`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@ M("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@(#PO='(^#0H@("`@ M#0H@("`@("`@("`@("`\='(@6QE/3-$)U!!1$1) M3D"<^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@ M("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T M<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#DL M.3DP/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@ M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$ M24Y'+4)/5%1/33H@-'!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^#0H@("`@#0H@("`@("`@("`@("`@("`@ M/&9O;G0@"<^#0H@ M("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9"<^#0H@(`T*("`@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@("`-"B`@ M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY'6QE/3-$ M)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$8V5N=&5R/@T*("`@("`-"B`@("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&86ER#0H@#0H@("`@ M("`@("`@("`@("`@("!686QU93PO9F]N=#X-"B`@#0H@("`@("`@("`@("`@ M("`@/"]D:78^#0H@("`@#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@("`@ M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@ M("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4 M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`@(`T*("`@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD,2XS-SPO9F]N=#X-"B`@(`T*("`@ M("`@("`@("`@("`\+W1D/@T*(`T*("`@("`@("`@("`@("`\=&0@;F]W6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)TQ)3D4M2$5) M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO8VL[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS M1&QE9G0^#0H@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@ M("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S@R,3$[/"]F;VYT/@T*("`@(`T*("`@("`@ M("`@("`@("`\+W1D/@T*(`T*("`@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X- M"B`-"B`@("`@("`@("`@(#PO='(^#0H@("`@#0H@("`@("`@("`@("`\='(@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY697-T960\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`@("`@/"]D:78^#0H@("`@#0H@("`@("`@("`@ M("`@(#PO=&0^#0H@#0H@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*(`T*("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH."PS,S8\+V9O;G0^#0H@("`@ M#0H@("`@("`@("`@("`@(#PO=&0^#0H@#0H@("`@("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`- M"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)TQ) M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@ M8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A M;&EG;CTS1&QE9G0^#0H@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`@(`T*("`@("`@("`@ M("`@("`@("`@/&9O;G0@6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@("`@ M("`@/'1D(&%L:6=N/3-$"<^#0H@("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^#0H@("`-"B`@("`@("`@("`@("`@/"]T9#X-"B`-"B`@("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!S='EL93TS M1"=415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@ M("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXQ+C,W/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]T M9#X-"B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T.#'0O M:'1M;#L@8VAA'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA&-E<'0@4&5R(%-H87)E(&1A=&$L('5N;&5S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\T.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$ M971A:6PI("T@06YT:61I;'5T:79E(%-E8W5R:71I97,@17AC;'5D960@1G)O M;2!T:&4@1&EL=71I=F4@0V%L8W5L871I;VYS/&)R/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA65E(%-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^,B!Y96%R6UE;G0@ M07=A'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$65E(%-E'1087)T7S0X-S)F860V7V-B-C9?-&4V-%]A.&(Q7SAB.3`X960S9#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\T.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M2!42!(96%L=&@@4V-I96YC97,@3$Q#(%M-96UB97)=+"!54T0@)"D\ M8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L M6%L='D@4F%T93PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S6%L='D@17AP96YS M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!2871E/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC M&UL/@T*+2TM+2TM M/5].97AT4&%R=%\T.# XML 15 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 1 - Nature of Operations and Basis of Presentation
3 Months Ended
Mar. 31, 2013
Business Description and Basis of Presentation [Text Block]
1.
NATURE OF OPERATIONS AND BASIS OF PRESENTATION

Nature of Operations

Natural Health Trends Corp. (the “Company”), a Delaware corporation, is an international direct-selling and e-commerce company headquartered in Dallas, Texas.  Subsidiaries controlled by the Company sell personal care, wellness, and “quality of life” products under the “NHT Global” brand.  In most markets, we sell our products to an independent member network that either uses the products themselves or resells them to consumers.

Our majority-owned subsidiaries have an active physical presence in the following markets:  North America; Greater China, which consists of Hong Kong, Taiwan and China; Russia; South Korea; Japan; and Europe, which consists of Italy and Slovenia.

Basis of Presentation

The unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  As a result, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.  In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial information for the interim periods presented.  The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year.  These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our 2012 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (SEC) on March 12, 2013.

XML 16 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (Unaudited) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Dec. 31, 2012
ASSETS    
Cash and cash equivalents $ 5,173 $ 4,207
Accounts receivable 179 122
Inventories, net 888 867
Other current assets 406 641
Total current assets 6,646 5,837
Property and equipment, net 123 121
Goodwill 1,764 1,764
Restricted cash 231 239
Other assets 255 258
Total assets 9,019 8,219
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Accounts payable 1,811 1,385
Income taxes payable 22 10
Accrued distributor commissions 1,512 1,308
Other accrued expenses 1,403 1,688
Deferred revenue 1,136 836
Deferred tax liability 92 92
Other current liabilities 856 991
Total current liabilities 6,832 6,310
Commitments and contingencies 0 0
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 1,761,900 shares designated Series A convertible preferred stock, 138,400 shares issued and outstanding at December 31, 2012 and March 31, 2013, aggregate liquidation value of $333 124 124
Common stock, $0.001 par value; 50,000,000 shares authorized; 11,324,048 and 11,323,369 shares issued and outstanding at December 31, 2012 and March 31, 2013, respectively 11 11
Additional paid-in capital 80,603 80,584
Accumulated deficit (78,421) (78,708)
Foreign currency translation adjustments (130) (102)
Total stockholders’ equity 2,187 1,909
Total liabilities and stockholders’ equity $ 9,019 $ 8,219
XML 17 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Comprehensive Income (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Net income $ 287 $ 507
Other comprehensive income (loss), net of tax:    
Foreign currency translation adjustment (28) 51
Comprehensive income $ 259 $ 558
XML 18 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 4 - Contingencies (Detail)
Mar. 31, 2013
USD ($)
Dec. 31, 2012
USD ($)
Nov. 18, 2007
Not Deemed Registrable Securities [Member]
Seven Year Warrants [Member]
Mar. 31, 2013
Korean Business Segment [Member]
USD ($)
Mar. 31, 2013
Korean Business Segment [Member]
KRW
Oct. 31, 2010
Seven Year Warrants [Member]
Oct. 31, 2007
Seven Year Warrants [Member]
USD ($)
Oct. 31, 2010
One Year Warrants [Member]
Other Assets, Noncurrent (in Won) $ 255,000 $ 258,000   $ 91,000 100,000,000      
Other Assets, Noncurrent (in Dollars) 255,000 258,000   91,000 100,000,000      
Convertible Debt (in Dollars)             $ 4,250,000  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 3,704,854   1,495,952     1,495,952   1,495,952
XML 19 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 6 - Subsequent Events (Detail)
0 Months Ended
Mar. 31, 2013
Apr. 10, 2013
Subsequent Event [Member]
Preferred Class A [Member]
Apr. 21, 2013
Subsequent Event [Member]
Apr. 04, 2013
Subsequent Event [Member]
Conversion of Stock, Shares Issued   14,707    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 3,704,854   149,595 2,059,307
XML 20 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 21 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 287 $ 507
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 12 12
Stock-based compensation 30 20
Accounts receivable (59) (240)
Inventories, net (28) 95
Other current assets 232 (102)
Other assets (2) 3
Accounts payable 428 (213)
Income taxes payable 12 11
Accrued distributor commissions 215 78
Other accrued expenses (279) 306
Deferred revenue 304 359
Other current liabilities (134) 24
Net cash provided by operating activities 1,018 860
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment, net (14) (18)
Decrease in restricted cash   247
Net cash provided by (used in) investing activities (14) 229
CASH FLOWS FROM FINANCING ACTIVITIES    
Repurchase of common stock (12)  
Net cash used in financing activities (12)  
Effect of exchange rates on cash and cash equivalents (26) 52
Net increase in cash and cash equivalents 966 1,141
CASH AND CASH EQUIVALENTS, beginning of period 4,207 1,617
CASH AND CASH EQUIVALENTS, end of period $ 5,173 $ 2,758
XML 22 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $)
In Thousands, except Share data, unless otherwise specified
Mar. 31, 2013
Dec. 31, 2012
Preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, aggregate liquidation value (in Dollars) $ 333  
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 50,000,000 50,000,000
Common stock, shares issued 11,326,323 11,324,048
Common stock, shares outstanding 11,326,323 11,324,048
Total [Member]
   
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares designated Series A convertible preferred stock 5,000,000 5,000,000
Series A Convertible Preferred Stock [Member]
   
Preferred stock, shares authorized 1,761,900 1,761,900
Preferred stock, shares designated Series A convertible preferred stock 1,761,900 1,761,900
Preferred stock, shares issued 138,400 138,400
Preferred stock, shares outstanding 138,400 138,400
XML 23 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 2 - Summary of Significant Accounting Policies (Detail)
Mar. 31, 2013
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares) 3,704,854
XML 24 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document And Entity Information
3 Months Ended
Mar. 31, 2013
Apr. 30, 2013
Document and Entity Information [Abstract]    
Entity Registrant Name NATURAL HEALTH TRENDS CORP  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   11,335,276
Amendment Flag false  
Entity Central Index Key 0000912061  
Entity Current Reporting Status No  
Entity Voluntary Filers No  
Entity Filer Category Smaller Reporting Company  
Entity Well-known Seasoned Issuer No  
Document Period End Date Mar. 31, 2013  
Document Fiscal Year Focus 2013  
Document Fiscal Period Focus Q1  
XML 25 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 2 - Summary of Significant Accounting Policies (Detail) - Basic and Diluted Income Per Share (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Net income available to common stockholders (in Dollars) $ 283 $ 503
Net income available to common stockholders 11,069 10,863
Net income available to common stockholders (in Dollars per share) $ 0.03 $ 0.05
Effect of dilutive securities:    
Non-vested restricted stock 179 318
Net income available to common stockholders plus assumed conversions (in Dollars) $ 283 $ 503
Net income available to common stockholders plus assumed conversions 11,248 11,181
Net income available to common stockholders plus assumed conversions (in Dollars per share) $ 0.03 $ 0.04
XML 26 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Net sales $ 8,651 $ 9,090
Cost of sales 2,228 2,399
Gross profit 6,423 6,691
Operating expenses:    
Distributor commissions 3,674 3,691
Selling, general and administrative expenses (including stock-based compensation expense of $20 and $30 during the three months ended March 31, 2012 and 2013, respectively) 2,445 2,437
Depreciation and amortization 12 12
Total operating expenses 6,131 6,140
Income from operations 292 551
Other income (expense), net 7 (63)
Income before income taxes 299 488
Income tax provision (benefit) 12 (19)
Net income 287 507
Preferred stock dividends (4) (4)
Net income available to common stockholders $ 283 $ 503
Income per share:    
Basic (in Dollars per share) $ 0.03 $ 0.05
Diluted (in Dollars per share) $ 0.03 $ 0.04
Weighted-average number of shares outstanding:    
Basic (in Shares) 11,069 10,863
Diluted (in Shares) 11,248 11,181
XML 27 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 5 - Related Party Transactions
3 Months Ended
Mar. 31, 2013
Related Party Transactions Disclosure [Text Block]
5.
RELATED PARTY TRANSACTIONS

In February 2013, the Company entered into a Royalty Agreement and License with Broady Health Sciences, L.L.C. (“BHS”) regarding the manufacture and sale of a new product called Restor™.  Under this agreement, the Company has agreed to pay BHS a royalty of 2.5% of sales revenue for this product for 2011 and subsequent years in return for the right to manufacture (or have manufactured), market, import, export and sell this product worldwide, with certain rights being exclusive outside the United States.  George Broady, a director of the Company and owner of more than 5% of its outstanding common stock, is owner of BHS, a Texas limited liability company.  During 2011 and 2012, BHS permitted the Company to manufacture (or have manufactured), market and sell the Restor™ product.  In April 2012, the Company reimbursed BHS $42,000 in expenses incurred in 2011 to promote the Restor™ product on the Company’s behalf.  To permit the Company to continue selling Restor™ and obtain certain exclusive rights outside of the United States, BHS requested that the Company enter into the Royalty Agreement and License.  This agreement was reviewed, considered, authorized and approved by the sole disinterested, non-employee member of the Board of Directors under appointment by the full Board of Directors as an ad hoc committee for this purpose.  Upon signing this agreement, the Company paid BHS $12,000 and $25,000 as royalties for 2011 and 2012, respectively.  Royalties accrued, but unpaid for the first three months of 2013 are approximately $7,000.  The Company is not required to purchase any product under the agreement, and the agreement may be terminated at any time on 120 days’ notice or, under certain circumstances, with no notice.

The Company is considering entering into another royalty agreement and license with BHS regarding the manufacture and sale of a new product called Soothe™, which the Company began selling in the fourth quarter of 2012 with the permission of BHS.  To continue selling this product, BHS has requested that the Company pay a royalty of 2.5% of sales revenue for 2012 and subsequent years.  The Company is considering that proposal and discussing the terms of a definitive agreement.  At a royalty of 2.5% of net sales, the Company calculates that royalties for 2012 and the first three months of 2013 would total approximately $2,400.

XML 28 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 4 - Contingencies
3 Months Ended
Mar. 31, 2013
Commitments and Contingencies Disclosure [Text Block]
4. 
CONTINGENCIES

Consumer Indemnity

As required by the Door-to-Door Sales Act in South Korea, the Company maintains insurance for consumer indemnity claims with a mutual aid cooperative by possessing a mutual aid contract with Mutual Aid Cooperative & Consumer (the “Cooperative”).  The contract secures payment to distributors in the event that the Company is unable to provide refunds to distributors.  Typically, requests for refunds are paid directly by the Company according to the Company’s normal Korean refund policy, which requires that refund requests be submitted within three months.  Accordingly, the Company estimates and accrues a reserve for product returns based on this policy and its historical experience.  Depending on the sales volume, the Company may be required to increase or decrease the amount of the contract.  The maximum potential amount of future payments the Company could be required to make to address actual distributor claims under the contract is equivalent to three months of rolling sales.  At March 31, 2013, non-current other assets include KRW 100 million (USD $91,000) underlying the contract, which can be utilized by the Cooperative to fund any outstanding distributor claims.  The Company believes that the likelihood of utilizing these funds to provide for distributors claims is remote.

Registration Payment Arrangements

Pursuant to the agreement with the investors in the Company’s October 2007 financing of variable rate convertible debentures having an aggregate face amount of $4,250,000, seven-year warrants to purchase 1,495,952 shares of the Company’s common stock, and one-year warrants to purchase 1,495,952 shares of the Company’s common stock, the Company was obligated to (i) file a registration statement covering the resale of the maximum number of Registrable Securities (as defined) that is permitted by SEC Guidance (as defined) prior to November 18, 2007, (ii) cause the registration statement to be declared effective within certain specified periods of time and (iii) maintain the effectiveness of the registration statement until all Registrable Securities have been sold, or may be sold without volume restrictions pursuant to Rule 144(k) under the Securities Act.  The Company timely filed that registration statement covering the shares of common stock underlying the debentures, which have been redeemed, and the one-year warrants, which have expired.  At the time, the 1,495,952 shares of common stock underlying the seven-year warrants were not deemed Registrable Securities and were not included in the Registration Statement.  If they are subsequently deemed Registrable Securities and we fail to file a new registration statement covering them, then the warrants may be exercised by means of a cashless exercise. The maximum number of shares that could be required to be issued upon exercise of the warrants (whether on a cashless basis or otherwise) is limited to the number of shares indicated on the face of the warrants.  As of March 31, 2013, no contingent obligations have been recognized under registration payment arrangements.

XML 29 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 5 - Related Party Transactions (Detail) (Broady Health Sciences LLC [Member], USD $)
1 Months Ended 3 Months Ended 12 Months Ended
Apr. 30, 2012
Mar. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Jun. 30, 2012
Royalty Rate     2.50% 2.50%  
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners         5.00%
Related Party Transaction, Expenses from Transactions with Related Party $ 42,000        
Royalty Expense   2,400 25,000 25,000  
Accrued Royalties   $ 7,000      
Net Sales [Member]
         
Royalty Rate     2.50%    
XML 30 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 2 - Summary of Significant Accounting Policies (Detail) - Antidilutive Securities Excluded From the Dilutive Calculations
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Antidilutive Securities 179,000 318,000
Warrant [Member]
   
Antidilutive Securities 3,704,854 3,704,854
Restricted Stock [Member]
   
Antidilutive Securities 98,607  
Convertible Preferred Stock Antidilutive [Member]
   
Antidilutive Securities 138,400 138,400
XML 31 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 2 - Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2013
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   
Three Months Ended March 31,
 
   
2012
   
2013
 
   
Income
(Numerator)
   
Shares
(Denominator)
   
Per Share Amount
   
Income
(Numerator)
   
Shares
(Denominator)
   
Per Share Amount
 
Basic EPS:
                                   
Net income available to common stockholders
    $503       10,863       $0.05       $283       11,069       $0.03  
                                                 
Effect of dilutive securities:
                                               
Non-vested restricted stock
            318                       179          
                                                 
Diluted EPS:
                                               
Net income available to common stockholders plus assumed conversions
    $503       11,181       $0.04       $283       11,248       $0.03  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
   
Three Months Ended March 31,
 
   
2012
   
2013
 
             
Warrants to purchase common stock
    3,704,854       3,704,854  
Non-vested restricted stock
          98,607  
Convertible preferred stock
    138,400       138,400  
XML 32 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 6 - Subsequent Events
3 Months Ended
Mar. 31, 2013
Subsequent Events [Text Block]
6.
SUBSEQUENT EVENTS

On April 10, 2013, 14,707 shares of the Company’s Series A preferred stock were converted into an equal number of shares of common stock.

On April 21, 2013, warrants issued to the placement agent in an October 2007 convertible debentures financing representing the right to purchase 149,595 shares of the Company’s common stock expired unexercised.  On May 4, 2013, warrants issued by the Company in a May 2007 private equity placement representing the right to purchase 2,059,307 shares of common stock expired unexercised.

XML 33 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Accounting Policies, by Policy (Policies)
3 Months Ended
Mar. 31, 2013
Consolidation, Policy [Policy Text Block]
Principles of Consolidation

The consolidated financial statements include the accounts of the Company and all of its majority-owned subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]
Use of Estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period.

The most significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates associated with obsolete inventory and the fair value of acquired intangible assets, including goodwill, as well as those used in the determination of liabilities related to sales returns and income taxes.  Various assumptions and other factors prompt the determination of these significant estimates.  The process of determining significant estimates is fact specific and takes into account historical experience and current and expected economic conditions.  The actual results may differ materially and adversely from the Company’s estimates.  To the extent that there are material differences between the estimates and actual results, future results of operations will be affected.
Income Tax, Policy [Policy Text Block]
Income Taxes

The Company recognizes income taxes under the liability method of accounting for income taxes.  Deferred income taxes are recognized for differences between the financial reporting and tax bases of assets and liabilities at enacted statutory tax rates in effect for the years in which the differences are expected to reverse.  Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized.  The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution.  The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense.  Deferred taxes are not provided on the portion of undistributed earnings of subsidiaries outside of the United States when these earnings are considered permanently reinvested. 

The Company and its subsidiaries file income tax returns in the United States, various states, and foreign jurisdictions.  The Company is no longer subject to U.S. federal income tax examinations for years prior to 2009, and is no longer subject to state income tax examinations for years prior to 2008.  No jurisdictions are currently examining any income tax returns of the Company or its subsidiaries.
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair Value of Financial Instruments

The carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value because of their short maturities.  The carrying amount of the noncurrent restricted cash approximates fair value since, absent the restrictions, the underlying assets would be included in cash and cash equivalents.

Accounting standards permit companies, at their option, to choose to measure many financial instruments and certain other items at fair value.  The Company has elected to not fair value existing eligible items.
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition

Product sales are recorded when the products are shipped and title passes to independent distributors.  Product sales to distributors are made pursuant to a distributor agreement that provides for transfer of both title and risk of loss upon our delivery to the carrier that completes delivery to the distributors, which is commonly referred to as “F.O.B. Shipping Point.”  The Company primarily receives payment by credit card at the time distributors place orders.  Amounts received for unshipped product are recorded as deferred revenue.  The Company’s sales arrangements do not contain right of inspection or customer acceptance provisions other than general rights of return.

Actual product returns are recorded as a reduction to net sales.  The Company estimates and accrues a reserve for product returns based on its return policies and historical experience.

Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized over the term of the arrangement, generally twelve months.  Enrollment packages provide distributors access to both a personalized marketing website and a business management system.  No upfront costs are deferred as the amount is nominal.

Shipping charges billed to distributors are included in net sales.  Costs associated with shipments are included in cost of sales.

Various taxes on the sale of products and enrollment packages to distributors are collected by the Company as an agent and remitted to the respective taxing authority.  These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority.
Earnings Per Share, Policy [Policy Text Block]
Income Per Share

Basic income per share is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding during the period.  Diluted income per share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of non-vested restricted stock and shares that might be issued upon the exercise of outstanding warrants and the conversion of preferred stock.

The dilutive effect of non-vested restricted stock and warrants is reflected by application of the treasury stock method.  Under the treasury stock method, the amount of compensation cost for future service that the Company has not yet recognized and the amount of tax benefit that would be recorded in additional paid-in capital when the award becomes deductible are assumed to be used to repurchase shares.

The following tables illustrate the computation of basic and diluted income per share for the periods indicated (in thousands, except per share data):

   
Three Months Ended March 31,
 
   
2012
   
2013
 
   
Income
(Numerator)
   
Shares
(Denominator)
   
Per Share Amount
   
Income
(Numerator)
   
Shares
(Denominator)
   
Per Share Amount
 
Basic EPS:
                                   
Net income available to common stockholders
    $503       10,863       $0.05       $283       11,069       $0.03  
                                                 
Effect of dilutive securities:
                                               
Non-vested restricted stock
            318                       179          
                                                 
Diluted EPS:
                                               
Net income available to common stockholders plus assumed conversions
    $503       11,181       $0.04       $283       11,248       $0.03  

Certain non-vested restricted stock is anti-dilutive upon applying the treasury stock method since the amount of compensation cost for future service results in the hypothetical repurchase of shares exceeding the actual number of shares to be vested.  Other common stock equivalents are also anti-dilutive since the average market price of the related common stock for the period exceeds the exercise price.

The following securities were not included for the time periods indicated as their effect would have been anti-dilutive:

   
Three Months Ended March 31,
 
   
2012
   
2013
 
             
Warrants to purchase common stock
    3,704,854       3,704,854  
Non-vested restricted stock
          98,607  
Convertible preferred stock
    138,400       138,400  

Warrants to purchase 3,704,854 shares of common stock were still outstanding at March 31, 2013.  Such warrants have expirations through April 21, 2015
New Accounting Pronouncements, Policy [Policy Text Block]
Recently Issued and Adopted Accounting Pronouncements

In February 2013, the FASB issued Accounting Standards Update ("ASU") No. 2013-02, Comprehensive Income (Topic 220) —Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, to require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component.  In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items in net income but only if the amount reclassified is required under U.S. generally accepted accounting principles ("GAAP") to be reclassified to net income in its entirety in the same reporting period.  For other amounts that are not required under U.S. GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under U.S. GAAP that provide additional detail about those amounts.  ASU 2013-02 is effective prospectively for reporting periods, including interim periods, beginning after December 15, 2012.  The Company’s adoption of the standard on January 1, 2013 did not have a material impact on its consolidated financial statements.

In March 2013, the FASB issued ASU No. 2013-05, Foreign Currency Matters (Topic 830) —Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity, to clarify the guidance for entities that cease to hold a controlling financial interest in a subsidiary or group of assets within a foreign entity when (1) the subsidiary or group of assets is a nonprofit activity or a business (other than a sale of in substance real estate or conveyance of oil and gas mineral rights) and (2) there is a cumulative translation adjustment balance associated with that foreign entity.  ASU 2013-05 is effective prospectively for reporting periods, including interim periods, beginning after December 15, 2013.  Early adoption is permitted.  The Company is currently evaluating the impact of adopting ASU 2013-05.

Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company’s present or future financial statements.
XML 34 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 3 - Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2013
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
   
 
Shares
   
Wtd. Avg.
Grant-Date
Fair Value
 
       
Nonvested at December 31, 2012
    261,658       $0.37  
Granted
           
Vested
    (51,668 )     0.37  
Forfeited
           
Nonvested at March 31, 2013
    209,990       0.37  
   
 
Shares
   
Wtd. Avg.
Grant-Date
Fair Value
 
       
Nonvested at December 31, 2012
    100,000       $1.37  
Granted
           
Vested
    (8,336 )     1.37  
Forfeited
           
Nonvested at March 31, 2013
    91,664       1.37  
XML 35 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 3 - Stock-Based Compensation (Detail) - Restricted Stock Activity (USD $)
3 Months Ended
Mar. 31, 2013
Restricted Stock [Member]
 
Shares 261,658
Wtd. Ave. Grant-Date Fair Value (in Dollars per share) $ 0.37
Shares 209,990
Wtd. Ave. Grant-Date Fair Value (in Dollars per share) $ 0.37
Shares 0
Wtd. Ave. Grant-Date Fair Value (in Dollars per share) $ 0
Shares (51,668)
Wtd. Ave. Grant-Date Fair Value (in Dollars per share) $ 0.37
Shares 0
Wtd. Ave. Grant-Date Fair Value (in Dollars per share) $ 0
Performance Shares [Member]
 
Shares 100,000
Wtd. Ave. Grant-Date Fair Value (in Dollars per share) $ 1.37
Shares 91,664
Wtd. Ave. Grant-Date Fair Value (in Dollars per share) $ 1.37
Shares (8,336)
Wtd. Ave. Grant-Date Fair Value (in Dollars per share) $ 1.37
XML 36 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Operations (Unaudited) (Parentheticals) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Stock-based compensation expense included in selling, general, and administrative expense $ 30 $ 20
XML 37 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 3 - Stock-Based Compensation
3 Months Ended
Mar. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
3.
STOCK-BASED COMPENSATION

Stock-based compensation expense totaled approximately $20,000 and $30,000 for the three months ended March 31, 2012 and 2013, respectively.  No tax benefits were attributed to the stock-based compensation because a valuation allowance was maintained for substantially all net deferred tax assets.

The following table summarizes the Company’s restricted stock activity:

   
 
Shares
   
Wtd. Avg.
Grant-Date
Fair Value
 
       
Nonvested at December 31, 2012
    261,658       $0.37  
Granted
           
Vested
    (51,668 )     0.37  
Forfeited
           
Nonvested at March 31, 2013
    209,990       0.37  

As of March 31, 2013, total unrecognized stock-based compensation expense related to non-vested restricted stock was approximately $79,000, which is expected to be recognized over a weighted-average period of 1.0 year.

On August 13, 2012, the Company’s Board of Directors authorized the Company, acting as trustee for certain of its non-officer, overseas employees, to execute a Rule 10b5-1 plan to purchase 100,000 shares of its common stock in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934 and the Company's policies regarding stock transactions.  The employees will receive the stock as incentive compensation in quarterly increments over three years beginning March 15, 2013, provided that they are employees of the Company on the date of the distribution.  The following table summarizes this stock award activity:

   
 
Shares
   
Wtd. Avg.
Grant-Date
Fair Value
 
       
Nonvested at December 31, 2012
    100,000       $1.37  
Granted
           
Vested
    (8,336 )     1.37  
Forfeited
           
Nonvested at March 31, 2013
    91,664       1.37  

As of March 31, 2013, total unrecognized stock-based compensation expense related to these stock awards was approximately $111,000, which is expected to be recognized over a weighted-average period of 2.7 years.

XML 38 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 39 127 1 false 15 0 false 5 false false R1.htm 000 - Disclosure - Document And Entity Information Sheet http://naturalhealthtrendscorp.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 001 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://naturalhealthtrendscorp.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets (Unaudited) false false R3.htm 002 - Statement - Consolidated Balance Sheets (Unaudited) (Parentheticals) Sheet http://naturalhealthtrendscorp.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Unaudited) (Parentheticals) false false R4.htm 003 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://naturalhealthtrendscorp.com/role/ConsolidatedIncomeStatement Consolidated Statements of Operations (Unaudited) false false R5.htm 004 - Statement - Consolidated Statements of Operations (Unaudited) (Parentheticals) Sheet http://naturalhealthtrendscorp.com/role/ConsolidatedIncomeStatement_Parentheticals Consolidated Statements of Operations (Unaudited) (Parentheticals) false false R6.htm 005 - Statement - Consolidated Statements of Comprehensive Income (Unaudited) Sheet http://naturalhealthtrendscorp.com/role/ConsolidatedComprehensiveIncome Consolidated Statements of Comprehensive Income (Unaudited) false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://naturalhealthtrendscorp.com/role/ConsolidatedCashFlow Consolidated Statements of Cash Flows (Unaudited) false false R8.htm 007 - Disclosure - Note 1 - Nature of Operations and Basis of Presentation Sheet http://naturalhealthtrendscorp.com/role/Note Note 1 - Nature of Operations and Basis of Presentation false false R9.htm 008 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://naturalhealthtrendscorp.com/role/Note0 Note 2 - Summary of Significant Accounting Policies false false R10.htm 009 - Disclosure - Note 3 - Stock-Based Compensation Sheet http://naturalhealthtrendscorp.com/role/Note00 Note 3 - Stock-Based Compensation false false R11.htm 010 - Disclosure - Note 4 - Contingencies Sheet http://naturalhealthtrendscorp.com/role/Note000 Note 4 - Contingencies false false R12.htm 011 - Disclosure - Note 5 - Related Party Transactions Sheet http://naturalhealthtrendscorp.com/role/Note0000 Note 5 - Related Party Transactions false false R13.htm 012 - Disclosure - Note 6 - Subsequent Events Sheet http://naturalhealthtrendscorp.com/role/Note00000 Note 6 - Subsequent Events false false R14.htm 013 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://naturalhealthtrendscorp.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) false false R15.htm 014 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://naturalhealthtrendscorp.com/role/NoteTables Note 2 - Summary of Significant Accounting Policies (Tables) false false R16.htm 015 - Disclosure - Note 3 - Stock-Based Compensation (Tables) Sheet http://naturalhealthtrendscorp.com/role/NoteTables0 Note 3 - Stock-Based Compensation (Tables) false false R17.htm 017 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Detail) Sheet http://naturalhealthtrendscorp.com/role/NoteDetail0 Note 2 - Summary of Significant Accounting Policies (Detail) false false R18.htm 018 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Detail) - Basic and Diluted Income Per Share Sheet http://naturalhealthtrendscorp.com/role/BasicandDilutedIncomePerShareTable Note 2 - Summary of Significant Accounting Policies (Detail) - Basic and Diluted Income Per Share false false R19.htm 019 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Detail) - Antidilutive Securities Excluded From the Dilutive Calculations Sheet http://naturalhealthtrendscorp.com/role/AntidilutiveSecuritiesExcludedFromtheDilutiveCalculationsTable Note 2 - Summary of Significant Accounting Policies (Detail) - Antidilutive Securities Excluded From the Dilutive Calculations false false R20.htm 020 - Disclosure - Note 3 - Stock-Based Compensation (Detail) Sheet http://naturalhealthtrendscorp.com/role/NoteDetail00 Note 3 - Stock-Based Compensation (Detail) false false R21.htm 021 - Disclosure - Note 3 - Stock-Based Compensation (Detail) - Restricted Stock Activity Sheet http://naturalhealthtrendscorp.com/role/RestrictedStockActivityTable Note 3 - Stock-Based Compensation (Detail) - Restricted Stock Activity false false R22.htm 022 - Disclosure - Note 4 - Contingencies (Detail) Sheet http://naturalhealthtrendscorp.com/role/NoteDetail000 Note 4 - Contingencies (Detail) false false R23.htm 023 - Disclosure - Note 5 - Related Party Transactions (Detail) Sheet http://naturalhealthtrendscorp.com/role/NoteDetail0000 Note 5 - Related Party Transactions (Detail) false false R24.htm 024 - Disclosure - Note 6 - Subsequent Events (Detail) Sheet http://naturalhealthtrendscorp.com/role/NoteDetail00000 Note 6 - Subsequent Events (Detail) false false All Reports Book All Reports Element us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount had a mix of decimals attribute values: -3 0. Element us-gaap_OtherAssetsNoncurrent had a mix of decimals attribute values: -6 -3 0. Process Flow-Through: 001 - Statement - Consolidated Balance Sheets (Unaudited) Process Flow-Through: Removing column 'Mar. 31, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 002 - Statement - Consolidated Balance Sheets (Unaudited) (Parentheticals) Process Flow-Through: 003 - Statement - Consolidated Statements of Operations (Unaudited) Process Flow-Through: 004 - Statement - Consolidated Statements of Operations (Unaudited) (Parentheticals) Process Flow-Through: 005 - Statement - Consolidated Statements of Comprehensive Income (Unaudited) Process Flow-Through: 006 - Statement - Consolidated Statements of Cash Flows (Unaudited) nhtcpk-20130331.xml nhtcpk-20130331.xsd nhtcpk-20130331_cal.xml nhtcpk-20130331_def.xml nhtcpk-20130331_lab.xml nhtcpk-20130331_pre.xml true true XML 39 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 3 - Stock-Based Compensation (Detail) (USD $)
0 Months Ended 3 Months Ended
Aug. 13, 2012
Mar. 31, 2013
Mar. 31, 2012
Allocated Share-based Compensation Expense   $ 30,000 $ 20,000
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense   0 0
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized   111,000  
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition   2 years 255 days  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares) 100,000    
Restricted Stock [Member]
     
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized     $ 79,000
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition   1 year